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i
introduction
“Not everything that can be counted counts, and not everything that counts can be counted”
Albert Einstein
Measurements are essential in medical practice. Throughout their training, doctors are 
taught the adage “meten is weten” (the knowledge is in the numbers). In this thesis we 
explore this theorem within the field of paediatrics by investigating four specific aspects 
of measurements: what it is a certain measurement actually measures (validity); how 
precise the measurement is (accuracy, reliability); the degree of variation between the 
individuals performing the measurement (intraobserver and interobserver agreement); 
and why we should perform the measurement in the first place (utility).
While measurements can take place at two different levels – either for diagnostic 
purposes or to evaluate a treatment effect – the studies in this thesis mainly focus on 
diagnostic measurements. For such diagnostic measurements to be useful, they should 
have sufficient validity, reliability and utility. Although this may be self-evident, many 
diagnostic measurements are either incompletely validated or not at all, and reliability is 
hardly ever perfect. As a result, each and every measurement in medicine is surrounded 
by a certain degree of uncertainty. Not only is uncertainty around measurements dif-
ficult to explain to patients – and in paediatrics to their parents – but doctors also tend 
to be uncomfortable admitting uncertainty to themselves.1,2
When making a diagnosis, the most important instruments at a physician’s disposal 
are taking the patient’s history and performing a physical examination. Nevertheless, 
when after a thorough history taking and physical examination, uncertainty around a 
diagnosis remains, a physician will often perform additional testing, which is sometimes 
excessive and not indicated. The choice of additional tests and the extent to which phy-
sicians order them varies considerably, depending on experience and specific knowl-
edge, as well as on personal characteristics and self-confidence. Throughout the history 
of medicine, tradition and training have generated many myths, which may prompt 
physicians to perform unnecessary testing based on rationalisations such as “We always 
do it this way” or “I was taught to…”.3 Another conventional justification for ordering 
diagnostic testing is providing reassurance to the patient, which is doubtful in patients 
with a low probability of serious disease.4,5
This thesis addresses a number of diagnostic measurements commonly performed in 
different areas of paediatric practice, thereby emphasising that – apart from additional 
tests – every part of the history taking and physical examination can be viewed as a 
diagnostic test.6 We attempt to provide answers to questions regarding the validity and 
reliability of the measurement, the variability within and between users, and whether the 
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measurement is useful in improving patient care. This introductory chapter first discusses 
the general aspects of uncertainty in medicine. This is followed by a brief explanation of 
the methodological issues concerning diagnostic research and the clinimetric evaluation 
of measurements, and the way in which evidence-based medicine may help doctors to 
deal with this feeling of uncertainty. Finally, in the outline of the thesis, we provide back-
ground information concerning the different areas in which our questions were explored.
uncertainty in medicine
“Medicine is a science of uncertainty and an art of probability”
William Osler
In general, people dislike ambiguity and try to avoid risks and uncertainty. When pa-
tients consult a doctor, they expect their doctor to give clear and unequivocal advice.7 
However, although medicine strives to be a rigorous science, uncertainty is inherent in 
medical practice. “The only thing certain about ambiguity is that it is a fixed part of medi-
cine”.7 For example, it is hard to explain to patients that a positive test result does not 
always confirm the presence of the disease and that – on the other hand – a negative 
test result does not rule out the possibility that one might still have the disease. Few di-
agnostic measurements have been rigorously studied and even if they have, diagnostic 
tests seldom show perfect accuracy. Most of the time, therefore, we cannot give patients 
(or ourselves!) clear-cut answers, and 100% certainty is seldom obtained.
Physicians have to deal with a wide range of diagnostic uncertainties: “Does this 
patient have disease X?”, “How can I be sure my diagnosis is correct?”, “To what risk am 
I exposing my patient by performing this invasive diagnostic test?” One of the ways 
physicians deal with diagnostic uncertainties is by performing additional tests or by 
combining data from history and physical examination in scores or scales, as if quantita-
tive results from a computer, machine or calculation yield a higher level of certainty. 
However, normal results may give false reassurance and there is no absolute guarantee 
that a result, positive or negative, is correct.
There is increasing awareness that excessive testing and procedures are a problem, re-
sulting in increased cost and sometimes harm to the patient.8,9 In the USA, the American 
Board of Internal Medicine Foundation recently started the Choosing Wisely campaign, 
an initiative set up to reduce waste and overuse in healthcare. Since the campaign was 
launched in 2012, more than 130 tests and procedures have been called into question 
by 25 medical specialty societies (www.choosingwisely.org).
The awareness of the potentially harmful effects of additional diagnostic measurements 
is also increasing in the Netherlands. A number of recent papers in Medisch Contact, the 
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journal of the Royal Netherlands Medical Society (KNMG), introduced the term “VOMIT” 
– Victim Of Modern Imaging Technology – to describe patients who had undergone a 
radiological investigation (judged to be uncalled for in retrospect), that led to further 
unnecessary investigations and even to unnecessary surgery or treatment.10,11,12,13
evidence-Based medicine
“The process of diagnosis is complex and poses many challenges to practicing clinicians,
attempting to practice in an evidence based manner”
Strauss 200614
Evidence-based medicine (EBM) is one of the ways of dealing with uncertainties in medi-
cal practice. EBM as defined by Sackett is “The integration of best research evidence with 
clinical expertise and patient values” (Figure 1).15 The development of EBM has been a ma-
jor advance in healthcare and it can help when making choices in healthcare. Moreover, 
EBM provides several ways of quantifying and communicating uncertainty. However, 
most of the available evidence comes from studies done in the domain of therapy. Since 
the evaluation of most diagnostic tests is often far less rigorous than that of new drugs, 
evidence-based decision making in the diagnostic area remains a challenging task for 
practising physicians.16 Apart from the need to investigate new diagnostic tests, it is strik-






















figure 1. Principles of evidence-based medicine, showing the five steps
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Since 2005, the paediatricians at Isala, a teaching hospital in Zwolle, a city with about 
120.000 citizens have been implementing evidence-based practice, which includes a 
weekly EBM meeting during which a critically appraised topic is presented and dis-
cussed. The questions explored in this thesis were raised during these EBM meetings. 
For example, in cases where the conclusion of a critically appraised topic was that there 
was “absence of evidence”, we would formulate a research question that was suitable for 
investigation in our own patient population. Although the medical topics addressed in 
this thesis are not necessarily either cutting-edge or new, they all originated from our 
own paediatric practice, emphasising the clinical relevance.
diagnostic and clinimetric research
“Much effort is directed towards optimising doctor-patient communication and avoiding mis-
understandings. The language of everyday diagnostic reasoning as it routinely occurs among 
doctors in teaching hospitals could benefit from similar attention”
Matt Bianchi17
Making a diagnosis involves balancing evidence. Several differential diagnoses may 
have to be considered and it is seldom for the final diagnosis to rely entirely on a single 
test.7,14 Moreover, it is important to realise that apart from laboratory tests, radiology and 
other diagnostic tests, all patient features and thus all elements of the clinical history 
and physical examination qualify as diagnostic tests.6 As a result, evaluating the value of 
diagnostic tests or measurements is complex. Moreover, it can be addressed in different 
ways, depending on the nature of the diagnostic research question.15 The fact that the 
field of diagnostic research is developing strongly and that international consensus on 
the methods for assessing diagnostic tests is lacking16,18,19 further increases the complex-
ity of this part of clinical decision making.
There are various ways to look at diagnostic research. One such method divides di-
agnostic research into four phases, as shown in Table 1.15,16,20 The first phase deals with 
the question of whether the test results in affected patients differ from those in healthy 
persons, and whether patients with a certain test result are more likely to have the target 
disease.15,19 This phase is especially important when evaluating a new diagnostic test. In 
the next phase, diagnostic accuracy is determined through case-control studies, which 
include the assessment of the predictive value in patients with suspected disease.16 The 
accuracy of a diagnostic test is the ability to correctly identify patients with or without 
the disease, referred to as sensitivity and specificity.21 Sensitivity relates to the number 
of false negatives (negative result in the presence of disease) and specificity to false 
positives (positive result when no disease).7 In such diagnostic accuracy studies, an in-
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dependent, blind comparison of the test results with a reference standard, using a study 
population consisting of patients suspected of having the target disease is critical for 
adequate validity.15,22 Once the specificity and sensitivity of a test have been established, 
the next question is whether tested patients are better off than similar but untested 
patients.16 These studies are necessary to evaluate the beneficial and harmful effects 
of implementing a diagnostic test and usually require a randomised controlled trial.16 
In the fourth and final phase, the effects of introducing a diagnostic test into routine 
clinical practice are assessed by surveillance or cohort studies.
table 1. Four phases in architecture of diagnostic research
Phase 1 Determining the normal range of values Observational studies in healthy people
Phase 2 Determining the diagnostic accuracy Case-control study in patients with suspected 
disease
Phase 3 Determining the clinical consequences of a 
diagnostic test
Randomised trial
Phase 4 Determining the effects of introducing a 
diagnostic test
Surveillance, cohort studies
Adapted from Gluud and Sackett16,18
Apart from diagnostic accuracy and validity, other aspects are important when mea-
surements are being evaluated. Since diagnosis is seldom predicted by a single symptom 
or sign, numerous composite scores have been developed – comprising combinations 
of several different clinical signs and symptoms and sometimes also laboratory values – 
to help physicians in making a diagnosis. The methodology used to evaluate such scores 
or scales is called clinimetrics, and it is used to investigate reliability or agreement, 
accuracy, measurement error and utility, for example. Clinimetrics is a methodological 
discipline that focuses on the quality of measurement in medical research.23
Despite the fact that diagnostic accuracy or clinimetric studies are commonly used to 
evaluate newly available diagnostic tests, it is important to realise that many routinely 
used measurements – in particular elements from history taking or physical examina-
tion – have never been evaluated according to the clinimetric principles mentioned 
above. Below, in the outline of the thesis, we describe how we have used different study 
designs to explore our research questions.
outline of the thesis
The main goal of this thesis was to explore the validity, reliability, accuracy and utility of 
commonly used measurements in paediatrics. The clinical topics addressed in this thesis 
all arose from the day-to-day practice of paediatricians at Isala, a large teaching hospital 
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in Zwolle, The Netherlands. In the following paragraphs we briefly introduce these top-
ics and discuss the design of each study in relation to the architecture of diagnostic 
research as presented in Table 1.
Chapter 1 Semi-quantitative measurement of glucosuria in neonates
In this chapter, we present a study we performed to investigate the validity, reliability 
and utility of a simple diagnostic tool frequently used in many areas of medicine – not 
only in the field of paediatrics – namely, semi-quantitative measurement of glucosuria. 
Disturbed glucose homeostasis is frequently encountered in prematurely born neonates. 
In this patient category with a limited amount of blood (the circulating blood volume in 
an infant weighing 1000 grams is approximately 80 ml), it is vitally important to restrict 
blood sampling. This reduces the need for blood transfusion and avoids infant discom-
fort as much as possible. The bedside measurement of glucosuria with a reagent strip is 
non-invasive and cheap, making it a potentially feasible and suitable method for assess-
ing glucose balance in premature neonates. Despite the widespread use and availability 
of this semi-quantitative measurement of glucosuria, data on the validity and reliability 
of this method are sparse. We wanted to know the validity of this semi-quantitative 
measurement compared to the quantitative laboratory measurement, and whether this 
measurement can be used interchangeably between different professionals. Finally, we 
assessed whether the specific circumstances in the setting of a neonatal intensive care 
unit (NICU) influenced the measurement, by examining the impact of the way in which 
urine is collected from diapers and of the temperature in the environment (incubators).
To clarify these issues, we performed an observational study in an experimental set-
ting, in which we used 300 experimentally derived urine samples tested under NICU 
circumstances – assessed independently by three different nurses – and compared the 
results of the reagent strips with the urinary glucose concentrations measured quanti-
tatively in the laboratory.
Chapter 2 Early diagnosis of late-onset neonatal sepsis in preterm infants
Late-onset sepsis is a major health problem in neonatology, with considerable morbidity 
and mortality. Early and accurate diagnosis is difficult because symptoms are subtle and 
nonspecific. While late diagnosis may lead to mortality and morbidity, overtreatment 
may lead to unnecessary hospital stay and use of antibiotics. The unnecessary use of em-
piric antibiotics should be minimised to limit growing microbial resistance and to avoid 
any possible harmful effects on gastrointestinal immunity and allergy. Many attempts 
have been undertaken to improve accurate and early diagnosis of late-onset neonatal 
sepsis (LONS) in preterm neonates. In our neonatal intensive care unit, when deciding 
whether or not LONS was present in prematurely born neonates suspected of having 
this condition, the presence of glucosuria was one of the clinical factors considered, 
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although a literature search yielded no studies to support this policy. For this reason, 
we explored the predictive value of various clinical symptoms, including glucosuria, as 
markers for LONS. We did this by performing an observational study in 350 premature 
infants during a two-year period (2005-2007). We prospectively collected daily measure-
ments on glucosuria in all infants – blinded to treating physicians – and followed these 
children for the occurrence of septic episodes, thus creating a case-control study within 
this prospective cohort.
Chapter 3 Fluid balance charts in neonates
Recording a patient’s fluid balance is a time-honoured tradition, frequently used in 
many areas in medical practice, but rarely investigated for its reliability and utility. Dur-
ing daily ward rounds, we were often confronted with the results of fluid balances being 
inconsistent with daily weight changes or with the clinical condition of patients. Such 
discrepancies sometimes prompted additional investigations (sometimes extra labora-
tory tests), as well as recalculations and lengthy discussions during ward rounds, which 
usually ended with the conclusion that the recordings of fluid balance must have been 
inaccurate. These experiences prompted us to explore whether fluid balance recording 
is reliable, and whether it improves the health outcomes of the patients involved. To 
answer these questions, in 2009-2010 we performed a randomised controlled trial in 
172 neonates admitted to our high-care neonatal unit. In one group, physicians were 
blinded to the fluid balance data, while in the other group fluid balance data were made 
available to attending physicians. We also investigated reliability in this study population 
by comparing the data on daily fluid balance with that on daily changes in body weight.
Chapter 4 Clinical assessment of dyspnoea in children
Dyspnoea (difficulty in breathing) in children is one of the most commonly encountered 
problems in paediatrics. Evaluation of the severity of dyspnoea is important in clinical 
decision making and evaluation of treatment. Because pulmonary function tests are not 
readily available in the emergency department – particularly not for preschool children 
– the severity of dyspnoea is primarily assessed by physical examination. Since no single 
clinical finding accurately reflects dyspnoea severity, in children it is usually assessed 
using composite dyspnoea scores, which comprise a range of clinical findings. When we 
were developing a clinical practice guideline for patients hospitalised with dyspnoea 
– for example with a diagnosis of asthma or viral wheeze – we wanted to use a well-
validated dyspnoea score. We therefore performed a systematic review that assessed 
the validity of all published dyspnoea scores. We also explored the intraobserver and 
interobserver variability of the individual clinical items used in existing dyspnoea scores 
by asking several professionals to assess video recordings of 27 dyspnoeic children.
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Chapter 5 Viral tests for cohort isolation in children hospitalised for bronchiolitis
Every winter, the paediatric wards in many countries, including those in the Netherlands, 
are crowded with infants with bronchiolitis, commonly caused by the respiratory syn-
cytial virus (RSV). This epidemic causes major logistic problems because it is common 
practice to separate patients infected with RSV from those infected with other viruses 
(cohort isolation). This is done to avoid nosocomial co-infection, which is assumed to 
be associated with more severe disease. For this purpose, almost all patients with bron-
chiolitis undergo a rapid diagnostic RSV test. Confronted with a shortage of hospital 
rooms for isolating patients during the peak season, we investigated whether such 
cohort isolation was really necessary, thus questioning the use of expensive viral testing. 
As a proof of principle, during the winter season of 2011-2012, we first performed an 
observational cohort study in 48 patients who only shared rooms during the first day of 
admission, pending the results of the rapid RSV test. In the following season (2012-2013) 
we continued this study, including 65 patients who shared rooms during their entire 
stay in hospital.
General discussion and future perspectives
In this chapter we summarise our main findings in relation to the current available 
literature. We discuss pitfalls and implications for clinical and research practice and offer 
suggestions for future research.
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aBstract
Background: Measurement of glucosuria by means of a visually readable reagent test 
strip is frequently used in a wide variety of clinical settings. The aim of this study was to 
evaluate the validity and reliability of this semi-quantitative measurement of glucosuria 
compared to laboratory measurement of glucose concentrations in urine.
Methods: Reagent test strips (Combur3Testâ Roche) from 375 artificially supplemented 
samples of urine, covering a wide range of glucose concentrations, were independently 
read by 3 different observers. Scores of the strips were categorized as 0, 1+, 2+, 3+ or 
4+, in ascending degree of glucosuria. Results of the test-strips were compared to the 
quantitative measurement of urinary glucose concentration in the laboratory.
Results: 21.7% of reagent strips readings were disconcordant with the laboratory 
measurements (p<0.001). Under- or overestimating the degree of glucosuria occurs 
predominantly in category 1+ and 2+. In category “0” only 5.1% of the readings were 
incorrect. The interobserver-agreement was very good with 85% overall agreement and 
multirater Kappa 0.81. Interobserver-scores of the reagent strips never deviated more 
than 1 category from each other.
Conclusion: The validity as well as the interobserver-agreement for the semi-quantitative 
measurement of glucosuria using reagent strips is moderate, but sufficient for exclud-
ing glucosuria. However it is too imprecise for an accurate quantitative measurement. 
It might only be valuable in settings where automated readings are not available or 
suitable.
Validity and interobserver agreement of reagent strips for measurement of glucosuria 23
1
introduction
Glucosuria is frequently measured in a wide variety of clinical settings, for example in 
diabetes, renal disease or critical illness.1 Although monitoring of glucosuria in dia-
betes is no longer routinely recommended, urine glucose measurements may still be 
advocated to check for inappropriate use of blood examinations or for those patients 
unwilling to use blood sampling.2,3 Moreover, in less favourable economical situations, 
urine glucose monitoring is better than no monitoring.3,4 Also in newborns undergoing 
intensive care hyperglycemia is a common problem, especially in very low birth weight 
infants.5 In this patient category, with only limited availability of blood due to very low 
body weights (circulating blood volume in an infant weighing 1000 gram is approxi-
mately 80 mL), it is of major importance to restrict blood sampling in order to avoid the 
need for bloodtransfusions.6
Urinalysis can be performed quantitative in the laboratory by spectrophotometry or 
semi-quantitative by using reagent strips (dipsticks) that are interpreted visually. Testing 
urine for glucosuria using a reagent strip relies on a chemical reaction (glucose-oxidase/
peroxidase reaction) between the reagent on the strip and the glucose constituents of 
the urine. The degree of glucosuria is determined by the change in color of the test strip 
after dipping the stick in urine shortly. The analysis of the strip can be performed (semi)-
automated or by visual reading. Logically, (semi)-automated reading of strips will rule 
out human subjectivity in identifying the colors and in general will be preferred over 
visual reading of the reagent strips. However automated readers are not available, nor 
suitable in all settings. Still, the use of visually read reagent strips for measurement of 
glucosuria is quick, easy and economical and thus frequently applied as a point-of-care 
test.1 The advantage of having direct bedside results makes it suitable for use in hospital 
as well as outpatient settings. Moreover in neonates, in whom collection of urine is im-
peded by limited available amounts and use of diapers, direct bed-side visually reading 
of reagent strips amounts of urine is more suitable.7 In low-birth weight infants it is often 
not feasible to collect sufficient amounts of urine. As a consequence, in order to enable 
urinalysis, reagent strips are directly pressed on the wet diaper.
Despite its wide-spread use and availability, reports on the validity and reliability of 
this semi-quantitative method are sparse and with varying results.8,9,10,11,12 Also reports 
on interobserver variability, which seems rather relevant since the reagent strips are 
visually read, are lacking.
Validity is defined as the extent to which a test measures what is intended to measure. 
Reliability is defined as the extent to which a test is reproducible or consistent in differ-
ent settings, for example by different observers.13 Aim of this study is to determine the 
validity and interobserver agreement of the measurement of glucosuria by visually read 
reagent strips compared with laboratory performed urinalysis.
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methods
We used Combur reagent strips (Roche) to test artificially supplemented (contrived) 
urine, intended to simulate pathological specimens. Discriminatory power is defined as 
the ability of a test to discriminate among subjects, i.e. test results should be spread along 
the entire possible range.13 Hence, five different quantities of glucose corresponding with 
the midrange glucose concentrations provided by the package inserts of Combur strips, 
were added to freshly collected urine of healthy volunteers. A total of 375 urine samples, 
75 of each of 5 different glucose concentrations, were thus contrived. Glucose (Merck, 
Darmastadt, Germany) was added to the urine of healthy volunteers. Glucose concentra-
tion of the contrived urine samples were as follows: specimen A 0 mmol/L, specimen B 
2.8 mmol/L, specimen C 5.5 mmol/L, specimen D 17 mmol/L and specimen E 55 mmol/L. 
According to the package insert of Combur strips, the corresponding ranges were 0.6-5.0 
mmol/L for score 1+, 3.3-7.7 for score 2+, 14.8-19.2 for score 3+ and 52.8-57.2 for score 4+.
The reagent strips were dipped in the urine in a randomised order of glucose concen-
trations. All strips were independently read between 60-120 seconds after contact with 
the urine sample, by 3 nurses at the same time, who were unaware of the randomisation 
order. The observers were blinded to scores of others by dividers, practically eliminating 
visual or any other form of contact between observers. The glucose-concentration of 
each urine sample was also directly measured in the laboratory by the Gluco-quant glu-
cose/HK method (Roche Diagnostics, Mannheim, Germany) on a Modular P800 (Hitachi, 
Tokyo, Japan). This is an enzymatic hexokinase method, de rate of NADPH formation 
is measured photometrically. The laboratory staff was not aware of the reagent strip 
results.
Statistical methods
To assess whether the reagent strips scores were in agreement with the true glucose 
concentrations, we compared the test results of 1125 (3 times the scores of the 375 urine 
samples) categorized ratings of the reagent strips with the categorized ranges of the 
glucose concentrations measured in the laboratory, using Chi-square tests.
Interrater agreement was evaluated by calculating raw agreement and agreement 
adjusted for chance (weighted Kappa for agreement between two observers and Fleiss 
multi-rater Kappa for agreement amongst all 3 observers). The rationale for using these 
two methods is as follows: Raw agreement - the proportion of reagent strips ratings in 
which 2 observers rate the same category of glucosuria – can be misleading. In par-
ticular, if two observers both make a high or low proportion of positive ratings for a 
category, raw agreement will be high even if the observers are just guessing. That is, their 
agreement will be simply high by change. High agreement by chance tends to occur 
when two raters believe the prevalence of a clinical entity of interest is high or low in the 
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population under study.14 Because of this problem with raw agreement, we calculated 
change-corrected agreement using the Kappa statistic. Kappa is defined as the observed 
agreement beyond expected agreement (i.e. change) divided by the maximum agree-
ment possible beyond. Weighting of the Kappa statistic allows for the partial correction 
of discordant observations, with greater weight given when categories assigned by the 
different observers are closer together.15 Given the ordinal nature of the semi-quanti-
tative test strip score, a weighted Kappa using quadratic weights was used to quantify 
reliability. Weighted Kappa was calculated for the 3 observer pairs using http://faculty.
vassar.edu/lowry/kappa.html. Fleiss’ multi-rater Kappa for change-corrected agreement 
between 3 observers was calculated using http://justusrandolph.net/kappa/.16
We interpreted Kappa coefficients as follows: values of less than 0, poor; 0 to 0.2, 
slight; 0.2 to 0.4, fair; 0.4 to 0.6, moderate; 0.6 - 0.8, substantial agreement; and 0.8 - 1.0 
represent almost perfect agreement.17
negative
figure 1. Agreement between reagent strips and “true” glucose concentrations as measured in the 
laboratory
The “true glucose category” is the categorized measurement of the glucose concentration as measured 
in the laboratory by spectophometry. The “glucosticks” provide the associated result of the visually read 
reagent strip. The width of the stripes represents the number of observations.
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results
Figure 1 shows the results of the level of agreement between the categorized scores of 
the reagent strips and the categorized test results of the “true” glucose concentrations 
as measured in the laboratory.
Table 1 presents percentages of reagent strips predicting the correct true glucose 
concentrations. Of 1125 glucosticks, 21.7% were disconcordant with the laboratory 
measurements (p<0.001). Under- or overestimating the degree of glucosuria by means 
of the reagent strips predominantly occurred in category 1+ and 2+, with 34.2% and 
38.5% of sticks incorrectly predicting the degree of true glucosuria within these catego-
ries. In category “0” only 5.1% of readings were incorrect. The maximum urinary glucose 
concentration incorrectly categorized as “0” (negative for glucosuria) was 2.55 mmol/L.
The difference in the visual assessment scores of the reagent strips was never more 
than 1 category. Multi-rater Kappa was 0.811, representing almost perfect agreement, 
with 85% overall agreement.
table 1 Diagnostic accuracy of reagent strips for glucose for each rating category
Result of reagent strip for 
glucose
Concordance with “True” 
category (measured in the 
laboratory)
Underestimating 1 
category (“true” category 
1 higher)
Overestimating 1 
category (“true” category 
1 lower)
0 205/216 (94.9%) 11/216 (5.1%) Not applicable
+ 144/219 (65.8%) 55/219 (25.1%) 20/219 (9.1%)
++ 123/200 (61.5%) 7/200 (3.5%) 70/200 (35%)
+++ 196/255 (76.9%) 12/255 (4.7%) 47/255 (18.4%)
++++ 213/235 (90.6%) Not applicable 22/235 (9.4%)
Each of 5 categories of glucose concentration was represented by 225 urine samples
Figure 2 represents raw data on agreement between the three observer-pairs. The 
interobserver-agreement, as presented by percentage of agreement and Kappa coef-
ficients, was very good (table 2).
discussion
Principal findings
In this study the validity of the semi-quantitative measurement of glucosuria by visually 
read reagent strips was moderate, with more than one-fifth of reagent strips readings in-
correctly predicting the laboratory measurement. Under- or overestimating the degree 
of glucosuria occurs predominantly in category 1+ and 2+. In category “0” only 5.1% of 
readings were incorrect. Thus, the validity of the reagent strips for ruling out glucosuria 
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is fairly good. The discriminative power between the lower categories of glucosuria (1+ 
and 2+) is low, probably due to the dissimilar differences in concentrations between 
the lower and higher categories of glucosuria, with smaller differences in concentra-
tions between the lower categories. This is confirmed by product information from the 
manufacturer that indicate overlapping ranges for glucose concentrations between the 
lower categories 1+ (0.6-5.0 mmol/L) and 2+ (3.3-7.7 mmol/L).
We found a high degree of interobserver agreement in the assessment of the reagent 
strips, demonstrated by high Kappa-values. The scores of the different observers never 
deviated more than one category from each other, which seems fairly adequate for clini-
cal use.
 
 Observer 2   Observer 3  







0 71 0 0 0 0 71 0 66 5 0 0 0 71 
+ 8 51 1 0 0 60 + 0 59 1 0 0 60 
++ 0 24 44 2 0 70 ++ 0 20 48 2 0 70 
+++ 0 0 25 67 1 93 +++ 0 0 13 77 3 93 
++++ 0 0 0 9 72 81 ++++ 0 0 0 6 75 81 
 
Total 79 75 70 78 73 375  66 84 62 85 78 375 







0 66 13 0 0 0 79 
+ 0 66 9 0 0 75 
++ 0 5 50 15 0 70 
+++ 0 0 3 69 6 78 
++++ 0 0 0 1 72 73 
Total  66 84 62 85 78 375 
figure 2 Raw data of agreement in rating glucosuria with reagent strips between the three observer pairs
table 2 Agreement between raters for test results of the reagent strips
Rater 1 versus 2 Rater 1 versus 3 Rater 2 versus 3
Raw agreement 83.7% 86.7% 86.1%
Kappa 0.942 0.952 0.827
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Strength and weaknesses of the study
The strength of our study is the use of a large number of samples covering the complete 
range of glucose concentrations. In particular when using a Kappa value for evaluating 
interobserver agreement, this is of vital importance in order to prevent misleading high 
or low Kappa values. Another strength is that we thoroughly investigated interobserver 
variability based on an adequate blinding of the observers for or each other ratings to 
prevent bias in this respect.
Surely, this study suffers from several limitations. The use of predefined, categorized 
glucose concentrations scored under optimal controlled study conditions, may affect 
the generalizability of these results to real-life clinical practice. In clinical settings, the 
reagent-strip is read under variable circumstances, varying in light, temperature by well 
and less trained staff. In this study, all dippings of the reagent strips were done by one 
same person, strictly according to the manufacturer’s instructions, under controlled 
circumstances. Another concern that is relevant for clinical practice is the influence of 
medication on the results of the reagent strip. For example, high doses of salicylates or 
levodopa may produce false negative results, whereas high doses of ascorbic acid or the 
presence of ketones may depress the development of color on the reagent strip.1 Other 
factors that may threaten validity in real life clinical practice, are the timing of reading 
the strips (reagent strips are designed to react progressively, producing colour changes 
along the strip at specified times), the use of strips after the expiry date or improper 
storage of the strips.1 Since automated urinary strip readers will not be affected by the 
above mentioned factors, it is likely to be a more valid method.18
In summary, the semi-quantitative measurement of glucosuria using visually read 
reagent strip seems to be a valid method to rule out glucosuria and might be valuable 
in neonatal intensive care settings and in situations where automated readings are not 
available.
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aBstract
Background: In preterm infants, measurement of glucosuria using a visually readable 
reagent strip is frequently applied, for example in monitoring of total parenteral nutri-
tion, during sepsis or corticosteroids use. However, specific circumstances in a neonatal 
intensive care (NICU) setting, such as the use of diapers and the high temperature in 
incubators, could affect its reliability.
Objectives: To evaluate reliability of the semi-quantitative measurement of glucosuria 
under the specific circumstances of a NICU-setting.
Methods: A total of 900 assessments of artificially glucose-supplemented urine samples 
- kept in diapers -were performed under the following varying circumstances: environ-
mental temperature (21 and 34 degrees Celsius), different periods of contact time of the 
urine in the diaper and using two different methods of collecting urine from the diaper. 
Each reagent strip was read-out independently by three observers. Scores of the test 
strips are categorized as 0, 1+, 2+, 3+ or 4+, in ascending degree of glucosuria.
Results: Agreement was excellent under all different circumstances (temperature κw 0.92; 
method of urine collection κw 0.88, time p 0.266). Inter observer reliability was very good 
(multirater Kappa 0.81). The deviation between the different circumstances was seldom 
larger than one category (2.9%). Reagent strips readings were concordant with the true 
urinary glucose concentrations in 79.0% of assessments. The discordance was never 
larger than one category.
Conclusion: The reliability of the semi-quantitative measurement of glucosuria in new-
borns using reagent strips is good, even under the circumstances of a NICU-setting. 
Changes in rating of reagent strips of more than one category are most likely beyond 
measurement error.
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introduction
Disturbed glucose homeostasis is frequently encountered in preterm neonates. 1-5 Mea-
suring glucosuria in very prematurely born infants can be useful for example in adminis-
tration of monitoring total parenteral nutrition,6 insulin,7 corticosteroids,8 during sepsis9 
or for evaluation of renal function.10-11 Measurement of glucosuria can be performed 
quantitatively in the laboratory by spectrophotometry or semi-quantitatively by using 
reagent strips that are interpreted visually at the bedside. The use of reagent strips for 
urinalysis is quick, easy and economical and thus frequently applied as a point-of-care 
test.12 Previously, we showed good inter-rater reliability of reagent strips for measure-
ment of glucosuria (Kappa 0.81).13
However, the circumstances in a neonatal intensive or high care unit differ substan-
tially from those described in the manufacturer’s product information. Contact of the 
urine with diapers and high environmental humidity and temperature in the incubator 
are factors that may influence the results of the reagent strips. Another major issue is 
the minimally available quantities when considering urinalysis in (premature) neonates. 
Often it is not possible to collect a single large sample of urine to dip the strip in, as 
recommended by the manufacturer’s product information. As a consequence, reagent 
strips are often used by directly pressing the strip on the wet diaper.14 To our knowledge 
data on reliability of the use of reagent strips for the measurement of glucosuria in 
neonatology are lacking.
The aim of this study is to determine the reliability of the measurement of glucosuria 
by visually read reagent strips, under circumstances, specific for a neonatal intensive 
care unit.
methods
We used Combur reagent strips (Combur3Testâ Roche) to test artificially supplemented 
(contrived) urine, intended to simulate pathological specimens. Scores of the reagent 
strips are categorized as 0, 1+, 2+, 3+ and 4+, in ascending degree of glucosuria, 
resulting in five different colors of the test strip (webappendix 1). After 60 seconds of 
contact between the urine and the test strip, the color of the test strip is compared to a 
standardized color scale, corresponding with the five different categories of glucosuria. 
According to the product information of Combur strips, the corresponding ranges were 
0.6-5.0 mmol/l for score +, 3.3-7.7 mmol/l for score 2+, 14.8-19.2 mmol/l for score 3+ and 
52.8-57.2 mmol/l for score 4+. Five different quantities of glucose corresponding with 
the midrange glucose concentrations (respectively 0, 2.8, 5.5, 17.0 and 55.0 mmol/l), 
were added to freshly collected urine of healthy volunteers.
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A total of 300 urine samples were used, consisting of 60 samples of 5 different glucose 
concentrations. The urine samples were distributed over disposable diapers with insert 
gazes. Half of the diapers were kept in room temperature of 21 degree Celsius (oC) and 
half in an incubator at 34 oC. The reagent strips were read from urine collected by two dif-
ferent non-invasive methods: the “diaper-strip” and the “drip-strip”. The “drip-strip method” 
uses a piece of cloth (gaze) in the diaper. After compression of the wetted cloth, urine can 
be evacuated with a syringe and subsequently applied to the reagent strip. During the 
procedure gloves were worn. Alternatively, reagent strips are frequently interpreted after 
pressing the strip in a wet diaper for a few seconds. This method will be referred to as the 
“diaper-strip method”. The reagent strips were applied in a randomized order of glucose 
concentrations. At five different times of contact between the diaper and urine (0, 30, 60, 
120 and 180 minutes) reagent strips were read. All reagent strips were independently 
read by three different observers – intensive care neonatology nurses with at least 5 
years of experience- , between 60-120 seconds after contact with the urine sample.
Analysis of urinary glucose in the laboratory was done by the Gluco-quant glucose/
HK method (Roche Diagnostics, Mannheim, Germany) on a Modular P800 (Hitachi, 
Tokyo, Japan). This is an enzymatic hexokinase method, the rate of NADPH formation is 
measured photometrically. Urine collected by the diaper-strip method was used for this 
purpose. The laboratory staff was not aware of the reagent strip results.
Statistical methods
Assessments of agreement between the results of the reagent strips were quantified by 
calculating percentage agreement and weighted Kappa (κw) using quadratic weights 
(http://faculty.vassar.edu/lowry/kappa.html). We interpreted Kappa statistics as follows: 
poor (κ 0-0.40), fair (κ 0.41-0.75), or excellent (κ 0.76-1.0).15
We used non-parametric tests for the analysis of the effect of time spent in the diaper 
on the urine samples (Friedman’s ANOVA) and the effect of environmental temperature 
(Wilcoxon) on glucose concentrations.
All analyses, except for calculation of weighted Kappa, were performed in SPSS, ver-
sion 18.0.
results
Results of visual reading showed excellent agreement with the true concentration as mea-
sured by the laboratory (Table 1: κw 0.934, 95%CI 0.93-0.94, raw agreement 79.0%, 95%CI 
76.2-81.6). Results equally over and underestimate the true degree of glucosuria (8.7% too 
low vs. 12.3% too high). Agreement was lowest for categories 1+ and 2+ (67.2% and 63.5% 
respectively, versus 94.0%, 77.9% and 88.6% for categories 0, 3+ and 4+ respectively).
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As we showed in a previous report,13 inter observer reliability was good (85% overall 
agreement and multirater Kappa 0.81). Inter-observer-scores of the reagent strips never 
deviated more than one category from each other.
table 1 Agreement in rating of glucosuria through reagent strips compared to true urinary glucose 
concentrations as measured by the laboratory.
true glucosuria







0 173 11 0 0 0 184
+ 7 121 52 0 0 180
++ 0 48 94 6 0 148
+++ 0 0 34 152 9 195
++++ 0 0 0 22 171 193
Total 180 180 180 180 180 900
κw 0.934 (95%CI 0.928-0.940)
Temperature
Results of the comparisons between the two different environmental temperatures 
are presented in Table 2. The agreement of the reagent strips used in the two different 
environmental temperatures is excellent (κw 0.921, 95%CI 0.909-0.933, raw agreement 
74.9%, 95%CI 70.6-78.8). The samples in room temperature were rated higher than the 
incubator (higher in 21.6%, lower in 3.6%). This difference was significantly influenced 
by the time the urine spent in the diaper (p 0.027, Friedman): ratings of reagent strips 
of urine samples in room temperature were higher than ratings of samples in incubator 
temperature in 15.6%, 20.0%, 18.9%, 28.9% and 24.4% after respectively 0, 30, 60, 120 
and 180 minutes.
table 2 Agreement in rating of glucosuria through reagent strips between two environmental 
temperatures
room temperature












0 83 15 0 0 0 98
+ 3 55 48 0 0 106
++ 0 4 36 20 0 60
+++ 0 0 4 76 14 94
++++ 0 0 0 5 87 92
Total 86 74 88 101 101 450
κw 0.921 (95%CI 0.909-0.933)
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Agreement with the true glucose concentration was excellent for both environmental 
temperatures (room: κw 0.919 with 78.0% raw agreement, incubator: κ 0.949 with 80.0% 
raw agreement). Overestimating the true glucose concentration occurred in 17.3% of 
samples in room temperature compared to 7.3% in the incubator. Underestimating 
the true glucose concentration was found in 4.7% of samples in room temperature 
and in 12.7% of samples in the incubator. The measured glucose concentration in the 
laboratory of samples retrieved through the diaper stick method was also higher in 
room temperature than in incubator temperature (mean difference 0.93 mmol/l, 95%CI 
0.52-1.35 mmol/l; Wilcoxon, p<0.001). Still, all measured laboratory concentrations, both 
from room and incubator samples remained within the ranges corresponding to the 
categories of the reagent strip as provided by the manufacturer.
Urine collection method
Results of agreement between the different urine collection methods are presented 
in Table 3, showing good agreement between the different methods (κw 0.877, 95%CI 
0.864-0.890, agreement 62.2%, 95%CI 58.9-66.7%). Results of drip-strip scored higher 
than diaper-strip in 37.8% of assessments, and lower in 0.0%. The diaper-strip method 
shows better agreement with the true glucose concentration compared to the drip-strip 
method (diaper-strip: κw 0.965 with 82.9% raw agreement, drip-strip: κ 0.905 with 75.1% 
raw agreement). Overestimating the true glucose concentration occurred in 24.4% 
of drip-strips compared to 0.002% in diaper-strips. Underestimating the true glucose 
concentration was found in 0.004% of drip-strips and in 16.9% of diaper-strips.
table 3 Agreement in rating of glucosuria through reagent strips between two methods of urine 
collection from the diaper
drip-strip








0 83 15 3 0 0 101
+ 0 36 83 10 0 129
++ 0 0 16 30 0 46
+++ 0 0 0 63 29 92
++++ 0 0 0 0 82 82
Total 83 51 102 103 111 450
κw 0.877 (95%CI 0.864-0.890)
Time
Accuracy of the reagent strips showed statistically significant differences in categories 
2+ and 4+, however no trend with time is seen (Table 4), meaning that the accuracy was 
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not worse or better the longer the urine stayed in the diaper. Maximum change in time 
of reagent strips readings was one category.
The measured glucose concentration by the laboratory collected through the drip-
strip method did not change significantly over the 180 minutes of time spent in the 
diaper (Friedman’s ANOVA, p 0.266).
table 4 Agreement for glucosuria between visually read reagent strips and “true” glucosuria (laboratory 
measurement) after different periods of contact
time (minutes)
















0 91.7% 100% 100% 94.4% 94.4% 0.061
+ 77.8% 63.9% 58.3% 72.2% 63.9% 0.184
++ 44.4% 63.9% 44.4% 47.2% 61.1% 0.003
+++ 83.3% 83.3% 77.8% 88.9% 88.9% 0.056
++++ 75.0% 92.7% 100% 100% 100% <0.001
Total 74.4% 80.6% 76.1% 80.6% 82.7% <0.001
* Friedman’s ANOVA
discussion
The urinary glucose concentration as measured by the reagent strips is not influenced 
by the time spent in the diaper, and only slightly influenced by the temperature of 
the incubator and by the method of urine collection. The variability largely remains 
restricted to only one category difference, and is seen mainly in category 1+ and 2+. 
This can be explained by the fact that the ranges of glucosuria of the categories 1+ and 
2+ are overlapping (0.6-5.0 mmol/l for category 1+, 3.3-7.7 mmol/l for category 2+). We 
therefore conclude that the use of reagent strips for semi-quantitative measurement is 
reliable enough for use in NICU-circumstances, especially when categories 1+ and 2+ 
are taken together as one category. To our knowledge this is the first study to address 
the reliability of reagent strips for measurement of glucosuria in a NICU-setting.
The two factors that slightly influenced the measurement of glucosuria were tem-
perature and the collection method. We have purposely used the room temperature 
as a reference standard and have chosen the maximum temperature used in our NICU-
department, arguing that this would reveal the maximum possible difference in results. 
Since we found only slight, not clinically relevant influence of these two “extreme” 
temperatures, we can conclude that lesser differences in temperature will even more 
certainly not influence the results. Concerning the method of urine collection:the 
reagent strips can be best used by pushing the strip to the wetted diaper (the diaper 
method). This is the most reliable and simple method, the contents of the diaper do not 
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appear to influence the glucose concentrations, which is in accordance to earlier reports 
in the literature.14,16,17 When too little urine is available, for example in case of extremely 
absorbing diapers, the urine can be collected by putting a gaze in the diaper. The urine 
collected by this drip-stick method tends to overestimate the degree of glucosuria. This 
finding may be explained by the fact that more water could have evaporated from the 
gaze compared to urine collected in the diaper. Still, the largest part of the variation in 
reagent strips result can be explained by the inter observer reliability (κw 0.81).
13 This 
inter-observer variation is a factor that cannot be neglected, since in daily clinical prac-
tice it is unavoidable that different professionals use the reagent strip.
Strength and weaknesses of the study
The strength of our study is the use of a large number of samples covering the com-
plete range of glucose concentrations. In particular when using a Kappa value for the 
evaluation of reliability, it is of vital importance to be cautious in case of low or high 
prevalences.18 By use of equally distributed prevalence of all degrees of glucosuria we 
aimed to prevent misleading high or low Kappa values. Another strength is the fact that 
we studied the reliability under specific NICU-circumstances, which was not reported 
earlier.
Surely, this study suffers from limitations. The use of predefined, categorized glucose 
concentrations scored under optimal controlled study conditions, may affect the gener-
alizability of our results to real-life clinical practice. In clinical settings, the reagent-strip 
is read under variable circumstances, varying in room light, and importantly by well and 
less trained staff. Future studies using urine samples from patients in real-time clinical 
practice with a wide spectrum of glucosuria are needed to elucidate this matter.
In summary, the semi-quantitative measurement of glucosuria using visually read 
reagent strip seems to be a reliable and simple bedside method, suitable for use in a 
NICU-setting. Changes in rating of reagent strips of more than one category are almost 
certainly beyond measurement error. Moreover this measurement error may be largely 
avoided, when the category 1+ and 2+ are taken together as one category.
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aBstract
Late-onset neonatal sepsis (LOS) in preterm infants is an important cause of morbidity 
and mortality in preterm infants. Since presenting symptoms may be non-specific and 
subtle, early and correct diagnosis is challenging. We aimed to develop a nomogram 
based on clinical signs, to assess the likelihood of LOS in preterms with suspected infec-
tion without the use of laboratory investigations. We performed a prospective cohort 
study in 142 preterm infants <34 weeks admitted to the NICU with suspected infection. 
During 187 episodes 21 clinical signs were assessed. LOS was defined as bloodculture-
proven and/or clinical sepsis, occurring after 3 days of age. Logistic regression was used 
to develop a nomogram to estimate the probability of LOS being present in individual 
patients. LOS was found in 48% of 187 suspected episodes. Clinical signs associated with 
LOS were: increased respiratory support (OR 3.6; 95%CI 1.9-7.1), capillary refill (OR 2.2; 
95%CI 1.1-4.5), gray skin (OR 2.7; 95%CI 1.4-5.5) and central venous catheter (OR 4.6; 
95%CI 2.2-10.0) (AUC 0.828; 95%CI 0.764-0.892).
Conclusion: Increased respiratory support, capillary refill, gray skin and central venous 
catheter are the most important clinical signs suggestive of LOS in preterms. Clinical 
signs that are too non-specific to be useful in excluding or diagnosing LOS were tem-
perature-instability, apnoea, tachycardia, dyspnoea, hyper –and hypothermia, feeding 
difficulties and irritability.
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introduction
Late-onset neonatal sepsis (LOS), defined as neonatal sepsis occurring after three days 
of age, is an important cause of morbidity and mortality in preterm infants.2,3,19 Early and 
correct diagnosis of LOS is a challenging task. Especially in preterm infants the present-
ing signs are often very subtle and non-specific. Furthermore, as microbiological culture 
results are not available within 48 hours, early identification of a genuine sepsis is a major 
problem. Considering the possibly devastating consequences of missing LOS, providers 
often have a low threshold for starting antibiotic therapy. However, unnecessary use 
of empirically started broad-spectrum antibiotics should be minimized for reasons of 
growing resistance against antibiotics and possible harmful effects on gastro-intestinal 
immunity and allergy.4,12
Although many authors state that clinical signs are unreliable in the diagnosis of LOS 
in neonates,8,14 good quality studies addressing the value of clinical signs are sparse, 
especially in preterm neonates.5,9,11,14,18 Furthermore, most studies relied on blood-
culture proven sepsis as definite outcome measure. However, sepsis-like episodes with 
false-negative blood-cultures (i.e. clinical sepsis) are frequently encountered in preterm 
infants because of the limitation in number of blood-cultures taken and quantity of 
blood drawn.6,13
In the era of sophisticated laboratory techniques, much emphasis has gone to the 
value of haematological and biochemical markers in the diagnosis of LOS. 10,15,16 Hence, 
clinical judgement might unjustly be undervalued. Still, it remains of great importance 
to investigate the diagnostic value of clinical judgement.
The aim of this study was to evaluate the value of various clinical signs in identifying 
both blood-culture proven as well as clinical LOS in preterm neonates in a NICU-setting, 
without the use of laboratory investigations. In addition we wished to develop a nomo-
gram, consisting of clinical signs, to assist in decision-making for treatment in preterm 
neonates suspected of LOS.
methods
Patients and data collection
A prospective cohort study was undertaken at our level-III neonatal intensive care unit 
(NICU) in Zwolle, the Netherlands, from July 2005 until November 2007. Eligible patients 
included all patients with a postconceptional age < 34 weeks, and more than 72 hours 
postnatal age and not on antibiotic therapy for the last 24 hours. Patients were followed 
until a corrected gestational age of 35 weeks or until discharge to other hospitals before 
35 weeks.
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An episode of suspected infection was defined as a clinical suspicion of infection by 
the attending neonatologist. The clinical suspicion of infection ranged from very mild 
to very severe. Each patient with mild to severe suspicion of infection was included ir-
respective of the prescription of antibiotics. In this way inclusion of a wide spectrum of 
disease severity was aimed for in order to minimise the chance of overestimating the 
diagnostic accuracy of the clinical signs. In case of a very mild suspicion of infection, 
where no antibiotics were started nor blood-cultures were taken, the episode was evalu-
ated for the occurrence of LOS over the following 3 days. We reasoned that in case of 
withholding antibiotics, without further aggravation of clinical symptoms, no clinically 
relevant bloodstream infections would be missed.
At the onset of each episode, data on clinical signs were assessed in a standardised 
way. Before the start of antibiotic treatment blood for blood cultures (1-3 ml), C-reactive 
protein (CRP) and full blood count was drawn.
Clinical signs and symptoms
Based on the literature5,8,10,7 and clinical experience a total of 14 clinical signs were as-
sessed: pallor or gray skin colour, capillary refill time > 2 seconds,20 dyspnoea (grunting, 
nasal flaring and/or chest retractions), tachypnoea (respiratory rate > 60/min during > 
1 hour), need for increased respiratory support ( intensifying the modus, i.e. low flow, 
CPAP or endotracheal ventilation and/or degree of respiratory support), increasing need 
for supplemental oxygen, tachycardia (pulse >180/min during > 1 hour), temperature 
instability (difference in body temperature > 0.5O Celsius within 24 hours), hyperthermia 
(rectal temperature > 38.0O Celsius), hypothermia (rectal temperature < 36.0O Celsius), 
feeding difficulties (vomiting or gastric aspirates > 50% of feed volume), increasing 
frequency of apnoea, bradycardia and/or cyanotic spells, lethargy and irritability. The 
clinicians and research nurses prospectively assessed these signs at the onset of each 
episode using a standardised form. Furthermore, the following 7 risk factors were noted: 
gestational age at birth, birth weight, sex, central venous catheter (CVC) or removal of a 
CVC in the preceding 24 hours, mechanical ventilation, actual weight and postnatal age.
Laboratory investigations
Bloodsamples for C-reactive protein, leucocytes with differential count and blood-cul-
ture were taken at onset of clinical symptoms signalling suspected infection. C-reactive 
protein was measured by immunoturbidimetry on a Roche modular P instrument using 
the C-reactive protein latex Tina-quant® assay (Roche Diagnostics). CRP > 10 mg/l was 
judged to be indicative for sepsis. Leukocytes and differential count was measured 
by flowcytometry on a Celldynn 4000 machine (Abbott). Leucocytosis was defined as 
leucocytcount ≥ 25 x10E9/l and leucopenia ≤ 5 x10E9/l.
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Bloodcultures were drawn before the start of antibiotic therapy (1-3 ml in 40 ml Cul-
ture vials: BactecTM). A positive blood-culture with organisms regarded as commensals 
(predominantly Coagulase-negative Staphylococcus) was defined as contamination. 
However a positive blood culture with skin commensals was defined as proven sepsis 
when the same organism was found in at least 2 blood cultures and/or signs of catheter-
related sepsis were present (ie. Inflammation of the skin at the site of line insertion).
Final diagnosis of LOS
The outcome of each episode was classified in 3 mutually exclusive categories: blood-
culture proven sepsis, clinical sepsis and rejected sepsis. The classification was made 
by the researchers based on the course of the episode after the start of antibiotics and 
laboratory values (CRP, full blood count). Blood-culture proven sepsis was defined as an 
episode with positive non-contaminated blood-culture. Infants were classified as having 
clinical sepsis in case of a strong clinical suspicion for infection despite negative blood-
cultures as defined by the attending neonatologist or in case of raised CRP (> 10 mg/l), 
leucocytosis or leukopenia or haematological markers. Rejected sepsis was defined as 
an episode with negative blood-culture and/or an episode with a favourable course 
where no blood-culture was done ánd no antibiotics were started in case of low CRP 
and normal haematological markers. In all our analyses and results, LOS was defined as 
blood-culture proven and/or clinical sepsis.
Statistical analysis
We used logistic regression to examine the association between clinical signs and the 
presence or absence of LOS. Some patients (n=38) experienced more than one episode 
of suspected infection. To avoid inaccurately extra weighing of risk factors in these pa-
tients, we evaluated patient-specific risk factors (gestational age, birth weight and sex) 
only for the first episode. Odds ratios (OR) and 95% confidence intervals (95%CI) were 
used to quantify the strength of these associations.
Our variable selection and modelling approach was based on the following steps. 
Simultaneously fitting all 14 clinical signs and 7 risk factors in a single model would lead 
to overfitting (ratio of variables to number of events = 1:4) and unpredictable results.17 
Therefore, we classified all signs into four clinically coherent groups, so that the signs 
within each group shared common features related to pathophysiology. These four 
groups were: respiratory, circulatory, general symptoms and risk factors.
Within each group we applied backward logistic regression to select only those signs 
that were significantly associated with LOS using a p-value <0.1 as criterion to stay. 
We then built a multivariable model with the selected signs from each group. Model 
evaluation consisted of receiver operating characteristics analysis (AUC) and Hosmer-
Lemeshow goodness-of-fit-test.
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Bootstrapping was used to correct for possible overoptimistic results of the final 
model. Bootstrapping is an internal validation technique, where many repeated samples 
are drawn with replacement from the data set at hand. Bootstrapping generates an 
estimate of how well the model might fit in a new study population. In other words 
bootstrapping estimates the expected optimism in model performance or shrinkage of 
the model.17
Finally, a nomogram was developed to visualize the predictive strength of the differ-
ent clinical signs and risk factors in a single diagram. This nomogram allows readers to 
calculate an expected risk of LOS based on the specific profile of a patient. The number 
of points for each predictor was based on the regression coefficients of the reduced mul-
tiple regression model. The total numbers of points derived by the presence or absence 
of all predictors was used to calculate the expected probability of LOS.
Analyses were performed using the statistical package SPSS (PASW) version 18.0.
Consent and ethical approval
The study was approved by the local medical ethical committee of our hospital. Written 
informed consent was obtained from the parents.
results
During the 2-years study period, a total of 319 eligible patients were admitted to our 
NICU of whom 142 experienced one or more episodes of suspected infection. A total 
of 187 episodes of suspected infection occurring in 142 patients were evaluated. Basic 
characteristics of included patients are presented in Table 1; inclusion and classification 
of episodes is presented in Figure 1.
table 1. Characteristics of the study population: patients with suspected infection. Data from patients 
who experienced more than one episodes of suspected infection are from their first episode.
Patients with suspected infection
n=142
Gestational age in weeks+days (mean, ± SD) 29+6 (± 2+1)
Birthweight in gram (mean, ± SD) 1207 (± 351)
Male sex (n,%) 79 (56%)
Died during admission (n,%) 2 (1.4%)
Age at onset of suspected infection (median,IQR) 10* (7-15)
Follow-up in days (median,IQR) 24* (14-35)
SD standard deviation, IQR inter quartile range
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Final diagnosis: 
figure 1. Inclusion and classification of episodes of suspected late-onset sepsis.
Final diagnosis
A final diagnosis of LOS was made in 89 (48%) out of the 187 episodes of suspected 
infection. Twenty-six per cent (n=50) of the episodes were classified as proven sepsis 
and in 21% (n=39) clinical sepsis was judged to be present (Figure 1 and Table 2). Of the 
39 episodes of clinical sepsis, in 46% (n=17) laboratory values were normal (low CRP and 
haematological markers) and the diagnosis clinical sepsis was made on the basis of the 
severity and the course of clinical signs alone. Median CRP in the clinical sepsis group 
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was 11 mg/l (range 0-86). A positive bloodculture was found in 56 episodes, of which 6 
were considered contaminated. Among the 50 episodes of proven sepsis Staphylococ-
cus Epidermidis was the most common isolate (50%), followed by Bacillus Cereus (28%), 
Staphylococcus Aureus (12%), gram negatives (6%), Streptococcus (2%) and Candida 
(2%).
Clinical signs and risk factors for late-onset sepsis
Table 2 shows data on clinical signs and risk factors for the different outcome groups. 
Clinical signs and risk factors associated with LOS at the p 0.05 level were: weight at 
the episode, CVC, respiratory insufficiency, lethargy, capillary refill, pallor/gray skin and 
increased oxygen requirements. Clinical signs that showed no significant association 
with LOS were: temperature instability, apnoea, tachypnoea, tachycardia, dyspnoea, 
hyper- and hypothermia, feeding difficulties and irritability.
Results of multiple regression analysis
Selection of variables
After backward elimination within each of the 4 clinically coherent categories sepa-
rately, the following variables remained significantly associated with LOS within the 4 
categories: respiratory signs: increased respiratory support, circulatory signs: capillary 
refill time and pallor/gray skin, general signs: lethargy, risk factors: weight at episode and 
a central venous catheter.
Multiple regression model
The remaining variables were entered in a multiple regression analysis and the corre-
sponding results are presented in table 3. Performance of this “full” model for predict-
ing LOS was good, with AUC 0.80 (95%CI 0.74-0.87; p<0.001) and Hosmer-Lemeshow 
goodness-of-fit-test p=0.438.
The expected optimism in model performance evaluated by bootstrapping was small 
(e.g. a decrease in AUC from 0.80 to 0.71, a shrinkage factor of 0.89).
In the next step we applied backward elimination (p<0.1 as criterion to stay) to see 
whether variables could be excluded without a relevant loss in performance. Four 
variables remained significantly associated with LOS: increased respiratory support, 
capillary refill time, pallor/gray skin and a central venous catheter (Table 3). Labelling 
infants as low risk for sepsis when all four factors are absent, which was the case in 36 
infants, would miss 3 infants (8.3%) with clinical and proven sepsis and 1 infant (2.8%) 
with proven sepsis. Sensitivity of the presence of one or more of these 4 factors for LOS 
was 97% and specificity 37%.
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A nomogram was constructed based on the reduced model and is shown in Figure 
2. The value of each predictor corresponds to a score. The scores for all predictors are 
summed to a total score, which is then translated into a probability for LOS.
table 3. Results from multivariable logistic regression analysis
clinical and proven sepsis Proven sepsis
full model or 95%-ci P or 95%-ci P
CVC in last 24 hours 4.39 2.02-9.52 <0.001 7.13 3.15-16.16 <0.001
Increased respiratory support 3.33 1.67-6.63 <0.001 2.16 0.97-4.84 0.06
Pallor/ gray skin 2.66 1.29-5.48 0.008 1.25 0.52-2.97 0.62
Capillary refill time > 2 seconds 2.13 1.03-4.42 0.04 2.32 1.00-5.37 0.05
Weight at episode < 1200 gr 1.72 0.87-3.40 0.12 1.75 0,80-3.85 0.16
Lethargy 1.14 0.55-2.36 0.73 2.61 1.14-6.01 0.02
reduced model or 95%-ci P or 95%-ci P
CVC in last 24 hours 4.63 2.16-9.95 <0.001 7.10 3.19-5.78 <0.001
Increased respiratory support 3.63 1.85-7.11 <0.001 2.33 1.05-5.15 0.04
Pallor/ gray skin 2.73 1.35-5.52 0.005 Not in this model
Capillary refill > 2 seconds 2.20 1.09-4.48 0.029 2.46 1.11-5.48 0.03
Lethargy Not in this model 2.78 1.25-6.21 0.01
CVC central venous catheter
Difference between clinical sepsis and proven sepsis
When the analysis approach was repeated but now for the associations with solely 
proven sepsis, instead of clinical ánd proven sepsis, the same clinical signs stayed in the 
final model, except for pallor and/or gray skin (Table 3). Performance of these models 
for predicting proven sepsis were also good with AUC 0.84 (95%CI 0.78-0.90; p<0.001) 
and Hosmer-Lemeshow goodness-of-fit-test p=0.319 for the full model, and AUC 0.83 




This study shows that most clinical symptoms in isolation have only moderate predic-
tive value for identifying LOS in preterm infants suspected for infection. The strongest 
predictive signs were: increased respiratory support, capillary refill time > 2 seconds, 
pallor or gray skin colour and a central venous catheter in 24 hours preceding the onset 
of suspected infection.
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Combining several clinical signs in a nomogram augments the predictive value for 
identifying LOS. This nomogram allows users to calculate an expected risk of LOS in an 
individual patient with suspected infection, based on the specific profile of the patient.
Clinical signs that are too nonspecific to be useful in excluding or diagnosing LOS 
were temperature instability, apnoea, tachypnoea, tachycardia, dyspnoea, hyper- and 
hypothermia, feeding difficulties and irritability. Even when two or more of these non-
figure 2. Nomogram for prediction of LOS in preterms suspected of infection with use of clinical signs 
and risk factors. LOS is defined as clinical and/or blood-culture proven sepsis.
Instructions: Determine how many points the patient receives for each feature using the upper part of the 
nomogram. Sum the points for all features. Locate this sum score on the “total points” axis. Draw a straight 
line to the lower axis “probability sepsis” to find the estimated probability of that patient having LOS 
(clinical and/or proven LOS).
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specific signs occur simultaneously the risk of neither clinical nor proven sepsis is hardly 
changed (data not shown).
Lack of clinical relevance of body temperature in diagnosing LOS in preterms, might be 
attributable to the use of incubators in this specific patient population. When changes 
in body temperature are observed, the environmental temperature in the incubator will 
be manipulated before serious hypo- or hyperthermia can occur. Probably, the need 
and magnitude of temperature adjustment of the incubator is a more valuable item to 
measure.
The marginal diagnostic value of general respiratory signs (apnoea, dyspnoea, tachy-
pnoea) might be explained by the high prevalence in preterms of non-infectious respira-
tory problems due to lung immaturity or bronchopulmonary dysplasia. The same might 
hold true for the minor clinical relevance of other general symptoms such as feeding 
intolerance and irritability.
Another interesting finding of this study is the difference in observed frequency of 
clinical signs between clinical and proven sepsis. In this study, especially pallor and/or 
gray skin colour was strongly associated with clinical sepsis compared to blood-culture 
proven sepsis. A gray skin colour is obviously considered a serious sign of sepsis by 
the medical team. The extent, to which this assumption of medical workers is correct, 
however, cannot be answered by this study. Future studies looking at for example viral 
cultures might possibly further elucidate the issue of blood-culture negative sepsis in 
preterm infants.
Strengths and weaknesses
The strength of our study is that the data were prospectively collected in a population of 
solely preterm infants. The latter is important because clinical symptoms in preterm in-
fants may have different clinical relevance compared to term infants.8 Several presumed 
signs of LOS can also be caused by prematurity itself, such as temperature instability, 
apnoea and feeding intolerance. Temperature problems for example, will be more in-
dicative for infectious disease in term infants than in preterms.
Another strength of our study is that we did not only evaluate the predictive aspects of 
blood-culture proven sepsis, but also clinical blood-culture negative sepsis. Certainly in 
clinical practice clinical sepsis is frequently encountered and cannot be simply ignored.
There are certain limitations of our study. One of the major problems is the definition 
of clinical sepsis. The clinical signs we have evaluated were to a certain extent all con-
tributing to the final diagnosis of clinical sepsis. This situation results in what is named 
incorporation bias. Since the symptoms and the diagnosis of clinical sepsis will be 
positively correlated in our study, misclassification may have resulted in overestimation 
of accuracy.1
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A serious threat when using multiple regression models, as we did in this study, is 
overfitting. Overfitting results in overly optimistic models. When the model is used in 
new patients the performance is often worse than expected. To minimize the problem 
of overfitting an adequate sample size, with enough events (i.e. LOS) compared to the 
potential predictors is very important. Taken to the extreme, if the number of predic-
tors equals the number of events, the model will fit perfectly, even if all predictors are 
entirely unrelated to the outcome variable.17 In general it is assumed that a minimum 
of 10 to 15 events per predictor variable will allow good estimates. Finally 6 predictors 
were used for multiple logistic regression, which seems fairly adequate, considering the 
89 observed events of LOS (ratio 1:14).
Clinical and research implications
Most important predictive signs for identifying LOS in preterm infants are: increased 
respiratory support, capillary refill, pallor/gray skin and a central venous catheter in 
the 24 hours preceding the episode of suspected infection. Our nomogram based on 
a combination of these clinical signs may predict LOS in preterms suspected of infec-
tion, even before ordering additional laboratory investigations. Clearly, we would like 
to emphasize that this model needs external validation in new patient groups. Still, the 
nomogram might be helpful in deciding on duration of antibiotic therapy, for example 
in situations were no bloodculture is available. Moreover the start of antibiotics could be 
postponed in case of low risk, under close monitoring of clinical symptoms. Furthermore 
further research evaluating the reliability and inter- and intra-observer variation for the 
more subjective symptoms is warranted.
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aBstract
Background: Early and accurate diagnosis of late-onset neonatal sepsis (LONS) in preterm 
infants is difficult since presenting signs are subtle and non-specific. Because neonatal 
sepsis may be accompanied by glucose intolerance and glucosuria, we hypothesized 
that glucosuria may be associated with LONS in preterms, in an early stage.
Objective: To evaluate the association of glucosuria and LONS in preterms.
Methods: We prospectively measured glucosuria semi-quantitatively at least 8 times a 
day in 316 preterms (gestational age <34 weeks) and followed the patients for occur-
rence of LONS. Attending physicians were blinded to glucosuria results. We assessed 
the predictive value of glucosuria for clinical LONS (clinical signs of sepsis but negative 
blood culture) and blood culture-proven LONS using logistic regression analysis.
Results: Glucosuria was found in 65.8% of patients, sepsis was suspected 157 times in 
123 patients. LONS was found in 47.1% of 157 suspected episodes (clinical sepsis in 
20.4% and culture-proven sepsis in 26.7%). Glucosuria was associated with lower birth 
weight (ORper 100g birth weight 0.80; 95%CI 0.75-0.85), lower gestational age (ORper week gestational age 
0.64; 95%CI 0.56-0.73) and with suspected LONS (OR 2.39; 95%CI 1.93-2.95). Glucosuria 
was more common in infants with confirmed LONS (70.3%) than in those in whom sepsis 
was ruled out (44.6%, p=0.007). After correction for gestational age, birth weight and 
postnatal age this association weakened to non-significant (OR 1.36; 95%CI 0.99-1.85, 
p=0.055). An increase in glucosuria in the 24 hours before onset of symptoms was as-
sociated with confirmed LONS (OR 2.52, 95%CI 1.13-5.59) with sensitivity 30.4% and 
specificity 85.2% (LR 2.05).
Conclusion: Glucosuria in preterms is positively associated with the occurrence of LONS. 
An increase in glucosuria is associated with the occurrence of LONS within 24 hours, 
however this association is too weak to be of diagnostic value.
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introduction
Late-onset neonatal sepsis (LONS), mostly defined as neonatal sepsis occurring after 
three days of age, is an important cause of morbidity and mortality in preterm infants.1 
Early and correct diagnosis of LONS in preterm infants is challenging because present-
ing signs are subtle and non-specific.2 Several screening tools have been investigated 
to improve early diagnosis of LONS, such as a combination of clinical signs3-6 haemato-
logical biomarkers5,7-9, changes in microcirculation10, heart rate monitoring11,12 and use of 
central-peripheral temperature gradient.13
Disturbed glucose homeostasis is frequently seen in prematurely neonates. Hyper-
glycaemia has been found in 25 to 80% of premature newborns, depending on their 
gestational age and birth weight.14,15 Because of inadequate hepatic and diminished 
pancreatic insulin secretory responsiveness, the risk of hyperglycaemia increases 
in stressful episodes, such as sepsis.16,17 Together with a lower renal threshold, such 
glycaemic instability may produce glucosuria in preterm infants, even in absence of 
hyperglycemia.18
Although it has been recognized that hyperglycaemia may be an important early 
sign in neonatal sepsis,17,19, 20 monitoring blood glucose levels requires repeated blood 
sampling, with its disadvantages of discomfort, stress and the risk of iatrogenic anemia 
and blood transfusions. To our knowledge, the usefulness of non-invasive measurement 
of glucosuria as an early sign of neonatal sepsis has not been prospectively investigated.
Therefore the aim of this study was to evaluate the diagnostic value of (changes in) 
glucosuria in the early detection of LONS in preterm infants.
methods
Patients
This study was part of a prospective cohort study investigating clinical signs and symp-
toms in preterms with suspected LONS, undertaken from July 2005 until November 
2007, at our level-III neonatal intensive care unit (NICU) in Zwolle, the Netherlands.21 
Eligible patients included all patients with a postconceptional age < 34 weeks, > 72 
hours after birth who had not been on antibiotic therapy for the last 24 hours. Patients 
were followed until a corrected gestational age of 35 weeks or until discharge to other 
hospitals before 35 weeks.21
Glucosuria measurement
We prospectively collected data on glucosuria and the occurrence of late-onset sepsis 
on a daily basis. Combur reagent strips (Combur3Testâ Roche) were used to test urine 
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samples for glucosuria, using a semi-quantitative scoring system of 0 (no glucosuria), 1+ 
(urine glucose level 0.6-5.0 mmol/L), 2+ (3.3-7.7 mmol/L), 3+ (14.8-19.2 mmol/L) and 4+ 
(52.8-57.2 mmol/L), according to the product information. Reagent strips were pressed 
into the wetted diaper directly or applied to urine collected by needle and syringe from 
a piece of gauze in the diaper. Glucosuria was assessed at least 8 times each day of 
admission in each infant until a corrected age of 35 weeks. Measurement of glucosuria 
was performed by the attending nurse and were collected only for research purposes. 
Treating clinicians were unaware of glucosuria results.
Definition
A change in glucosuria was defined as an increase of at least one category; category 
1+ and 2++ were pooled since we previously showed that these categories cannot be 
reliably distinguished, because the glucosuria ranges that can be found in these two 
categories overlap.22
An episode of suspected sepsis was defined as a clinical suspicion by the attending 
neonatologist. At the onset of each episode, data on clinical signs were assessed in a 
standardised way, by means of a form where the physician filled in the clinical signs on 
which the suspicion of LONS were based, and routine laboratory investigations, includ-
ing blood cultures, C-reactive protein (CRP) and full blood count were performed.22
The outcome of each episode was classified in 3 mutually exclusive categories: blood-
culture proven sepsis, clinical (blood-culture negative) sepsis and rejected sepsis. The 
classification was made by the researchers based on the course of the episode after the 
start of antibiotics. Blood-culture proven sepsis was defined as an episode with positive 
non-contaminated blood-culture. Infants were classified as having clinical sepsis in case 
of a negative blood culture despite strong clinical suspicion of sepsis as defined by the 
attending neonatologist or raised CRP (>10 mg/l) or positive haematological markers. 
Rejected sepsis was defined as an episode with negative blood culture (plus CRP < 10 
and negative haematological markers) or an episode in which no blood culture was 
performed and no antibiotics were started. In all our analyses and results, LONS was 
defined as blood-culture proven and/or clinical sepsis, unless stated otherwise.
Statistical analysis
Associations of the degree of glucosuria with patient characteristics and LONS were 
analysed by ANOVA or Chi2 as appropriate.
Association between the presence of glucosuria as well as an increase in glucosuria 
and the occurrence of LONS was analysed in the group of patients with suspected 
infection using multivariate logistic regression analysis, adjusting for birth weight, ges-
tational and postnatal age, and the as known risk factors for glucosuria. Furthermore we 
used a multivariable model based on backward regression analysis, to correct for some 
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major clinical signs that were shown to be the strongest predictors of LONS in this study 
population, as we reported earlier, i.e. increased respiratory support, lengthened capil-
lary refill, grey skin and the presence or recent removal of a central venous catheter.21
Analyses were performed using SPSS version 20.0.
Consent and ethical approval
The study was approved by the local medical ethical committee of our hospital. Written 
informed consent was obtained from the parents.
results
During the 2-years study period, a total of 316 of 360 eligible patients < 34 weeks were 
included. Reasons for exclusion were: short admission < 1 day (n=7), antibiotics during 
the entire admission (n=31) or missing measurements of glucosuria (n=6). A total of 187 
episodes of suspected sepsis occurred in 142 patients. After excluding 30 episodes with 
missing glucosuria measurements, we evaluated 157 episodes of suspected infection in 
123 patients. Patient characteristics and their suspected sepsis episodes are presented 
in tables 1 and 2.
table 1. Characteristics of the study population.
all included patients
n=316
Patients with suspected infection
n=123
Gestational age, weeks+days 30+3 (2+1) 29+1 (2+1)
Birthweight, g 1431 (481) 1187 (345)
Male sex, n (%) 181 (57.3%) 70 (56.9%)
Died during admission, n (%) 4 (1.3%) 1 (0.8%)
Age at onset of suspected infection, days na 12 (7-18)
Follow-up, days 16 (9-16) 24 (14-35)
Mean (standard deviation) for gestational age, birth weight. For age at onset and follow-up in days 
median (p25 and p75) are given because of skewed distribution. Data from patients who experienced 
more than one episode of suspected infection are from their first episode.
Glucosuria
Glucosuria within the individual patient at any moment during the study period and in 
varying degrees, was found in the majority (65.8%) of patients (+ or ++ in 40.2%, +++ 
in 17.7% and ++++ in 7.9%). Glucosuria was negatively associated with gestational age 
(ORper week gestational age 0.64; 95%CI 0.56-0.73, p<0.001) and birth weight (ORper 100g birth weight 
0.80; 95%CI 0.75-0.85, p<0.001). Glucosuria was found in 92.2% of patients with gesta-
tional age ≤ 30 weeks, as compared to 57.7% in gestational age 31-32 weeks and 21.9% 
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in 33-34 weeks (p=0.001). Glucosuria was more common in patients with birth weight < 
1200 g (90.8%) than in those > 1200 g (52.7%, p< 0.001).
Glucosuria was equally common in males and females (63.5% versus 68.8%; p=0.321).
Sepsis diagnosis
A diagnosis of LONS was made in 74 (47.1%) of the 157 suspected sepsis episodes: 32 
(20.4%) clinical sepsis and 42 (27%) culture-proven sepsis. In the culture proven sepsis 
episodes the following microbacteriae were found: Staphylococcus Epidermidis (57.1%), 
Staphylococcus Aureus (14.3%), Bacillus Cereus (19.0%), gram negative strains (5.0%), 
Streptococcus (2.3%) and Candida (2.3%).
Association of glucosuria with late onset sepsis
The 108 patients who never had glucosuria had fewer suspected sepsis episodes (13.9%) 
than the 208 patients with glucosuria ever (60.1%, OR 9.34; 95%CI 5.06-17.22, p<0.001). 
This association remained significant after correction for gestational age and birth 
weight (OR 4.19; 95%CI 2.11-8.32, p<0.001).
table 2 Characteristics of included suspected sepsis episodes
n=157
respiratory symptoms
(Increase in) apnea, bradycardia and/or cyanotic spells 56.1%
Increased respiratory support 45.2%
circulatory symptoms
Pallor/gray skin 48.4%







CRP (mg/l) 2 (0-12)
Leucocytes (10E9/l) 12.5 (8.9-17.9)
Rods (%) 0 (0-3)
IT-Ratio (%) 0 (0-5.1)
risk factors
CVC in last 24 hours 31.2%
Mechanical ventilation 8.9%
Number (percentage) are given, except for “Laboratory values” where mean (p25-p75) are presented
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Glucosuria in the period before onset of LONS
Suspected sepsis episodes were commonly preceded by glucosuria between 48 and 24 
hours (46.5%), or in the 24 hours before onset of clinical suspicion (56.7% of episodes). 
Glucosuria 48-24 hours before onset was not associated with confirmed LONS, defined 
as clinical ánd proven sepsis (OR 1.08, 95%CI 0.77-1.51, p 0.705), nor with solely culture-
proven sepsis (OR 0.84, 95%CI 0.56-1.26, p=0.401). The degree of glucosuria in the 24 
hours before clinical suspicion was positively associated with confirmed LONS (OR 2.95, 
95%CI 1.50-5.77, p=0.002), but not with culture-proven sepsis (OR 1.23;95%CI 0.91-1.66, 
p=0.185, Table 3). After adjustment for gestational age, birth weight and postnatal age, 
the association between the degree of glucosuria in the 24-hours before the episode 
and confirmed LONS became almost non-significant (OR 1.36, 95%CI 0.99-1.85, p=0.055). 
Diagnostic value of the presence of glucosuria in the 24-hours period before suspected 
LONS is presented in table 4.
table 3 Association of glucosuria in the 24-hours period before clinical suspicion of infection and the final 













































0 68 (43.3%) 46 (67.7%) 9 (13.2%) 13 (19.1%)
0.031
+ 35 (22.3%) 15 (42.9%) 8 (22.9%) 12 (34.3%)
++ 34 (21.7%) 14 (41.2%) 10 (29.4%) 10 (29.4%)
+++ 15 (9.6%) 6 (40.0%) 2 (13.3%) 7 (46.7%)
++++ 5 (3.1%) 2 (40.0%) 3 (60.0%) 0 (0%)
Increase in glucosuria* 33 (22.0%) 12 (36.4%) 8 (24.2%) 13 (39.4%) 0.017
*Data on change in glucosuria in the 24-hour period before onset of clinical suspicion of sepsis were 
missing in 7 of 157 episodes
table 4 Diagnostic value of glucosuria in LONS
157 episodes of suspected LONS Confirmed clinical and culture proven LONS
n=74 (47.1%)
prevalence sensitivity specificity ppv npv LR+ LR-
Presence of glucosuria 56.7% 70.3% 55.4% 58.4% 67.6% 1.6 0.54
Increase in glucosuria 22.0% 30.4% 85.2% 63.6% 59.4% 2.1 0.82
LONS Late-onset neonatal sepsis, ppv positive predictive value, npv negative predictive value, LR 
Likelihoodratio
Increase in glucosuria in the period before onset of LONS
A change in glucosuria in the 24-hours preceding before the onset of suspected LONS 
was found in 48 (32%) of episodes (decrease in 10%, no change in 68%, one category 
increase in 20%, two categories increase in 3% (Table 3)).
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An increase in glucosuria in the 24 hours before onset of symptoms was associated 
with confirmed clinical and culture-proven LONS (OR 2.52, 95%CI 1.13-5.59) but not for 
solely culture-proven sepsis (OR 2.26 95%-CI 0.99-5.19, p=0.05). After adjustment for 
gestational age, birth weight, and postnatal age, this association weakened and was 
no longer significant (adjusted OR 2.19; 95%CI 0.96-4.97, p=0.061). Diagnostic value of 
the increase in glucosuria in the 24-hours period before suspected LONS is presented in 
table 4.
Comparison of glucosuria with other clinical signs and symptoms in LONS
Correction with some major clinical signs that were shown to be the strongest predictors 
of LONS in this study population, as we reported earlier21, weakened the association of 
an increase in glucosuria to non-significant (OR 1.6; 95%CI 0.61-4.00, p0.356). When put-
ting all the signs in a multivariable model, using backward logistic regression analysis, 
the increase in glucosuria was left out of the final model, meaning that this factor does 
not add to the predictive value of the combination of the other signs and symptoms.
discussion
Principal findings
This study shows that glucosuria is very common in preterm infants, with increasing 
prevalence with lower gestational age, lower birth weight, and with the occurrence of 
late onset sepsis. Although an increase in the degree of glucosuria in the 24 hours before 
clinical suspicion of sepsis is associated with confirmed LONS, the diagnostic value is 
only marginal. This is probably due to the fact that glucosuria is merely associated with 
gestational age and weight, which are well-known, and stronger risk factors for the oc-
currence of LONS. The measurement of glucosuria doesn’t seem to be of additive value 
in detecting LONS, when compared to the stronger clinical signs, such as increased re-
spiratory support severe respiratory or circulatory symptoms.21 Because glucosuria was 
more strongly associated with confirmed LONS (either clinical sepsis or culture-proven 
sepsis) than with solely culture-proven LONS, it appears that (an increase in) glucosuria 
can possibly be regarded as a sign of stress and not as a specific marker of infectious 
sepsis. This is in accordance with earlier reports of the association of hyperglycaemia 
with LONS.14,15,17
Our study confirms earlier observations that preterm infants have an increased risk of 
glucosuria and that glucosuria is negatively associated with gestational age and birth 
weight.14,20,23 Our study is the first, however, to assess the value of the presence and 
degree of glucosuria as an early marker in detecting LONS in preterm infants.
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Strengths and weaknesses
The strength of our study is that the data were prospectively collected in a well-defined 
population of preterm infants suspected of late-onset sepsis. This is important because 
both clinical symptoms and inflammatory responses may differ between preterm and 
term infants.24 Attending physicians and researchers who classified the sepsis episodes 
were strictly blinded to glucosuria results. This is crucial to prevent incorporation bias 
and thus overestimation of diagnostic accuracy or associations.25
We consider it to be an additional strength that we did not only include blood-culture 
proven sepsis, but also clinical blood-culture negative sepsis, reflecting daily practice in 
neonatal intensive care wards.
An important weakness of our study was the lack of a strict definition of suspicion of 
sepsis. We left the treating physician to judge whether the signs and symptoms gave 
rise to clinical suspicion of a LONS, realizing that this will lead to a certain inter-physician 
variation. Another point of criticism is that we only analyzed the glucosuria results in 
suspected episodes of LONS and thus did not further analyse the predictive value of 
glucosuria. This means that we do not know how often preterms experience a change 
in degree of glucosuria without subsequent clinical suspicion of sepsis. It would be 
interesting to know whether monitoring of daily glucosuria, is of additional value above 
monitoring of clinical findings and vital parameters, for early detection of LONS.
In conclusion, we demonstrate that changes in the degree of glucosuria occur early in 
the course of LONS in preterm infants, but that this marker is only of marginal diagnostic 
value.
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aBstract
Aim: To assess the reliability of fluid balance charts in neonates.
Methods: An observational study in 170 non-breastfed neonates, requiring continuous 
monitoring on a high care unit, but not critically ill. The fluid balance was compared to 
daily body weight changes using Bland-Altman analysis. Differences more than 20% of 
daily fluid intake were considered clinically relevant.
Results: The mean gestational age was 36+2 weeks (SD 18.7 days) and mean birth weight 
2782 g (SD 749 g). The mean difference between 394 fluid balances over 24 hours (in ml) 
and daily weight changes (in g) was -12.1 (limits of agreement -128.1 to 103.8). In 40% of 
comparisons the difference with daily weight change was more than 20% of daily fluid 
intake.
Conclusion: Fluid balance charts both over- and underestimate body weight changes in 
an unpredictable pattern and are therefore unreliable as a single measure of fluid status 
in neonates.
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introduction
Fluid balances are widely used in several clinical settings. In neonatal high-care, keeping 
a fluid balance is accepted as part of routine care.1,2,3 Accurately keeping a fluid balance 
is a challenging and time-consuming task for the nursing staff.3 Problems in estimating 
the quantities of body fluids leaking into bed sheets and diapers, insensible losses and 
errors in calculations threaten the accuracy of the fluid balance results.4,5 In neonates 
insensible water loss is particularly difficult to estimate because it is influenced in an 
uncertain way by various factors such as ambient humidity, gestational age, respiratory 
rate, and phototherapy.1,6 Furthermore the fluid intake of breastfed infants is uncertain 
because there is no reliable and practical method to assess milk intake in breastfeeding 
infants.7
Despite its widespread use, studies evaluating the reliability of the fluid balance are 
sparse, showing poor accuracy in adults.4,5,8,9 No studies to date have evaluated the reli-
ability of fluid balance recording in neonates. Therefore we performed an observational 
study in sick neonates to investigate the reliability of fluid balances by comparing fluid 
balance data to daily changes in body weight, which we consider the most accurate 
estimation of fluid status.
methods
Patients
From June 2009 through March 2010, we conducted this study in our neonatal high 
care ward. Patients admitted to this high care ward (approximately 500 per year) are 
sick, but non-critically ill neonates with gestational age > 32 weeks or moderate disease 
severity, requiring continuous monitoring of cardiorespiratory status without the need 
for intensive care. Whenever possible, infants are breastfed, however in this high-care 
population, most infants (or their mothers) are too sick to breastfeed. The majority of 
infants receive tube feeding or bottle feeding (when possible with expressed mother’s 
milk).
Each neonate initially admitted to the neonatal high care ward was eligible for inclu-
sion in the study. We chose only to include patients who were not breastfed, because 
there is no reliable method for assessing milk intake in breastfed neonates.7 Patients 
transferred from the neonatal intensive care unit were excluded, because these patients 
are well stabilized and routine fluid balance keeping in this patient category is not com-
mon practice in our clinic.
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Assessment of daily fluid balance and body weight
In all included patients, fluid input and output, fluid balance chart, and body weight 
were assessed daily during the first three days of admission to the ward. In the majority 
of patients this will be the first 3 days after birth.10,5 Insensible water loss was calculated 
as 30 ml/kg/day for neonates born at a gestational age between 32 and 37 weeks, and 
20 ml/kg/day for neonates born after 37 weeks.11 Patients were weighed daily without 
clothes, diaper and monitor or pulse oximeter wires, before feeding between 6:00 and 
9:00 am.
Statistical analysis
The correlation between fluid balance and daily body weight changes was assessed 
using Pearson correlation coefficients. We assumed 1 milliliter of fluid to correspond 
with 1 gram of bodyweight. The agreement of the fluid balance with daily body weight 
changes was assessed by a Bland-Altman plot.12 The Bland-Altman plot is the preferred 
method for assessment of the agreement between two different measurements of a 
continuous measure. The Bland Altman plot assigns the average of the weight change 
and the fluid balance on the x-axis, and the difference between the weight change and 
the fluid balance on the y-axis. With the Bland-Altman plot the mean difference between 
the two methods is given and the limits of agreement (±1.96SD), allowing the reader to 
judge on the clinical relevance of the agreement.12
Before the start of the study, we defined differences between the two methods of more 
than 20 percent of the daily fluid intake (accounting for approximately 50 ml or grams 
change in body weight), to be clinically relevant. We used t-tests to assess the influence 
of potential confounding factors (mentioned in table 2) on the difference between the 
fluid balance and body weight change and ANOVA for the influence of postnatal age.
To rule out the possibility of human calculation errors in calculating the fluid balance, 
we entered all recorded data on fluid intake and output in a spread sheet program and 
recalculated the fluid balance electronically.
All p values mentioned are two-sided. Analyses were performed with Statistical Pack-
age for the Social Sciences (SPSS) software, version 18.0.
Ethical approval
Written informed consent was obtained from the parents or caretakers of the partici-
pants. The study was approved by the institutional’s ethics review board.
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results
Figure 1 presents the enrolment of patients. During the study period 321 patients were 
admitted to the neonatal high care ward. Finally, fluid balance calculations and body 
weight changes were compared on 394 days in 170 patients. Table 1 shows the baseline 
characteristics of included patients. Of 170 included patients, 136 (80%) were included 
on the first day, 17 (10%) on the second day, 6 (4%) on the third day and 11 (6%) beyond 
the third day after birth.
 
381 patients admitted during 9-months study 
period 
164 not eligible (fluid balance not routinely 
indicated) 
70 transferred from neonatal 
intensive care 
60 medium care 
34 other  
observation for peri-operative  
complications 
post-vaccination 
social indication, etc 
217 eligible 
170 included in prospective cohort 
47 missed inclusion 
10 no parental consent 
37 missed  
(referral within 24 hours, data not collected) 
figure 1. Patient enrolment
The correlation coefficient between fluid balance (in ml) and body weight change (in 
g) over 24 hours was 0∙64 (p<0∙001) and 0.925 over 3 days (p<0.001). The mean differ-
ence when subtracting the 24-hour fluid balance (in ml) from the daily change in body 
weight (in g) was –12∙1 (limits of agreement -128∙1 to 103∙8). In 158 comparisons (40%), 
the difference between the fluid balance and change in body weight exceeded 20% of 
the daily fluid intake, our predefined threshold of clinical relevance Complete data on 
weight change and fluid balance on all 3 days were available in 85 patients. The mean 
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table 1 Characteristics of patients
characteristics n=170
Male sex 100 (59%)
Gestational age (weeks +days)





























































figure 2. Bland Altman plot for agreement between daily fluid balance and difference in body weight.
The fluid balance includes correction for insensible water losses. Every dot represents a measurement 
(n=394). Mean difference between daily difference in body weight and the fluid balance is -12.1 (95% CI 
-128.1 to 103.8).
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difference between the total of weight differences and the total of fluid balances over 3 
days was -44.5 (limits of agreement -246.2 to 157.2). In 21.2% of comparisons the total 
difference over 3 days was more than 5% of birth weight. Fluid balances both over- and 
underestimated body weight changes in an unpredictable pattern (Figure 2).
The difference between fluid balance and body weight change was significantly 
influenced by regurgitations/vomiting and prematurity: in patients with regurgitations/
vomiting lower agreement between fluid balance and daily weight change was found 
(p=0∙03), whilst in premature patients with gestational age < 36 weeks, agreement was 
higher (p<0∙01). The imprecision of the fluid balance was not significantly related to 
respiratory support (p=0∙06) nor to phototherapy (p=0∙53) Fever and tachypnoea were 
only present in a very small number of days, precluding meaningful statistical analysis 
(Table 2). Postnatal age did not influence the difference between weight change and 
fluid balance: differences on day 1, 2 and 3 respectively were -17.3 ml, -7.8 ml and -24.1 
ml (ANOVA p=0.11).
table 2 Factors that might influence the reliability of the fluid balance. Discrepancy in daily bodyweight 
changes and fluid balance in patients with and without potential confounding factors.
Potential 
confounding factors
factor present factor absent
n
Mean difference 
between fluid balance 




between fluid balance 







16 * 378 -12∙08 (59∙88) * *
Respiratory support # 46 6∙65 (72∙60) 345 -15∙03 (56∙46) -0∙64:44∙01 0∙06
Frequent defecation 
(≥3 times a day)
263 -13∙71 (58∙70) 131 -8∙20 (57∙19) -12.94: 23∙96 0∙56
Phototherapy 67 -19∙59 (56∙99) 327 -10∙62 (59∙58) -24∙57: 6∙62 0∙26
Fever (>38 oC) 7 * 387 -12∙92 (57∙96) * *
Premature 274 -2∙1 (53∙54) 120 -35∙08 (64∙98) 19∙66:46:31 <0∙01
Vomiting/
regurgitation
125 -21∙88 (58∙46) 269 -7∙62 (59∙06) -26∙79:-1∙73 0∙03
Total comparisons between daily bodyweight changes and fluid balance was 394. n= number 
of comparisons, mean = mean difference between fluid balance and daily body weight change: 
subtracting the fluid balance (in ml) from the change in body weight (in g), SD= standard deviation, CI= 
95% confidence interval and p-value using t-test. * due to small number mean and SD and t-test not 
applicable. # Nasal continuous positive airway pressure or supplemental oxygen through nasal canula.
Recalculating the fluid balance data by a spreadsheet program yielded a number of 
179 human calculation errors (45%). The differences in relation to the hand-recorded 
fluid balances were small, with a median difference of 0∙0 ml (interquartile range -8∙0 
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to 0∙00, p 0∙11) . More over the agreement of the fluid balance with daily body weight 
changes did not improve when spreadsheet-calculated data were used. The mean dif-
ference between the calculated fluid balance (in ml) and body weight change (in g) was 
slightly larger than that observed for the hand-recorded fluid balance data (-19∙3, 95% 
CI: -131∙7 to 93∙2).
discussion
This study shows that keeping a fluid balance on a neonatal high-care ward shows poor 
agreement with daily changes in body weight, with more than 40% of the comparisons 
showing clinically relevant differences. Our findings confirm earlier reports in adults 
showing poor agreement of fluid balance with changes in body weight4,5,13, central 
venous monitoring14 or bioelectrical impedance measurements.15
Although the concept of estimating fluid status by recording fluid in- and output 
seems logical, the inaccuracy of the fluid balance raises serious doubt about the useful-
ness of keeping a fluid balance in clinical practice. The numerous assessments of fluid 
volumes during a day are all subject to measurements errors. Although measuring fluid 
intake in sick newborns appears to be straightforward, spilling of milk while feeding and 
regurgitation or vomiting may reduce the precision of such intake recordings. In our 
study, vomiting significantly influenced the imprecision of the fluid balance. Similarly, 
problems may occur in estimating the quantities of fluid output. Measuring urinary 
output is usually performed by weighing diapers before and after micturation. This does 
not take spilling of urine into bedsheets into account. In addition, the scales used to 
weigh diapers are unlikely to be sensitive enough to pick up small weight changes of the 
diaper.7 Defecation might be another factor increasing inaccuracy of the fluid balance. 
It is uncertain how much fluid is lost through defecation, however frequent defecation 
(>3 times a day) did not significantly influence the imprecision of the fluid balance in our 
study (p=0∙56).The insensible losses may be influenced by several factors. In this study, 
tachypnoea and fever were only present in a small number of comparisons, limiting our 
ability to study their influence on the imprecision of the fluid balance. Respiratory sup-
port and phototherapy did not significantly influence the difference between the fluid 
balance and weight change, possibly because it is routine on our ward to nurse infants 
with respiratory support or phototherapy in incubators, ensuring humidification The 
significant difference in imprecision of the fluid balance between premature and term 
infants is remarkable. A possible explanation might be that the (calculated) correction 
for insensible water loss is more accurate in premature infants (30 ml/kg/day) than in 
term infants (20 ml/kg/day).11
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We acknowledge the following limitations of our study. Firstly, it could be argued 
that using another measure of fluid status, such as central venous pressure monitoring 
or body impedance measurements, would have been valuable. Because we wanted to 
assess the reliability of the fluid balance in clinical practice, we purposely chose (trends 
in) body weight as comparison, since this is most frequently used in clinical practice, 
and probably the most adequate and simple method to estimate total fluid balance over 
time.in neonates. Secondly, this study was not performed in infants requiring neonatal 
intensive care, in whom recording a fluid balance may have the largest clinical impact 
and usefulness. We deliberately chose a high-care population, in whom recording all 
required data (including daily body weight measurements) would be most practical and 
feasible. This means that we cannot conclude on usefulness of keeping a fluid balance in 
critically ill patients. It can be argued that urinary output and trends in fluid balance and 
body weight remain indispensable in critically ill patients. Thirdly, the frequent use of 
incubators in our population might threaten generalizability of the results. For reasons 
of optimal humidification and facilitation of close observation, it is common practice in 
our hospital to prefer an incubator over a cot or open radiant table, however this policy 
is merely a matter of tradition and is at least debatable. Since use of an open radiant 
table augments the insensible losses, the reliability of the fluid balance might even be 
diminished in this situation.
The main strengths of our study are that we examined the reliability of fluid balances 
as they are currently recorded in many neonatal wards and the large size of our study 
group.
In conclusion, this study demonstrates the imprecision of fluid balance in neonates. 
Fluid balance charts both over- and underestimate body weight changes in non-critically 
ill neonates in an unpredictable pattern and are therefore unreliable as a single measure 
of fluid status
references
 1. Aggarwal R, Deorari AK, Paul VK. Fluid and electrolyte management in term and preterm neo-
nates. Indian J Pediatr 2001;68:1139-42.
 2. Scales K, Pilsworth J. The importance of fluid balance in clinical practice. Nurs Stand 2008;22:50-7.
 3. Tsang LD, DeMarini S, Rath LL. Electrolytes, vitamins, trace minerals. In: Kenner C, Wright Lott J. 
Neonatal nursing 3rd ed. Philadelphia: WB Saunders, 2003:409-24.
 4. Chung LH, Chong S, French P. The efficiency of fluid balance charting: an evidence-based man-
agement project. J Nurs Manag 2002;10:103-13.
 5. Daffurn K, Hillman KM, Bauman A, Lum M, Crispin C, Ince L. Fluid balance charts: do they measure 
up? Br J Nurs 1994;3:816-20.
 6. Grunhagen DJ, de Boer MG, de Beaufort AJ, Walther FJ. Transepidermal water loss during halogen 
spotlight phototherapy in preterm infants. Pediatr Res 2002;51:402-5.
80 Chapter 3 : Fluid balance charts in neonates
 7. Savenije OE, Brand PL. Accuracy and precision of test weighing to assess milk intake in newborn 
infants. Arch Dis Child Fetal Neonatal Ed.2006;91:F330-32.
 8. Eastwood GM. Evaluating the reliability of recorded fluid balance to approximate body weight 
change in patients undergoing cardiac surgery. Heart Lung 2006;35:27-33.
 9. Mank A, Semin-Goossens A, Lelie J, Bakker P, Vos R. Monitoring hyperhydration during high-dose 
chemotherapy: body weight or fluid balance? Acta Haematol 2003;109:163-8.
 10. Brand PLP Test weighing for term and premature infants is an accurate procedure: author’s reply. 
Arch Dis Child Fetal Neonatal Ed 2007; 92: F328.
 11. Davis ID, Avner ED. Fluid and Electrolyte Management. In: Martin RJ, Fanaraff AA, Walsh MC. 
Neonatal-perinatal medicine: diseases of the fetus and infant 8th ed. Mosby, 2005.
 12. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of 
clinical measurement. Lancet 1986;1:307-10.
 13. Meier PP, Engstrom JL. Test weighing for term and preterm infants is an accurate procedure. Arch 
Dis Child Fetal Neonatal Ed 2007;92:F155-6.
 14. Craig J, Mathieu S. Is central venous pressure monitoring appropriate for assessment of periop-
erative fluid balance? Br J Hosp Med (Lond) 2006;67:108.
 15. Nenchev N, Hatib F, Daskalov I. Monitoring relative fluid balance alterations in haemodialysis of 
diabetic patients by electrical impedance. Physiol Meas 1998;19:35-52
Usefulness of the fluid balance: A 




J Paediatr Child Health 2013;49:486-92
82 Chapter 3 : Fluid balance charts in neonates
aBstract
Aim: To assess the effects of fluid balance charts in neonates with moderate disease 
severity on duration of hospitalisation and medical interventions.
Methods: Randomised, controlled trial in a neonatal ward in a general teaching hospital 
in the Netherlands between June 2009 and March 2010.
170 neonates with moderate disease severity, requiring continuous monitoring of vital 
parameters (mean gestational age 36+2 weeks (SD 2+5 days), mean birth weight 2782 
g (SD 749 g)) participated. In the control group (n=86), attending physicians could ac-
cess all fluid balance data, whilst these data were blacked out in the intervention group 
(n=84). Primary outcome was length of hospital stay. Secondary outcomes were per-
centage weight loss, interventions based on the fluid status, unblinding of fluid balance 
data and incident reporting.
Results: Length of hospital stay did not differ significantly between the intervention and 
the control group (Median 9 versus 8 days, with ratio of geometric mean 1∙25, 95%-CI 
0∙99 to 1∙57; p 0.06). We found no significant differences in secondary outcomes.
Conclusions: Routinely keeping fluid balances in neonates with moderate disease sever-
ity does not affect duration of hospitalisation or medical treatment.
Trial registration: ClinicalTrials.gov, number NCT00962754.
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introduction
Assessment of fluid status is commonly performed in a wide variety of clinical settings, 
especially in critically ill patients. Several methods of examining the fluid status are 
used: physical examination aimed at identifying clinical symptoms of overhydration 
or dehydration, laboratory investigations (blood or urine osmolarity and electrolytes), 
more invasive haemodynamic measurements (central venous pressure monitoring) or 
bioelectrical impedance measurements. The most commonly used method, however, 
is keeping a fluid balance. This includes meticulously measuring fluid in- and output, 
taking insensible water losses into account.1 Accurately keeping a fluid balance chart is 
a challenging and labour-intensive task. Despite its widespread use, only a few studies 
have examined its reliability, most in adults, and these studies showed poor accuracy.2-7 
Earlier we published a study which confirmed poor accuracy of fluid balances in neo-
nates.8 Moreover, the clinical usefulness of keeping a fluid balance is unknown. To our 
knowledge, no studies to date have assessed whether keeping a fluid balance improves 
patient care, and if so, against what costs.
In intensive care settings, keeping a fluid balance is commonly accepted as part of 
routine care.9 No studies to date have evaluated the usefulness of fluid balance record-
ing in neonates. Therefore we undertook a randomised controlled trial to evaluate the 
effects of fluid balance recording in sick neonates on duration of hospitalisation, weight 
loss and medical interventions aimed at the patient’s fluid status. For safety reasons 
we chose a patient group with moderate disease severity as a proof of principle before 
studying more critically ill patients in a Neonatal Intensive Care unit We also analysed 
the time spent keeping and calculating a fluid balance.
materials and methods
Trial design
From June 2009 through March 2010, we conducted a randomised controlled in 
neonates with moderate disease severity (Patients), comparing the situation were the 
physician has access to all fluid balance data (Control) to the situation were the fluid 
balance data were blacked out (Intervention). The primary outcome was the duration of 
hospitalisation (Outcome)
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Patients
Setting
The study was conducted in the Neonatal High Care ward of the Isala Klinieken, a 
large general teaching hospital in Zwolle, the Netherlands. Patients admitted to this 
12-bed High Care ward are neonates with moderate disease severity requiring con-
tinuous monitoring of cardiorespiratory status without the need for intensive care. The 
population primarily consists of preterm infants (gestational age 32-35 weeks), low birth 
weight infants (birth weight 1200-1800 grams), infants needing non-invasive respiratory 
support (nasal continuous positive airways pressure or supplemental oxygen through 
nasal canula) and infants treated for neonatal hyperbilirubinemia, hypoglycaemia or 
(suspected) neonatal sepsis. The majority of patients are nursed in a humidified (50%) 
incubator, also (near) term newborns. The choice for the use of humidified incubators is 
mainly based on the nurses’ preferences to observe the sick babies in our ward without 
clothes or blankets, especially during the first 1-2 days after birth. More over our ward 
has only access to a limited number of open beds with radiant heathers. Neonates need-
ing mechanical ventilation or inotropic support are admitted to the Neonatal Intensive 
Care, as well as preterm neonates born at less than 32 weeks gestational age or with 
birth weight less than 1200 grams. The Neonatal High Care ward receives approximately 
500 admissions per year.
Eligibility
Each neonate initially admitted to the Neonatal High Care ward was eligible for inclusion 
in the study, because it was routine practice in our clinic to record the fluid balance 
in these patients. Patients transferred from the Neonatal Intensive Care unit were ex-
cluded, because these patients are well stabilized and routine fluid balance keeping in 
this patient category is not common practice in our clinic.
Study intervention
In all included patients, fluid input and output, fluid balance chart, and body weight were 
assessed daily during the first three days of admission to the ward, which in the majority 
of patients means the first 3 days after birth. In the control group, all fluid balance data 
were available to the attending physician. In the intervention group, these data on fluid 
intake, fluid output and fluid balance charts were masked except for daily body weight 
measurements and the number of wet diapers. As part of routine care diapers of admit-
ted neonates are refreshed every 3 hours. The attending physician had the opportunity 
to unblind the fluid balance data when this was judged to be clinically necessary.
Usefulness of the fluid balance: A randomised controlled trial in neonates 85
3
Procedures (assessment of daily fluid balance and body weight)
The fluid balance was calculated every 24 hours by subtracting daily fluid output and 
calculated insensible water losses from daily fluid intake. Fluid intake was calculated by 
adding the amount of enteral feeding, intravenous fluids and oral or intravenous medi-
cation. Urinary output and defaecation were determined by weighing diapers. When a 
diaper was soiled with stool, the weight of the full diaper was denoted as defaecation 
and added to the daily output. Fluid output was not adjusted for vomiting because such 
estimation has been found to be unreliable in previous studies.6 Insensible water loss 
was calculated as 30 ml/kg/day for neonates born at a gestational age between 32 and 
37 weeks and 20 ml/kg/day for neonates born after 37 weeks.10 Patients were weighed 
daily without clothes, diaper and pulse oximeter, before feeding between 6:00 and 9:00 
am. One single infant weighing scale was used, which was calibrated monthly according 
to hospital and manufacturer guidelines.
Outcome measures
The primary outcome measure was length of hospital stay. Secondary outcomes 
included the maximum percentage of weight loss during the study period, medical ac-
tions relevant for the fluid status, unblinding of the fluid balance data by the attending 
physician and adverse clinical incident reporting. The maximum percentage of weight 
loss was computed by calculating the difference between birth weight and the lowest 
weight during the study period (ie the first 3 days after birth) as a proportion of birth 
weight (maximum percentage weight loss = [birth weight - lowest weight postpartum]/
birth weight *100%). Adverse clinical incidents are recorded electronically in a dedi-
cated system on the hospital’s Intranet11. We judged medical actions to be relevant to 
the fluid status when they were aimed at influencing the fluid status, for example when 
the physician prescribed intravenous fluid boluses or diuretics. Also, situations in which 
fluid intake deviated from our local protocol with more than 10 ml/kg per day were 
considered relevant. The primary study investigator (YvA) attended daily ward rounds 
during the week, making sure that each of these interventions was recorded for study 
purposes. Unblinding of the fluid balance data in the intervention group by the treating 
physicians and reported incidents were also used to detect any potential disadvantage 
of not using the fluid balance.11
The time spent on recording a fluid balance was assessed in 10 patients, by following 
the nurse, recording the time spent on recording the fluid balance with a stop-watch.
Randomisation and blinding
Randomisation was performed following a computer generated list of random numbers 
prepared by an independent statistician. No stratification was performed. Concealment 
of allocation was ensured by recording the randomisation codes in opaque, sealed, 
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numbered envelopes. On admission the nurse opened the randomisation envelope in 
consecutive order. As soon as possible informed consent was obtained from the parents. 
We chose to randomise the patients first, before informed consent was given, because 
we didn’t want to bother the parents directly after giving birth. We made sure informed 
consent was given during a convenient moment, before the first ward round in the 
morning when fluid balances were reported to the attending physician. Inherent to 
the study design, parents were blinded to the study intervention but the treating nurse 
and the treating physician were not. The study investigators performing the statistical 
analyses (YvA/JB) were not aware which of the two groups was the intervention group.
Sample size
We determined the required sample size for our study from patient admission data in 
2005. These admission data showed a positively skewed distribution (skewed-to-the-
right) of the length of hospital stay (median 11 days, range 2-43 days). Since our primary 
outcome measure, length of hospital stay did not show a normal distribution, logarith-
mic transformation was performed, showing a geometric mean of recorded length of 
hospital stay of 10∙7 days (SD 2∙09 days). We calculated that 85 patients in each group 
would give a power of at least 85% to detect a difference of two days or more in the 
geometric mean length of hospital stay with a two-sided significance level of 0.05. In 
order to account for potential patient withdrawal and missing data, we aimed to include 
and randomise 190 patients.
Statistical analysis
The difference in length of hospital stay was assessed by obtaining mean differences 
with 95% confidence intervals from a linear regression model, incorporating gestational 
age, birth weight and early discharge with tube feeding, since these factors are known 
to be associated with length of hospital stay. Gestational age and birth weight are un-
derstandably inversely associated with length of hospital stay. On the other hand, early 
discharge with tubefeeding will shorten length of hospital stay. In our clinic, preterm 
neonates can be discharged early with tube feeding under close supervision of a nurse.12
As the mean length of hospital stay was log transformed before analysis, the differ-
ence between the two groups is expressed as a ratio of geometric means for length of 
hospital stay. In addition we calculated the difference in median length of hospital stay 
with 95% confidence intervals.13 The length of hospital stay was also shown graphically 
with the use of Kaplan-Meier survival estimates.
All p values mentioned are two-sided. Analyses were performed with Statistical Pack-
age for the Social Sciences (SPSS) software, version 18.0.
This trial was registered with ClinicalTrials.gov, number NCT00962754.
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Ethical approval
Written informed consent was obtained from the parents or caretakers of the partici-
pants. The study was approved by the institutional’s ethics review board.
results
Patients
Overall, 287 neonates were screened for eligibility, 190 of which were enrolled and 
randomised (figure 1). After randomisation, 14 patients were excluded for failure to 
meet eligibility criteria or refusal of parental consent. These 14 patients were not sicker 
than included patients (mean gestational age 36+1 weeks, birth weight 2705 g, 2/14 had 
respiratory support). Six envelopes used for study group assignment were opened but 
not assigned to a patient. The remaining 170 patients were included in the intention-to-
treat analysis (figure 1).
 
287 Patients assessed for eligibility 
97 not enrolled 
70 transferred from neonatal 
intensive care 
27 missed inclusions 
190 randomised 
95 allocated to control group 
(with fluid balance data) 
95 allocated to intervention group 
(no fluid balance data) 
86 included in the intention to treat analysis 84 included in the intention to treat analysis 
2 did not meet inclusion 
criteria 
5 withdrew consent 
4 envelopes not 
assigned to a patient 
2 did not meet inclusion 
criteria 
5 withdrew consent 
2 envelopes not 
assigned to a patient 
figure 1. Enrolment of patients
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Table 1 shows the baseline characteristics of included patients. Overall mean gesta-
tional age was 36+2 weeks (SD 2+5 weeks), mean birth weight 2782 gram (SD 749 g). We 
observed a notable difference in gestational age, with more preterm infants (73%) in the 
intervention group compared to the control group (49%). This also caused a difference 
in body weight (intervention: 2614 g, versus control: 2947 g) and the number of patients 
discharged early with tube feeding (intervention: 26%, versus control: 16%).







Male sex 51 (61%) 49 (57%)
Gestational age (weeks +days) 35+5 (2+4) 37+0 (2+5)
• Preterm (< 37 weeks) 61 (73%) 42 (49%) 
Mean birthweight (g) 2614 (713) 2947 (749)
• <1800 g 10 (12%) 4 (5%) 
Breastfeeding 24 (29%) 34 (40%)
Respiratory support  
(supplemental O2, low flow or nasal CPAP)
28 (33%) 20 (23%)
Phototherapy 10 (12%) 20 (23%)
Incubator 73 (87%) 68 (79%)
Early discharge home with tube feeding† 22 (26%) 14 (16%)
Data are mean (SD) or number (%). CPAP is Continuous Positive Airway Pressure.
† In our clinic, preterm neonates can be discharged early with tube feeding under close supervision of a 
nurse shortening hospital stay11
Primary outcome
Median length of hospital stay in the intervention group was nine days (range: 2-37 days) 
compared to eight days (range 2-27 days) in the control group (table 2), with ratio of 
geometric mean 1∙25 (95%-CI 0∙99 to 1∙57; p 0.06). The Kaplan-Meier estimates showed 
no significant difference in length of hospital stay (p 0.07) (Figure 2). After adjustment 
for gestational age, birth weight and early discharge with tube feeding, the ratio of geo-
metric mean hospital duration was 0.98 (95% confidence interval 0∙81 to 1∙19; p=0.84) 
(table 2). This means that the length of hospital stay in the intervention group could be 
19% shorter or 19% longer than the duration in the control group.
Secondary outcomes
No differences in secondary outcomes were found (table 3). In the intervention group 
three incidents were reported: the lamp for phototherapy should have been replaced 
earlier, blood transfusion was given two days after the result of the blood haemoglobin 
showed anaemia and a wrong medication order. In the control group five incidents were 
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9 8 1 (0-4)
Range of distribution 
(min.-max)
2-37 2-27
Log10 mean ±SD 0.93 ±0.35 0.84 ±0.31
Geometric mean (days) 8.51 6.92
Ratio of geometric means
(95%CI)
1.25 (0.99-1.57) NA 0.06
Adjusted ratio of 
geometric means (95%CI)†
0.98 (0.81-1.19) NA 0.84
The duration of hospitalisation was log transformed before analysis, since this variable was positively 
skewed. The effect of the intervention refers to the ratio of geometric means for the duration of 
hospitalisation. The duration of hospital stay of one patient in the control group was withdrawn because 
there was an exceptional non-medical reason for the long hospital stay (55 days).
†A linear regression model was used to adjust for factors influencing the duration of hospital stay 

































Duration of hospitalisation (days) 
- - -  Control group 
 Intervention group 
figure 2. Kaplan-Meier estimations of the proportions of the neonates remaining in the hospital (logrank 
test, p=0.07)
Solid line represents patients without fluid balance (intervention) and the dashed line patients with fluid 
balance (control)
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reported: the hot-water bottle had not been replaced (2 infants), wrong positioning 
of a biliblanket and wrong medication order (2 infants). Some of the incidents might 
have lengthened the hospitalisation, however none of the incidents was related to the 
intervention.
In one situation the attending physician unblinded the fluid balance data, because of 
oedema in the patient. The fluid balance information didn’t give new insights nor did it 
influence medical treatment.
Time investment of fluid balance keeping
The mean time spent on a daily fluid balance was 7∙2 minutes per neonate per day (SD 
0∙39).
discussion
This study shows that keeping a fluid balance does not influence length of hospital stay 
or medical interventions in neonates with moderate disease severity. We found a differ-
ence of one day in favour of the control group with a range of 0-4 days, meaning that 
there is no clinically relevant difference in the length of hospital stay, with an uncertainty 
that the hospital duration in the intervention group could be equal to or 4 days longer 
than the duration in the control group.
To our knowledge, this is the first randomised controlled trial examining the clinical 
usefulness of the fluid balance. Our findings confirm earlier reports in different patient 















(-1.4 to 5.5) 0.90*
Medical actions relevant to fluid status†
Intravenous fluid bolus 1 3 0.621§
diuretics 0 0 NA
deviation from fluid protocol 61/187 5%
 (per day) (33%) 53/192 (28%) (-2.3 tot 14.3) 0.29$ 
Unblinding of fluid balance data 1 NA
Incident reporting  
(which might influence hospital stay)‡ 5 2 0.28§
† Number of protocol deviations per days. ‡ None of the incidents was related to the study intervention. * 
T-test, § Fisher exact, $Chi2, NA denotes not applicable
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categories showing poor agreement of fluid balance with changes in body weight5, 
central venous monitoring14 or bioelectrical impedance measurements15.
Although the theoretical concept of estimating the fluid status by recording fluid 
in- and output seems logical and sound, the lack of usefulness of the fluid balance may 
be largely explained by the inaccuracy of the fluid balance. Earlier we reported on the 
accuracy of the fluid balance in this study population, were we found that 40% of the 
fluid balances showed clinically relevant differences with daily bodyweight measure-
ments.8 The numerous assessments of fluid volumes during a day are all subject to 
measurements errors. For example, in breastfed neonates there is no reliable method 
to assess milk intake.16 Similar problems occurring in estimating the quantities of fluid 
output, such as body fluids leaking into bed sheets and insensible losses. Furthermore, 
dry nappies can absorb moisture in the humidified environment of an incubator.17
To rule out the possibility of human calculation errors in adding and subtracting totals 
in calculating the fluid balance, we recalculated all fluid balance data by a spreadsheet 
program, but this did not influence agreement with the change in body weight (median 
difference 0 ml, interquartile range -8,0-0 ml, p=0.11).8
A remarkable finding was that in both groups a substantial deviation from the feed-
ing- and fluid protocol was found: The fluid intake deviated more than 10 ml/kg from the 
standard protocol on 33% and 28% of the observed days in respectively the intervention 
and the control group. An explanation could be that our fluid protocol may be too strict. 
Especially in self-drinking neonates, the actual fluid intake will often be individually 
adjusted, for example when breastfeeding on demand. Since the deviation from our 
fluid protocol equally occurred in both groups this finding most probably will not have 
influenced the main results.
Strengths and limitations of the study
The main strengths of our study include the design as a randomised controlled trial, the 
meticulous attention to avoiding revelation of the fluid balance data to the physicians in 
the intervention group, and the use of measurements and techniques readily available 
and commonly used in clinical practice.
A drawback of our study was the lack of a potentially more reliable assessment method 
of fluid status, such as central venous pressure monitoring or body impedance measure-
ments. We purposely chose body weight as comparison, since these two methods are 
most frequently used in clinical practice, in particular in neonates.
Another potential limitation of our study is the moderate disease severity in our 
patients. Medical interventions aiming at influencing the fluid status, apart from minor 
adjustments in fluid intake, were rare in our cohort. It may be argued that keeping a fluid 
balance is more useful in sicker newborns admitted to a neonatal intensive care unit. For 
safety reasons, we deliberately chose to perform this study in neonates with moderate 
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disease severity as a proof of principle before embarking on a similar project in more 
critically ill patients in a Neonatal Intensive Care unit.
A further limitation of our study is the choice of the primary outcome. The median 
hospitalisation duration in our study was eight days, and it may not be realistic to expect 
an effect of keeping a fluid balance during the first three days on such relatively long 
hospitalisation duration. This primary outcome might be more relevant if the study were 
repeated in a sicker group of infants, were this and additional outcomes such as chronic 
lung disease, duration of mechanical ventilation and incidence of persistent ductus ar-
teriosus may also be useful. Some may suggest that percentage weight loss electrolyte 
levels, for example serum sodium levels would have been better primary outcomes. Al-
though a secondary outcome measure we showed that keeping a fluid balance does not 
influence the percentage weight loss. And, for ethical reasons we preferred not to take 
extra blood samples only for study purpose, since in our ward is not common practice to 
take daily blood samples in the patient group we studied. The other secondary outcome 
measures occurred too rarely to serve as a valid, practical primary outcome measure and 
for ethical reasons we did not want to burden the patients with blood punctures.
A final limitation of our study is the unequal distribution of premature infants amongst 
the two study groups (table 1). The overrepresentation of preterm infants in the group 
in which fluid balance data were unavailable would have put this group at an increased 
risk of lengthened hospital stay and unfavourable secondary outcomes. The fact that 
all these outcomes were not significantly different between the two groups is therefore 
reassuring. In addition, when we adjusted for gestational age, the difference in hospital 
stay was close to zero, which supports the lack of usefulness of routinely keeping a fluid 
balance in sick newborns. In retrospective, stratification for gestational age before ran-
domisation could have avoided this demographic differences between the two groups.
conclusions
In conclusion, this study shows a lack of clinical usefulness of routinely keeping a fluid 
balance in newborns with moderate disease severity. Therefore, fluid balance charts 
are not useful as a routine procedure in moderately sick neonates. To investigate the 
generalisability of our results we hope our results encourage colleagues caring for other 
patient populations, for example in a neonatal intensive care setting, to further investi-
gate whether the time-consuming and error-prone ritual of fluid balance keeping really 
helps in improving patient care.
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aBstract
Background: A reliable, valid, and easy-to-use assessment of the degree of wheeze-
associated dyspnoea is important to provide individualised treatment for children with 
acute asthma, wheeze or bronchiolitis.
Objective: To assess validity, reliability, and utility of all available paediatric dyspnoea 
scores.
Methods: Systematic review. We searched Pubmed, Cochrane library, National Guideline 
Clearinghouse, Embase and Cinahl for eligible studies. We included studies describing 
the development or use of a multivariate score, assessing two or more clinical symp-
toms and signs, for the assessment of severity of dyspnoea in an acute episode of acute 
asthma, wheeze or bronchiolitis in children aged 0-18 years. Study selection and data 
extraction was done independently by two reviewers. We assessed validity, reliability 
and utility of the retrieved dyspnoea scores using a total of 15 quality criteria.
Results: We selected 60 articles describing 36 dyspnoea scores. Fourteen scores were 
judged unsuitable for clinical use, because of insufficient face validity, use of items 
unsuitable for children, difficult scoring system or because complex auscultative skills 
are needed, leaving 22 possibly useful scores. The median number of quality criteria that 
could be assessed was 7 (range 6-11). The median number of positively rated quality 
criteria was 3 (range 1-5).
Conclusion: None of the many dyspnoea scores has been sufficiently validated to allow 
for clinically meaningful use in children with acute wheeze. Proper validation of existing 
scores is warranted to allow paediatric professionals to make a well balanced decision 
on the use of the dyspnoea score most suitable for their specific purpose.
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introduction
Acute exacerbations of wheeze associated respiratory disease account for many hospital 
admissions and medical costs in children.1,2 In order to assess the severity of such an 
exacerbation, and to monitor the effects of treatment, clinicians and researchers need 
a valid and reliable measurement of the degree of dyspnoea and airway narrowing. In 
adults, lung function measurements are most commonly used for the latter purpose, 
but this is not suitable as a routine procedure in acute wheeze in children. First, because 
the best standardized pulmonary function test, the expiratory flow-volume curve,3 is de-
pendent on active cooperation of the child, it is unsuitable for use in preschool children, 
which constitute the largest group of children presenting with acute severe wheeze.4 
Second, even in school-aged children and adolescents, the severity of dyspnoea and 
unavailability of lung function equipment in the emergency room may hinder the 
assessment of lung function in acute wheeze or asthma. Third, the assessment and 
follow-up of severity of dyspnoea is not only made by physicians, but also by nurses and 
allied health professionals, who can not always be expected to have experience with 
lung function measurements. Therefore, clinical assessment remains of key importance 
in determining the severity of dyspnoea in acute wheeze, asthma exacerbations or 
bronchiolitis in children of all ages.
Because single clinical signs do not correlate well with the degree of dyspnoea and 
airway narrowing in acute wheeze,5 paediatric dyspnoea scores usually comprise a 
combination of clinical symptoms and signs. Over the past decades, a large number 
of such clinical scores have been developed, most commonly for use in clinical trials.6,7 
In order to be clinically useful, a dyspnoea score needs to be valid and reliable.8-10 Two 
earlier reviews focused only on asthma scores in preschool children, and concluded that 
available scores were poorly validated.6,7 These reviews, however, did not comprise the 
full paediatric age range, and several new scores have been developed after publica-
tion of these older reviews. Therefore, we performed a systematic review to evaluate 
the measurement properties and degree of validation of all available paediatric severity 




In health measurement literature, different definitions are being used, and terminology 
may be confusing.8 Therefore, we choose to explain and define the terms as they are 
being used in this review (Table 1).
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table 1. Quality criteria for measurement properties of paediatric dyspnoea scores
Property definition Quality criteria
validity
Face validity Qualitative judgement if the score is a 
good measurement of dyspnoea.7
+ At least 3 of the following items were part of the 
score: 1. respiratory and/or heart rate, 2. oxygen 
saturation or cyanosis, 3. work of breathing, 
retractions or use of muscles or dyspnoea, 4. 
wheezing or auscultatory findings, 5. mental status.
± 2 of the above mentioned items
- 1 item
Content validity* Appropriate representation of the concept 
dyspnoea by the items in the score (i.e., 
clear description of development process 
of the score).10
+ Clear description is provided for measurement 
aim, target population and item selection and 
–reduction
? Potential methodological shortcomings
- No clear description
Construct validity* Extent to which the score relates to other 
measures, consistent with theoretically 
derived prespecified hypotheses 
concerning dyspnoea10
+ Specific hypotheses were formulated and at least 
75% of the results are in correspondence with these 
hypotheses in subgroups of at least 50 patients.
? Less than 50 patients OR potential methodological 
shortcomings or no MIC




Criterion validity refers to the extent to 
which a score relates to the gold standard 
of the phenomenon. Because a gold 
standard of dyspnoea is unavailable, 
this is replaced by concurrent validity, 
the degree of agreement with other 
measurements of dyspnoea.10
+ Valid comparison (oxygen saturation, laboratory 
findings or pulmonary function tests) and 
correlation >0.70
? Doubts about gold standard
- Correlation < 0.70
0 No information
reliability
Measurement error* Absolute measurement error, usually 
expressed as smallest detectable change 
(SDC), i.e. the smallest within-person 
change in score which can be interpreted 
as real change above measurement 
error10
+ MIC>SDC or LOA<MIC10
? Potential methodological shortcomings or no MIC




Degree to which different users obtain the 
same result when using the score on the 
same patients at the same time
+ ICC or weighted kappa >0.70 in at least 50 patients
? Pearson correlation >0.70, or < 50 patients




Similarity of results when the score is 
repeated by the same user on the same 
patient under similar conditions
+ ICC or weighted kappa >0.70 in at least 50 
patients10
? Pearson correlation coefficient >0.70, or < 50 
patients
- ICC or kappa < 0.70
0 No information
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Internal consistency* Correlation between items of the score9,10 + Factor analysis performed and Cronbach’s alfa 
0.70-0.95
? No factor analysis OR potential methodological 
shortcomings
- Cronbach’s alfa < 0.70 or > 0.95
0 No information
Responsiveness* Ability of the score to detect change in 
time8
+ Guyatts’s RR >1.96 or AUC ≥ 0.70
? Potential methodological shortcomings
- RR ≤ 1.96 of AUC < 0.70
0 No information
utility
Suitability Suitability for use in children + No invasive techniques or items which may be 
difficult to obtain in young children (e.g. pulsus 
paradoxus, information on speech not specified 
for infants).
± As in + with information on speech specified for 
infants
- Use of invasive techniques or items which may be 
difficult to obtain in young children
Age span Coverage of the entire paediatric age span + Evaluated from infancy (<2 years) to puberty (>12 
years)
- Evaluated in a smaller age span
Ease of scoring Complexity of scoring system + <4 categories per item46
± 4 categories per item
- > 4 categories per item or complex calculations 
needed
Auscultation skills Feasibility in clinical practice by different 
health care providers
+ no auscultation skills required.
± no complex auscultation skills required (no 
inspiratory:expiratory ratio).
- complex auscultation skills required
Floor or ceiling 
effect*
Unequal distribution of score results10) + < 15% of patients with lowest or highest possible 
score in at least 50 patients
? Potential methodological shortcomings or < 50 
patients
- < 15% of patients with lowest or highest possible 
score
0 No information
Interpretability* Clinical meaningfulness + Mean scores and SD given in at least 4 relevant 
subgroups and MIC determined
? Potential methodological shortcomings or < 4 
subgroups or no MIC determined
0 No information
+ positive rating; ± indeterminate; - negative rating; ? unclear or potential methodological shortcomings; 
0 no information available (potential) methodological shortcomings = description of design or methods 
of the study not clear, or study group < 50 persons
*Items together form the Terwee checklist10
SDC smallest detectable change; MIC minimal important change; LOA limits of agreement; ICC intraclass 
correlation coefficient; SD standard deviation; RR Guyatt’s responsiveness ratio; AUC area under curve of 
the receiver operating curve
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We use the term “dyspnoea score” to comprise any clinical score which has been 
developed to assess the severity of dyspnoea in acute wheeze, asthma or bronchiolitis 
in children.
Dyspnoea scores can be used for discriminative, predictive and/or evaluative purposes. 
A discriminative score is used to rate the severity of dyspnoea at a single point in time. 
Predictive scores aim to predict the outcome of an acute exacerbation, and evaluative 
scores assess the changes over time, usually in response to treatment.8
Clinical scores need to be valid, reliable, and easy to use. Validity describes whether 
the instrument measures what it is supposed to, i.e. the correct signal. Validity includes 
face, content, construct and criterion (or concurrent) validity (Table 1). Reliability (also 
known as reproducibility or accuracy) refers to the extent to which patients can be 
distinguished from each other, despite measurement error.9 Reliability can be evaluated 
by assessing measurement error, inter and intra-observer reliability, internal consistency 
and responsiveness (Table 1). Utility refers to usability, thus suitability for use in children, 
the ease of scoring, skills needed to use the score, floor and ceiling effects, and interpret-
ability.7,10
Literature search and Study selection
We searched Pubmed, Cochrane library, National Guideline Clearinghouse, Embase and 
Cinahl (November 2011) for eligible studies using the terms “wheeze”, “asthma”, “score”, 
“scale”, “index”, “assessment”, “validity”, “validation”, “reliability”,” and limited to child 0-18 
when possible. The full search strategy in each database is available in appendix 1 of the 
online depository. References and “related articles” in Pubmed of selected articles were 
screened for additional relevant publications. We used no language restrictions. Eligible 
titles and abstracts (if available) were screened independently by two reviewers for 
inclusion (JB, RR). The final decision on inclusion in the review was made by consensus.
Inclusion and exclusion criteria
Studies that described the development or use of a multivariate score, assessing two 
or more clinical symptoms and signs, for the assessment of severity of dyspnoea in an 
acute episode of wheeze, asthma or bronchiolitis were considered eligible for inclusion 
in the review if they included children in the age range of 0 to 18 years. Scores that were 
designed for discriminative or evaluative purposes were selected for further review. 
Scores aimed at assessing asthma control or quality of life in children with asthma, and 
those including historical parameters (for example questionnaires for parents, medica-
tion use, and number of exacerbations), pulmonary function parameters, or laboratory 
parameters were excluded. We also excluded predictive scores.
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Data extraction
Two reviewers (JB, RR) extracted the data independently by using a data extraction 
form specifically designed for this study (online appendix 2). We extracted data on the 
individual items of the score, the scaling of the items, the calculation of the final (total) 
score, the number and age range of the children in which the score was used, the setting 
(emergency or outpatient department or hospitalized patients), and the clinical condi-
tion of the patients (wheeze, acute asthma, bronchiolitis). In addition, we recorded the 
purpose (discriminative, predictive or evaluative), the development process of the score 
and the use of the score in clinical trials. We assessed whether item selection and reduc-
tion were based on clinical observation, expert opinion, and theory, or on previously 
reported scores.
Methodological quality assessment of dyspnoea scores
Based on recent reviews of clinimetric measurements, we assessed each retrieved clini-
cal asthma score on a total of 15 methodological quality criteria: 4 on validity, 5 on reli-
ability, and 6 on utility.6,7 Each of these 15 criteria was rated as positive (+), intermediate 
(+), negative (-), unclear (?) or no information (0) using the criteria listed in table 1.
results
Search characteristics
Our search yielded 1014 possibly relevant titles, most of which evaluated scores for 
quality of life or control of asthma using medical history data or a parent-completed 
questionnaire. The selection procedure of included articles is depicted in figure 1. A 
total of 65 articles, describing a total of 36 different asthma scores, were selected for 
review of the full-text articles, including 60 original articles and 5 reviews.6,7 Two reviews 
evaluated dyspnoea scores6,7 and 3 reviews described studies concerning the treatment 
of asthma or bronchiolitis referring to articles using clinical scores. Van der Windt6 et al 
evaluated 16 scores for use in preschool children, 14 of which were developed for evalu-
ative or discriminative purposes. This review assessed 6 methodological criteria but did 
not specify how these were rated.6 Birken et al7 reviewed 10 asthma scores for use in 
preschool children on 10 methodological quality criteria, and found that only 2 scores 
could be evaluated on more than 4 criteria. Overall, validity was considered to be insuf-
ficient for most scores in both reviews. Responsiveness of the scores was only assessed 
in medication trials, and recorded as some degree of improvement after medication.7
The aim of the majority of selected articles (31 out of 60) was not to validate the score, 
but only described the use of dyspnoea scores in clinical trials.
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General characteristics of the scores
Appendix 2 (online) summarizes the characteristics of the 36 retrieved scores. The mean 
number of items recorded per score was 5 (SD 1.7; range 2 to 9), and the mean maximum 
possible result of the scores was 12 (SD 5.4; range 3 to 27). Accessory muscle use was 
included in almost all scores (in 35 (97%) of the scores), followed by wheeze in 34 (94%), 
respiratory rate in 26 scores (72%), cyanosis and mental status/activity level both in 17 
(47%), dyspnoea in 10 (28%) and inspiratory breath sounds or air entry in 9 (25%). Other 
 





Articles not relevant 
(n=910) 
Article could not be retrieved 
(Japanese) (n=1)72 
Articles included for full review (n=65) 
 60 original articles 
 5 reviews 
Additional records found through 
other sources  
(n=57) 
Records screened (Title and/or abstract) 
(n=1014) 
Full-text articles assessed for eligibility 
(n=87) 
Articles excluded (n=21): 
    No composite score used (11) 
    No full description of the score (4) 
    Blood gas analysis included (3) 
    Unclear reference (3) 
(not found in the databases 
mentioned in the methods) 
figure 1. Flowchart of selection process of articles included in the review
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items were used infrequently: inspiratory to expiratory ratio in 6, heart rate in 5, speech 
impairment in 4, grunting in 4, nasal flaring in 3, rales or rhonchi in 3, cough, liver and 
spleen size, pulsus paradoxus, nebulisations, intravenous infusion and resonance each 
in one score.
The development process of the score was described for 21 scores (58%). Only three 
scores were developed using a formal procedure for item selection and reduction (CAS, 
PRAM, RAD). Another 5 scores used merely expert opinion, and 14 scores were based on 
previous scores.
Forty-one percent (24/59, one study did not mention patient numbers) of the studies 
included less than 50 patients, which is below the minimal number of subjects required 
for adequate assessment of the quality criteria.10 Only 11 scores were developed to be 
used in a wide age range from infancy to puberty. Fourteen scores were used only in 
the outpatient ward or emergency department, 14 only in hospitalised patients, and 8 
in both settings.
The clinical characteristics of patients were described as asthma in 16 scores, bron-
chiolitis in 11, wheeze in 4, bronchusobstructive syndrome in 2, and both asthma and 
bronchiolitis patients were used in 3 scores. Ten scores were only described for use in 
medication trials, without any description of development or measurement properties 
of the score.
Methodological characteristics of the scores
Figure 2 summarizes the result of the methodological quality assessment of the retrieved 
scores, using the criteria described in table 1; a detailed description of this assessment 
of each score is presented in appendix 3. None of the scores could be assessed on all 
15 quality criteria. The number of quality criteria that could be assessed ranged from 6 
to 11, with a mean of 7.6 (SD 1.5). The mean number of positively rated quality criteria 
was 2.9 (SD 1.1; range 1-5). Assessment of the criteria measurement error, intra observer 
reliability, and floor and ceiling effect was impossible because no information on these 
criteria was given in any of the studies. In addition, quality assessment of construct va-
lidity, responsiveness, and interpretability was hampered by either absence of sufficient 
information or methodological shortcomings of the studies.
Validity
Face validity was good in almost all scores. The only exception was the RDAI which 
contains only 2 items: wheeze and retractions. Content validity was poor in all scores, 
apart from the three scores which were developed using a formal procedure of item 
development and reduction (PRAM, CAS and RAD). Criterion validity was described for 
16 scores, but received satisfactory ratings in only 2 (good correlations for comparison 
of CSGS-1 with blood gas analysis and for CSS-2 with SaO2).




None of the scores could be adequately 
assessed on the following 7 criteria 
because of insufficient information: 
 Construct validity 
 Measurement error 
 Intra observer reliability 
 Responsiveness  
 Floor and ceiling effect 
 Interpretability 
Exclusion of 14 scores because of 
insufficient rating on essential quality criteria 
Face validity inadequate:  
RDAI58-67 
Dyspnoea scores retrieved (n=36) 
Scores possibly suitable (n=22) 
Suitability for use in children insufficient:  
CAES-124,25, CSS-36 
Ease of scoring insufficient: 
BS-423, CSGS-130 and 231, RDAI58-67, RDI68,69, SS70 
Difficult auscultation skills needed: 
BS-120, CAS28, MPIS43, PASS44,45, PIS48-54, RA57 
Sum of positively rated quality criteria 
of possibly suitable dyspnoea scores: 
 
PRAM45-47   5 points 
 
ASS14-19 RAD45  4 points 
CAES-226 
 
AS13  CS29 
BS-221  CSS-234 3 points  










CAES-427   1 point 
Content validity adequate: 
PRAM45-47, RAD45 
Evaluated in entire age span of 
childhood: 
AS13, ASS14-19, CAES-226, CS29, 
PRAM45-47 
Interobserverreliability adequate: 
BS-221, CSS-738-40, PRAM45-47 
Criterion validity adequate: 
CSS-234 
Internal consistency adequate: 
none 
figure 2. Flowchart of quality assessment of dyspnoea scores on 15 quality criteria
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Reliability
Interobserver reliability was described for 16 scores, and rated positively in 8 (BS-2, 
CAS, CSS-7, PASS, PRAM, PIS, RA, RDAI). There were only three scores, (CAS, PRAM, PIS) 
in which internal consistency was calculated with Crohnbach’s alpha, with values of 
0.86, 0.71 and 0.84 respectively. Although these values indicated adequate internal 
consistency, we rated these criteria as indeterminate because no use of factor analysis 
was reported.10 Although many studies reported on improvement in scores after treat-
ment, however in none of the studies this done by calculating an area under the curve 
or Guyatt’s responsiveness ratio.
Utility
Suitability for use in children was judged to be good in all scores, except for CAES-1 
(because it includes blood gas analysis) and CSS-3 (includes pulsus paradoxus). Inter-
mediate ratings were given to AS and CAES-4 (because these scores include information 
on speech). The scoring system was rated as “easy-to-use” in 11 scores. Five scores were 
judged to have insufficient utility because of too complex rating scales or calculations. 
In all but one score (BS-4), auscultation was included. Six scores included inspiratory to 
expiratory ratio which we judged to be a difficult auscultation skill.
discussion
This study shows that none of the many scores used for assessment of the degree of 
wheeze-associated dyspnoea in children with acute asthma, wheeze or bronchiolitis.
has been sufficiently validated to allow clinically meaningful use in children. Although 
many scores have adequate face validity and are easy to use in children, important 
deficits were noted in all scores across the three methodological quality domains of 
validity, reliability, and utility. Out of the 15 methodological quality criteria considered 
to be important for clinical scores,7,10 the paediatric dyspnoea scores reported in the 
literature provided sufficient data on an average of only 7 criteria, and received positive 
ratings on a median of only 3 out of these 7 criteria (Figure 2). There is, therefore, insuf-
ficient evidence to trust the currently available paediatric dyspnoea scores to provide 
an accurate reflection of disease severity, either for research purposes, or for clinical use.
Although face validity is usually adequate, content and construct validity have been 
insufficiently addressed in almost all scores, primarily because these scores have been 
developed in an hoc fashion for use in clinical trials. Only three scores (CAS, PRAM and 
RAD) were developed using more formal methods, ensuring adequate content validity. 
Criterion validity was described for almost half of the scores, but received satisfactory 
ratings in only 2 (CSGS-1 and CSS-2). Information on reliabililty was lacking for the large 
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majority of scores. If available, it was usually limited to an assessment of interobserver 
reliability between two observers, and this was found to be adequate in 8 out of 16 
scores. No study assessed reliability between more than two observers, which is remark-
able given the large number of medical staff and allied health personnel involved in the 
assessment and follow-up of children with acute severe dyspnoea, in particular when 
hospitalized. Even more striking is the lack of data on responsiveness, which was lacking 
for 22 scores. Although many studies reported on improvement in scores after treat-
ment, however in none of the studies this done by calculating an area under the curve 
or Guyatt’s responsiveness ratio.
Responsiveness is important because it drives clinical decisions (when to increase or 
taper down medication, when to discharge). Although most scores were suitable for use 
in children, a number of scores were judged to be impractical or impossible to use in 
daily clinical practice because they involved complicated measurements (pulsus para-
doxus) or calculations. Auscultation skills, in different degrees, were needed in the large 
majority of scores, limiting the use of these scores to personnel with specific training in 
these skills.
We acknowledge the following main weaknesses of our study. First, we included scor-
ing systems used for different diagnostic categories (asthma, wheeze, and bronchiolitis). 
Although this may be viewed as an unjust comparison of measurement instruments 
for different disorders, the overlap in items recorded between the scores (Appendix 2) 
was considerable. Apparently, all these clinical scores aim at measuring the degree of 
dyspnoea in children, irrespective of the underlying disease causing airway narrowing. 
Thirdly, the importance of the utility items we assessed may be questioned. Using infor-
mation technology, even complicated scores can be calculated easily and reliably, for 
example. Similarly, although auscultation requires specific skills, it can be argued that an 
accurate assessment of dyspnoea in children is impossible without chest auscultation. It 
should be noted, however, that the poor methodological quality of the available scores 
was not limited to utility items, but almost always included validity and reliability issues. 
Finally, the relative importance of each of the validity and reliability items is debatable. 
Unfortunately, current health assessment literature does not allow a clear-cut definition 
of the relative merits of each of these issues.10
The main strengths of this study include the systematic nature of the literature review, 
the adherence to guidelines for such systematic reviews,11 and the detailed analysis 
and description of 15 methodological quality items of all available paediatric dyspnoea 
scores.10
We would like to emphasize that the limited methodological quality of the paediatric 
asthma and dyspnoea scores that we evaluated does not necessarily mean that these 
existing scores are not suitable for use in clinical practice and research. The main reason 
for the poor methodological quality that we report is that studies on existing asthma 
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scores provided insufficient data to enable quality scoring (absence of evidence). In 
other words, proper comprehensive validation has simply not been performed for any 
of these scores.
In conclusion, none of the many available paediatric dyspnoea or asthma scores has 
been sufficiently validated to allow for clinically meaningful use in children with acute 
asthma, wheeze or bronchiolitis, in particular not for evaluative purposes. Instead of 
developing new scores, we consider it to be more useful that existing dyspnoea scores 
are being validated in a more comprehensive and proper way. This will allow clinicians 
and researchers to make a well balanced decision on the use of the dyspnoea score most 
suitable for their specific purpose. It is preferable that only one or at least fewer scores 
are used. The large amount of different scores that are currently used is not beneficial 
for widespread use and hampers comparisons between different studies and patient 
groups.
aBBreviations of the scores with references
AS Asthma score;12 ASS asthma severity score;13-18 BS bronchiolitis score (original names: 
BS-2 respiratory scale; BS-3 clinical scoring; BS-4 severity score);19-22 CAES clinical asthma 
evaluation score (original names: CAES-2 clinical severity score or modified clinical 
asthma score; CAES-3 modified clinical asthma score);23-26 CAS clinical asthma score27; 
CS clinical score28; CSGS clinical symptom grading system;29,30 CSS clinical scoring 
system (original names: CSS-2 modified Tal’s clinical score; CSS-4 clinical score);5,31-40 
EDRAR escala de diffcultad respiratoria de la Argentina;41 EDRCH escala de dificultad 
respiratoria de Chile;41 MPIS modified pulmonary index score;42 PASS pediatric asthma 
severity score;43,44 PRAM paediatric or preschool respiratory assessment measure;44-46 PIS 
pulmonary index score;47-53 PS pulmonary score;44,45 RA respiratory assessment;56 RAD 
respiratory rate – accessory muscle use – decreased breath sounds;44 RDAI respiratory 
distress assessment instrument;57-66 RDI respiratory distress index;67,68 SS severity score;69 
SOIS severity of illness score.70
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aPPendix 1 search strategy Paediatric dysPnoea scores
Pubmed:
[asthma OR wheeze] AND [validity OR validation OR reliability] AND [score OR scale OR 
assessment OR index].
Cochrane Library:
“(asthma OR wheeze) and child and (scale OR index OR score) and (validation OR valida-
tion OR reliability)
Cinahl:
((MH “Asthma”) AND ((MH “Reliability”) OR (MH “Reliability and validity+”)) AND ((“index”) 
or (MH “Scales”) or (MH “Clinical Assessment Tools+”))
Embase:
((‘asthma’/exp OR ‘wheezing’/exp) AND (‘validity’/exp OR ‘reliability’/exp) AND (clinical 
assessment’/exp OR (score OR scale OR assessment OR index))) AND ([newborn]/lim OR 
[infant]/lim OR [preschool]/lim OR [school]/lim OR [child]/lim OR [adolescent]/lim)
National Guideline Clearinghouse:
Asthma, limit child
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aBstract
Objective: To determine intra- and inter-observer variation in clinical assessment of 
the severity of dyspnoea in children and to compare this variability to its change after 
therapy.
Study design and setting: We recorded 27 acutely wheezing children aged 0-8 years on 
video before and after treatment with inhaled bronchodilators. Nine observers indepen-
dently assessed these videorecordings by scoring wheeze, prolonged expirium, retrac-
tions, nasal flaring, mental status and a general assessment of dyspnoea on a Likert-scale 
(0-10). Assessment was repeated after two weeks to evaluate intra-observer variation.
Results: We analysed 972 observations. Intra-observer reliability was highest for supracla-
vicular retractions (kappa 0.84) and fair to substantial for other items (kappa 0.39-0.65). 
Inter-observer reliability showed highest reliability for subcostal retractions (kappa 0.46) 
and <0.4 for other items. The Smallest Detectable Change of the dyspnoea-score (>3 
points) was larger than the Minimal Important Change (<1 point), meaning that in 69% 
of observations a clinically important change after treatment cannot be distinguished 
from measurement error.
Conclusion: Intra-observer variation is modest, and inter-observer variation is large for 
most clinical findings in dyspnoeic children. The measurement error induced by this 
variation is too large to distinguish potentially clinically relevant changes in dyspnoea 
after treatment in two-third of observations.
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introduction
Acute dyspnoea is one of the most common reasons for emergency room visits and 
hospitalizations of children.1 It is most commonly caused by lower airway obstruction 
and accompanied by wheeze.2 Evaluating the severity of dyspnoea in these children 
is important in clinical decision making and evaluation of treatment. The severity of 
dyspnoea is primarily assessed by clinical findings, because pulmonary function tests 
are not readily available in the emergency department, particularly not for preschool 
children, the largest group presenting with acute dyspnoea.3
Like any clinical measurement, the usefulness of the clinical assessment of dyspnoea 
is strongly determined by its reliability.4-6 Variation within and between professionals 
assessing the degree of dyspnoea may importantly influence the reliability of this clini-
cal judgement. Since assessment of response to treatment, and follow-up of severity of 
dyspnoea is often performed by different professionals, knowledge of the inter-observer 
variation of the clinical assessment of dyspnoeic children is important.5 Only a few 
studies assessed the inter-observer variation of clinical findings in dyspnoeic children, 
demonstrating substantial variability between observers {webappendix 1}. The small 
number of observers in these studies (two in most studies; four in one study) limits their 
applicability in clinical practice, where the number of health care professionals involved 
in assessing dyspnoea in children may be considerably larger.7-14 Intra-observer varia-
tion has never been studied for these clinical findings. Although variation in dyspnoea 
assessment within and between observers may hinder identification of improvement in 
dyspnoea after (bronchodilator) therapy, the extent to which this occurs has not been 
studied to date.
The aim of this study was to determine the intra- and inter-observer variation of 
common clinical findings in children with acute severe dyspnoea and wheeze and to 
compare the variability of clinical dyspnoea assessment to its change after bronchodila-
tor therapy.
methods
Study design and setting
We performed an observational study using a crossed design, meaning that all observ-
ers performed two repeated assessments (before and after treatment) of all patients. 
We consecutively enrolled children aged 0 to 8 years presenting to the emergency 
department in the period September 2009 to September 2010 with acute dyspnoea and 
wheeze. The included patients are a convenience sample, since the persons (RR, ND, IMB) 
who recorded the videos had to be available. After undressing, the patient’s head and 
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chest were recorded on digital video for 2-3 minutes, before and 15 to 30 minutes after 
inhaling nebulized salbutamol (2.5 mg for patients aged < 4 years and 5 mg for ages ≥ 4 
years). Patients with transcutaneous oxygen saturation < 93% were given supplemental 
oxygen by nasal canula before recordings were made. Oxygen saturation and heart rate 
were measured by pulse oximetry, which was visible on the video. The video included 
sound recording.
The study was approved by the hospital’s ethical review board (09.0536n), and written 
informed consent was obtained from the parents.
Assessment of video recordings
The video recordings of all patients were assessed independently by five experienced 
consultant paediatricians and four masters of advanced paediatric nursing, after receiv-
ing written and verbal instructions. These observers all had at least five years of experi-
ence in assessing dyspnoeic children. All assessments were repeated in random order 
by the same observers after an interval of at least two weeks to assess intra-observer 
variation. Observers did not receive any clinical information regarding the patients, nor 
did they know whether the video was recorded before or after bronchodilator treat-
ment. Each observer recorded the presence and severity of the following clinical signs 
on a structured case report form: wheeze, prolonged expirium, subcostal retractions, 
intercostal retractions, jugular retractions, supraclavicular retractions, nasal flaring, and 
mental status. These items were chosen because they represent the items in all compos-
ite dyspnoea scores in the literature.15 Each item was rated as a binary variable (absent 
or present). Observers were also requested to give an overall assessment of the degree 
of dyspnoea on a Likert scale ranging from 0 (no dyspnoea) to 10 (very severe dyspnoea 
requiring mechanical ventilation), which we will call the dyspnoea score.
Terminology and definitions
To avoid confusion in the terminology in clinical measurement analysis, two terms 
should be explained: measurement error and reliability. Repeated measurements show 
variation such as variations within and between assessors and spontaneous variation 
within patients. The “standard error of measurements” (SEM) represents the magnitude 
of this measurement error.6 The SEM is interpreted as the standard deviation around a 
single measurement, describing the spread of repeated measurements in the unit of the 
measurement.6 Reliability is the degree to which the measurement is free from measure-
ment error.16 It is expressed as the proportion of the true difference between patients, 
compared to the total variance.16
Kappa and the intraclass correlation coefficient (ICC) are reliability parameters, ex-
pressing how well patients can be distinguished from each other despite the measure-
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ment error.6 Kappa and ICC range from 0 (totally unreliable) to 1(perfect reliability). In 
general a kappa or ICC > 0.70 represents sufficient reliability.6
Reliability depends on the relative magnitude of measurement error and variation 
between patients. If measurement error is small in comparison to variation between 
patients, the reliability parameter approaches 1. Large measurement error and relatively 
small variation between patients yields low reliability parameter values.6
Clinical relevance: smallest detectable change (SDC) and minimal important change (MIC)
In addition to reliability parameters, clinical measurements of dyspnoea should also be 
examined on their ability to identify change in the degree of dyspnoea in the individual 
patient over time, either spontaneously or as a result of treatment. This is expressed 
as the smallest detectable change (SDC), the smallest within-person change which can 
be interpreted as real change above measurement error. The SDC should be compared 
to the minimal important change (MIC),5 the smallest change in the measurement 
which the clinician or patient perceive as important.6 When the MIC exceeds the SDC, 
the measurement has good clinical value, because clinically relevant changes can be 
distinguished from measurement error.6 Conversely, if the MIC is smaller than the SDC, 
the clinical usefulness of the measurement is limited because changes larger than the 
MIC but smaller than the SDC cannot be distinguished from measurement error.
Statistical analysis
We excluded observations with missing or “don’t know” or “unsure” responses. Percen-
tiles of heart rate and respiratory rate were compared to reference values for age and 
categorized as <p1, p1-10, p10-25, p25-50, p50-75, p75-90, p90-99, and >p99.17 Tachy-
pnoea and tachycardia were defined as respiratory and heart rates ≥ p90.
Calculation of measurement error (SEM)
Quantifying the measurement error in the units of measurement, or comparing it with 
change over time or response to treatment, is only possible for continuous variables 
(dyspnoea score). We calculated the SEM due to variation within observers by using the 
formula: SEM = SDdifference/√2, where SDdifference is the standard deviation of the mean dif-
ference between the repeated observations.6 The SEM due to variation between observ-
ers was calculated by using the pooled SD of the mean scores of the different observers 
using the formula: SEM = SDpooled*Ö(1-ICCagreement). SDpooled was calculated as √(SD
2
observer1 
+ SD2observer2 + etc/2).
6
Calculation of reliability parameters (ICC and Kappa)
For the dichotomous clinical findings (present or absent) we calculated Kappa and per-
centage agreement. Kappa can be calculated in different ways, depending on number 
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of observers, variable distribution (dichotomous, categorical, continuous) and statistical 
package.18 For intra-observer reliability we calculated Cohen’s Kappa in SPSS, using 
Siegel and Castellan’s calculation.19 For inter-observer reliability we calculated Cohen’s 
kappa for each observer pair, and used their arithmetic mean to calculate multirater 
Kappa, i.e. Light’s Kappa.20
Kappa values were categorized as follows: values of less than 0, poor; 0 to 0.2, slight; 
0.2 to 0.4, fair; 0.4 to 0.6, moderate; 0.6 - 0.8, substantial agreement; and 0.8 - 1.0 repre-
sent almost perfect agreement.21
For the continuous variable (dyspnoea score), we calculated intra-class correlation co-
efficient (ICC) in SPSS, using two-way-mixed, absolute agreement and single measures 
calculations.
Calculation of the minimal important change (MIC) and the smallest detectable change 
(SDC)
We used the visual anchor based MIC-distribution to calculate the MIC of the dyspnoea-
score in our study population.6 This approach uses an external criterion, or “anchor”, a 
well-accepted and readily interpretable measurement instrument to determine what 
patients or their clinicians consider important improvement. We used two anchors: 
the clinical judgement of the consultant paediatrician who had assessed the patient in 
the emergency department and the difference in respiratory rate percentile categories 
before and after bronchodilator. The SDC was calculated by multiplying the standard 
deviation of the change in the dyspnoea-score after treatment in the stable group of 
patients (defined by the anchor as “not importantly changed”) by a factor of 1.96 which 
corresponds to 1,96Ö2SEM.6 Detailed explanation and calculation of the MIC and SDC 
are given in webappendix 2.
All analyses were performed in SPSS, version 20.0.
results
We included and video-recorded 27 patients twice, before and after bronchodilator 
therapy. Each of these 54 recordings was assessed by nine observers on two occasions, 
resulting in a total of 972 assessments. Characteristics of included patients are listed in 
Table 1. Overall, patients had mild to moderate dyspnoea. None of the patients required 
intensive care or mechanical ventilation.
Table 2 shows the mean values, intra- and inter-observer reliability and the measure-
ment error (SEM) of the dyspnoea score.
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Table 3 shows the prevalence, intra- and inter-observer reliability, and percentage 
agreement of the different binary clinical findings. Reliability within observers was fair to 
almost perfect, and reliability between observers was slight to moderate. Inter-observer 
reliability was considerably lower than intra-observer reliability for each item.
The MIC for the dyspnoea score as calculated in this study population, was 1 (0.5) for 
both anchors. The SDC in the dyspnoea score, again calculated in this study population, 
was 3.2 for the clinician’s judgement and 3.3 for the change in respiratory rate. For both 
anchors, therefore, the SDC was considerably larger than the MIC, the consequences of 
which are expressed in Figure 1. In only 5.8% of observations in our study, the change 
in dyspnoea-score was both statistically significant and clinically relevant (webappendix 
2).
table 1 Patient Characteristics
N=27
Age in months, median, (range) 19 (3-85)
Male gender, n (%) 17 (63%)
Hospitalization, n (%) 20 (74%)
Diagnosis, n (%)
Acute asthma 7 (26%)
Exacerbation of episodic viral wheeze 13 (48%)
Bronchiolitis 6 (22%)
Other* 1 (4%)
Clinical findings before treatment (‘live” assessment)
Tachypnea**, n (%) 20 (74%) 
Transcutaneous oxygen saturation ≤ 92%, n (%) 9 (33%)
Tachycardia**, n (%) 18 (67%)
* patient was finally diagnosed with foreign body aspiration
** ≥ P90 for age according to Fleming et al.17






Mean (SD) ICC SEM ICC SEM
Dyspnea score (0-10) 4.1 (1.8) 0.70 1.0 0.42 1.4
SD standard deviation; ICC Intraclass correlation coefficient; SEM standard error of measurements
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table 3 Intra- and inter-observer variation of categorical measures of dyspnoea in children





Subcostal retractions 68.0% 84.6% 0.65 (0.58-0.73) 70.4% 0.46 (0.44-0.49)
Prolonged expirium 61.1% 81.6% 0.61 (0.47-0.75) 61.6% 0.12 (0.19-0.28)
Jugular retractions 57.4% 78.8% 0.57 (0.48-0.66) 65.1% 0.29 (0.25-0.30)
Wheeze 42.6% 78.5% 0.56 (0.48-0.64) 68.0% 0.36 (0.33-0.39)
Intercostal retractions 42.0% 76.2% 0.49 (0.39-0.58) 67.6% 0.27 (0.24-0.30)
Nasal flaring 22.8% 88.6% 0.63 (0.52-0.74) 83.0% 0.31 (0.26-0.37)
Supraclavicular retractions 21.2% 96.0% 0.84 (0.75-0.93) 79.3% 0.37 (0.32-0.42)
Mental state affected 4.4% 94.9% 0.39 (0.16-0.62) 92.4% 0.10 (0.07-0.21)
* Cohen’s kappa (Siegel & Castellan)20, ** Multirater Kappa (Light)21
discussion
This study is unique because it examines both within- and between-observer varia-
tion amongst more than two observers of physical examination signs of dyspnoea in 
children, which are being used in all published composite dyspnoea severity scoring 
systems. The results of our study show fair to good intra-observer reliability but poor 
figure 1. Interpretation of change in dyspnoea score after treatment, explaining the relevance of the MIC 
being smaller than the SDC
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inter-observer reliability of the clinical assessment of dyspnoea. Due to this variation 
within and between observers, the smallest detectable change exceeded the minimally 
important effect of treatment in 69.4% of observations in our study, obscuring the de-
tection of a clinically important improvement in dyspnoea after treatment.
The poor inter-observer reliability we found is in accordance with the existing litera-
ture (see webappendix 1).15 To our knowledge, however, no earlier studies examined the 
clinical relevance of this variation between observers in terms of the ability to detect 
clinically relevant improvement after treatment, partly because the clinimetric method-
ology to assess this is relatively new.5,6
Our findings implicate that in clinical practice, assessment of the severity of dyspnoea in 
children is not interchangeable between professionals. The results of our study, there-
fore, argue for great caution in interpreting the effect of a trial treatment with bron-
chodilator, which is recommended in clinical guidelines for infants with bronchiolitis22 
and in young children with acute severe wheeze,23 in particular when the assessment 
of dyspnoea before and after bronchodilator is being performed by different observers. 
But even when the same professional assesses the degree of dyspnoea before and after 
bronchodilator, the considerable intra-observer variation (table 3) should be taken into 
account. If clinical dyspnoea scoring is being used in clinical trials of young children, 
the number of different observers should be presented and discussed, because of the 
large variation between observers (table 3). Although most published clinical dyspnoea 
scores report validation against lung function,24 we recently described that no clinical 
dyspnoea scoring system available to date has been sufficiently validated for routine 
clinical use.15 Even in large trials with considerable clinical impact, the degree of intra- 
and inter-observer reliability is not formally studied.24 Our results suggest that clinical 
dyspnoea scoring systems require further validation testing and assessment of variation 
between and within observers. Further studies are needed to assess whether training 
can reduce the amount of variation we observed in this study (table 3).
We also postulate that the use of more objective parameters, such as oxygen satura-
tion and lung function assessments with acceptably small measurement error, will give 
less variable and thus more reliable assessments of dyspnoea in children.
Strengths and limitations
The major strengths of our study include the measurement of intra- as well as inter-
observer reliability, the use of a large group of observers in a crossed design, and the 
assessment of the clinical impact of reliability of these clinical signs of dyspnoea by 
computing measurement error.
We acknowledge the following weaknesses of our study. The use of video recordings 
clearly has limitations. The video recordings were relatively short (2-3 minutes), which 
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may have led to less accurate ratings or missed observations and may have decreased 
the likelihood of detecting subtle signs on physical examination. For our study purposes, 
however, which included the assessment of variation between and within multiple 
observers, video recordings were considered to be the only feasible method. The lack of 
chest auscultation could also be viewed as a weakness, because this helps physicians to 
detect lower airway obstruction. However, previous studies have shown poor associa-
tion between wheeze severity on auscultation and the degree of airway obstruction and 
hypoxaemia.4, 25 Furthermore, leaving out auscultation in the assessment of dyspnoea 
severity in children reflects clinical practice where many assessments are being made by 
health care professionals who have not been trained in chest auscultation. We examined 
a limited number of patients for feasibility reasons, to avoid observer fatigue and bore-
dom when assessing the videos. The reliability of the dyspnoea score and the individual 
items may have been greater if we would have included more children with (very) severe 
dyspnoea. However, we argued that health care professionals are reasonably accurate in 
identifying severe dyspnoea, reducing the need for a scoring system to identify this. A 
clinical dyspnoea scoring system is potentially most useful in identifying and following 
up mild to moderate dyspnoea in clinical practice, which our study population repre-
sented.
A limitation of the Kappa statistic is its bias in case of low or high prevalence. Although 
we used a bias correcting-version of Kappa (Castellan & Siegel), no formal adjustment 
for the influence of prevalence on Kappa was made in our analyses.20 This may have 
played a role in explaining the low Kappa value for abnormal mental state, which had a 
low prevalence (6% and 2.9% before and after treatment, respectively).
conclusion
The measurement error induced by inter-observer variability of clinical signs of dys-
pnoea in children is considerable and cannot be distinguished from a possibly relevant 
effect of therapy in two thirds of patients. The poor inter-observer reliability of clinical 
dyspnoea assessment in children limits its usefulness in clinical practice and research, 
and highlights the need to use more objective measurements in these patients.
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weBaPPendix 2: exPlanation of the visual anchor Based method 
for calculation of the minimal imPortant change (mic).
Clinimetric textbooks recommend to use different anchors to assess minimal important 
change.6 We used two anchors: the clinical judgement of the consultant paediatrician 
who had assessed the patient in the emergency department and the difference in re-
spiratory rate percentiles before and after bronchodilator. Clinicians rated the change 
in the child’s condition after bronchodilator as worse, no change, slightly improved, or 
markedly improved. Respiratory rate percentile scores were categorized as <p1, p1-10, 
p10-25, p25-50, p50-75, p75-90, p90-99, and >p99.17 Changes in respiratory rate percen-
tile scores were categorized as two or one categories worse, no change, or as one, two 
or three categories improved. Table A presents the distribution of the dyspnoea score 
compared to the different anchors. For each of these anchor changes, we calculated the 
corresponding mean (SD) change in the dyspnoea score (table A).
The next step to obtain the MIC value is to determine the cut-off point on the different 
anchors, so the observations can be divided in two parts: observations which improved 
importantly and those which did not.6
The cut-off points on the anchors were laid between the categories “no change” and 
“slightly improved” for the judgement of the clinician. The cut-off point for the respira-
tory rate as anchor was laid between “1 category improved” and “2 categories improved”.
Subsequently, for each change in dyspnoea score, we calculated the proportion of ob-
servations classified as “improved” or “not importantly changed” according to the anchor 
(Table B and C). Thereafter sensitivity and specificity for each change in dyspnoea-score 
was calculated. The optimal ROC (receiver operating curve) cut-off (i.e. the change in 
dyspnoea-score for which the sum of 1-sensitivity and 1-specificity is smallest, thus with 
the least false negative and false positive classifications) is considered the MIC.6
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aBstract
Background: Bronchiolitis is a major cause for hospitalisation in young children during 
the winter season, with respiratory syncytial virus (RSV) as the main causative virus. 
Apart from standard hygiene measures, cohorting of RSV-infected patients separately 
from RSV-negative patients is frequently applied to prevent cross-infection, although 
evidence to support this practice is lacking.
Objectives: To evaluate the risk of room sharing between RSV-positive and RSV-negative 
patients.
Study design: We performed a prospective observational cohort study in children <2 
years hospitalised with acute bronchiolitis. During the first day of admission, patients 
shared one room, pending results of virological diagnosis (PCR). When diagnostic re-
sults were available, RSV-positive and RSV-negative patients were separated. Standard 
hygienic measures (gowns, gloves, masks, hand washing) were used in all patients.
Results: We included 48 patients (83% RSV-positive). Co-infection was found in nine 
patients at admission, and two during hospitalisation (23%). The two patients with ac-
quired co-infection had been nursed in a single room during the entire admission. None 
of 37 patients sharing a room with other bronchiolitis patients (20 with patients with a 
different virus) were co-infected during admission. Disease severity in co-infection was 
not worse than in mono-infection.
Conclusion: One in five patients with bronchiolitis was co-infected, but co-infection 
acquired during admission was rare and was not associated with more severe disease. 
Room sharing between RSV-positive and RSV-negative patients (on the first day of 
admission) did not influence the risk of co-infection, suggesting that cohorting of RSV-
infected patients separate from non-RSV-infected patients may not be indicated.
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introduction
Acute bronchiolitis is a major cause for hospitalisation in young children during the winter 
season.1,2 Human Respiratory Syncytial Virus (RSV) is the most frequently identified virus, 
however with the use of new and highly sensitive molecular amplification methods, the 
role of other viral pathogens in bronchiolitis has been increasingly recognized. Various dis-
ease severity has been shown for a range of respiratory viruses, and double viral infection 
is relatively common, occurring in about 10-30% of hospitalised patients.3-7 There is no 
consensus, however, on the impact of such co-infection on disease severity:5 Some stud-
ies showed more severe disease in co-infected children,8-14 while others did not.15-21 Most 
hospitals perform routine viral testing to identify and isolate RSV-infected infants, with 
the aim of reducing the risk of nosocomial cross-infection of other patients.22,23,24 However, 
no good evidence is available of how effective this approach is in preventing nosocomial 
cross-infections among admitted patients with the clinical diagnosis of bronchiolitis.
Because of limited isolation facilities, patients with bronchiolitis admitted to our 
pediatric ward initially share a room, pending the results of virological diagnosis. We 
hypothesize that contact isolation measures and maintaining enough distance between 
the beds in a shared room should be sufficient in preventing cross-infection, since the 
major route of transmission of respiratory viruses is by close contact with infected secre-
tions and not by small-particle aerosol.24,25
Objectives
The purpose of this study was to determine the incidence of cross-infection in children 
hospitalised for bronchiolitis, when patients with RSV share the same room with patients 
with bronchiolitis infected with another virus during the first day of admission.
study design
The study was conducted at our 30-bed pediatric ward. From December 2011 through 
March 2012, all eligible infants younger than two years of age hospitalised for acute 
bronchiolitis were prospectively enrolled. Bronchiolitis was defined as acute respiratory 
disease, accompanied by coryza, cough, inspiratory crackles and/or expiratory wheezing 
on auscultation. Infants with chronic lung disease, congenital heart disease and Down’s 
syndrome were excluded.
We prospectively collected the following demographic and clinical information, 
including presence and number of roommates, virological diagnosis of the patient and 
roommates, and daily dyspnoea score assessed by an independent researcher, who was 
unaware of virological diagnosis (Table 1).26
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A nasopharyngeal aspirate was collected for virological diagnosis by direct immu-
nochromatographic antigen detection (RespiFinder TwoStep kit, Pathofinder) imme-
diately at admission, every fourth day during admission, and five to seven days after 
discharge.27,28
All patients with bronchiolitis were treated with standard hygienic measures. Medi-
cal and nursing personnel wore gowns, gloves and masks during patient contact and 
washed their hands before and after patient contact. Parents and visitors were asked to 
wash hands before leaving the room. On the first day of admission, pending the results 
of the RSV-PCR, patients shared a two- or four-bed room, with beds separated at least 1,5 
meter. Cohorting of RSV-infected patients commenced as soon as the result of RSV-PCR 
was known, generally within one day after admission.








oxygen saturation ≥ 95% in room air 92-94% in room air < 92% in room air,or need for 
supplemental oxygen
wheezing none audible with stethoscope audible without stethoscope
retractions none mild-moderate severe









Chi-square test was used to compare categorical data, Mann-Whitney U-tests for con-
tinuous data because of skewed distributions. Statistical analyses were performed using 
Statistical Package for the Social Sciences (SPSS) version 19.
This study is registered at clinicaltrials.gov (NCT01441466).
results
Of the 84 patients with bronchiolitis hospitalised during the 11-weeks study period, 
36 were excluded for the following reasons: cardiac disease (2), chronic lung disease 
with home oxygen (2), Down’s syndrome (3), no parental consent (12), age > two (7), 
missed inclusion (6), missing nasal wash specimen at admission (3). A total of 48 patients 
completed the study (Table 2).
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table 2 Patient characteristics
n=48
age, months 3.2 (1.8-9.7)
male 26 (54.2%)
Birth characteristics
…….gestational age, weeks 38.5 (37.8-40.1)
…….preterm birth (<37 weeks) 2 (4.2%)
…….birth weight, gram 3420 (3120-3740)
environmental factors
…….day care attendance 16 (33.3%)
…….siblings 39 (81.2%)
disease severity
…….length of hospitalization (days) 1.9 (1.6-4.0)
…….oxygen supplementation 30 (62.5%)
…….tubefeeding 20 (41.7%)
…….highest dyspnoea score 3.0 (2.0-4.8)
…….mechanical ventilation 3 (6.2%)
Data are presented as median and interquartile range in parentheses, or number and percentage in 
parentheses. Highest possible dyspnoea score 10








….RSV-A 7 (14.5%) 6 (12.5%) 2 (4.5%)
….RSV-B 25 (52.1%) 19 (39.6%) 5 (11.4%)
….hMPV 2 (4.2%) 1 (2.1%) 1 (2.3%)
….RhV 3 (6.3%) 3 (.3%) 3 (6.8%)
….CoV 0 2 (4.2%) 1 (2.3%)
….AdV 0 0 3 (6.8%)
co-infections
RSV-A and hMPV 1 (2.1%) 1 (2.1%) 0
RSV-B and
….PIF 1 (2.1%) 0 0
….AdV 0 1 (2.1%) 0
….RhV 4 (8.3%) 4 (8.3%) 1 (2.3%)
….CoV 1 (2.1%) 0 0
….hMPV 1 (2.1%) 1 (2.1%) 0
CoV and PIF 1 (2.1%) 1 (2.1%) 0
no virus 2 (4.2%) 9 (18.8%) 28 (63.6%)
Number with percentage in parentheses
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The distribution of viral pathogens is shown in Table 3; RSV was the major pathogen 
detected in 83%. Co-infection was found in 11 (22.9%) patients, nine of whom were 
already co-infected at admission, and two acquired co-infection during admission.
Of all included patients, 37 (77.1%) had shared a room with other bronchiolitis pa-
tients, 20 of whom (54.1%) had shared a room with a patient infected with a different 
virus. The two patients who acquired co-infection during admission had never shared a 
room with another patient. None of the bronchiolitis-patients sharing rooms had been 
infected with another virus during admission.
Co-infected patients did not suffer from more severe disease than patients infected 
with a single virus, but, although not statistically significant, disease severity tended to 
be higher in RSV-infected patients compared to RSV-negative patients. (Table 4)
table 4 Comparison of disease severity between mono- versus co-infected patients and RSV-infected 
versus RSV-uninfected patients










age, months 4.3 (2.2-11.4) 3.2 (1.6-9.4) 0.413 3.3 (1.8-9.8) 3.0 (1.6-8.5) 0.740
length of hospitalization, days 2.0 (1.7-3.4) 1.9 (1.2-4.2) 0.864 2.5 (1.6-4.4) 1.8 (1.2-1.9) 0.162
oxygen supplementation 6 (54.6%) 24 (64.9%) 0.535 25 (62.5%) 5 (62.5%) 1.000
tubefeeding 4 (36.4%) 16 (43.2%) 0.681 18 (45.0%) 2 (25%) 0.295
highest dyspnoea score (0-10) 3.0 (2.0-4.0) 3.0 (1.5-5.0) 0.654 3.0 (2.0-5.0) 2.5 (1.0-4.0) 0.285
mechanical ventilation 1 (9.1%) 2 (5.4%) 0.658 3 (7.5%) 0 (0%) 0.424
Data are presented as median and interquartile range in parentheses, or number and percentage in 
parentheses as appropiate
P value: Mann-Whitney-U test for continuous variables, Х2 test for dichotomous variables
discussion
This study showed that nosocomially acquired co-infection is rare, even when RSV-
positive and RSV-negative patients share a room during the first day of hospital admis-
sion. Furthermore, co-infection was not associated with more severe disease. The small 
number of our study limits any firm conclusion, however these findings may suggest 
that separating RSV-infected from RSV-negative patients with bronchiolitis may not be 
indicated. Cohorting of patients with bronchiolitis as one group, irrespective of viral 
diagnosis, may suffice.
Our finding that cohorting of RSV-infected patients may not add to the prevention of 
co-infection is supported by the fact that the main route of transmission of respiratory 
viruses is through direct contact, with only a minor role for aerosol transmission.24,25 
Therefore, we stress that strict adherence to other hygienic measures by medical staff 
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and patient’s relatives is clearly of crucial importance.23,24 Hand washing is the single 
most important procedure in the prevention of nosocomial infections, yet it remains 
the most violated of all infection control procedures.23,24 It is conceivable that placing 
children in a cohort generates considerable peer and parental pressure to ensure that 
measures such as hand washing are followed.
Our results may also imply that routinely performing virological diagnostic testing 
is not needed in children with bronchiolitis. The diagnosis of bronchiolitis is a clinical 
diagnosis and for this purpose further diagnostic testing is not needed.29 Since cohort-
ing of RSV-infected patients is the most importance reason for virological testing in 
bronchiolitis, health care expenses can be reduced by omitting the routine use of these 
tests, provided that influenza, a serious and treatable infection, is excluded.
This does not exclude the potential usefulness of rapid broad range viral testing in 
specific circumstances, for example in young febrile infants, where rapid broad range 
viral testing might reduce the need for invasive sepsis workup, or in case of unclear 
clinical presentation (apnoea without respiratory signs) or for surveillance purposes.
Our findings add to the current controversy considering this issue and we realise that 
the small numbers of our study limit solid comments on this subject and no definite 
conclusions can be made. Another important limitation is the fact that we only evalu-
ated the risk of room sharing during the first 24 hours of admission. It is well possible 
that prolonged sharing of rooms increases the incidence of cross-infections. For practi-
cal and safety reasons, we deliberately chose to perform the study under these specific 
circumstances as a proof of principle, before embarking on a similar project with room 
sharing during the entire admission.
We conclude that, with standard hygiene control measures, the risk of nosocomially 
acquired co-infection is low, and does not appear to be related to room sharing be-
tween RSV-positive and RSV-negative patients (during the first day of admission). These 
findings argue against routine cohorting of RSV-infected bronchiolitis patients and 
against routinely carrying out broad range virological testing of infants hospitalised for 
bronchiolitis. Yet a larger number of patients, applying room sharing during the entire 
admission is needed before definite conclusions can be made.
Ethical approvement
Written informed consent from the parents was obtained before inclusion. The study 
was approved by the institutional’s ethical review board.
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aBstract
Background: In infants hospitalized for bronchiolitis, cohorting of RSV-positive patients 
separately from RSV-negative patients is a commonly applied procedure to prevent 
nosocomially acquired cross-infections. We previously described that cross-infections 
did not occur when patients shared a room on the first day of admission, irrespective of 
the causative viral agent.
Objective: To determine the incidence (and clinical severity) of cross- infections in pa-
tients admitted with bronchiolitis, when patients with different causative viral agents 
share a room during the entire admission course.
Methods: A prospective cohort of all infants < 2 years old, hospitalized with bronchiolitis 
during the winter season 2012-2013. Patients shared a 2 to 4-bed hospital room during 
the entire admission, irrespective of virological diagnosis. Standard contact hygienic 
measures were applied in all patients (gowns, gloves and hand-washing).
Results: We included 65 patients in the period December 2012 to March 2013 (94% 
RSV-positive), 56 of whom (85%) shared a room with another bronchiolitis patient, 18 
(28%) of which with a different causative virus. On admission, 10 patients (15%) were 
co-infected with another virus. During admission, 8 (12%) patients were cross-infected 
with a different virus. Of these cross-infected patients, one patient had shared a room 
with a virus identified in one of the roommates. We found no significant differences in 
disease severity between patients infected with single or multiple viruses, nor between 
RSV-positive versus RSV-negative patients.
Conclusion: Co-infection amongst patients with bronchiolitis is common. Roomsharing 
does not seem to play a meaningful role in the transmission of viruses between patients 
with bronchiolitis sharing one room.
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introduction
Acute bronchiolitis is an important cause for hospitalization in young children, espe-
cially during the winter season.1,2 Human Respiratory Syncytial Virus (RSV) is the most 
frequently identified virus, detected in 70-85% of hospitalized infants during the winter 
epidemic followed by rhinovirus (RV), human metapneumovirus (hMPV), adenovirus 
(AdV), influenza virus (IV), and parainfluenza virus (PIV).1-5 Traditionally, RSV was consid-
ered to be associated with more severe disease and need for hospitalization.5 Since the 
availability of new molecular amplification methods, the role of other viral pathogens, 
including co-infections, in bronchiolitis has been given more attention. Studies using 
multiplex polymerase chain reaction (PCR) have shown varying degrees of bronchiolitis 
severity for a range of respiratory viruses.3,5 In these studies, co-infection was relatively 
common, occurring in about 10-30% of hospitalized patients.3,5-7 There is no consensus, 
however, on the impact of such co-infection on disease severity:5 some studies showed 
more severe disease in co-infected children,8-14 while others did not.15-21 Since diagnosis 
of co-infection does not lead to specific therapy and it is unclear how it predicts se-
verity or length of disease,5 there is debate about whether RSV-testing of infants with 
bronchiolitis changes clinical management or outcome.1 Still, many hospitals perform 
routine viral testing to identify and isolate RSV-infected infants, with the aim of reduc-
ing the risk of nosocomial cross-infection of other patients.22 It has been shown that 
the combination of contact isolation measures (gowns, gloves and hand washing) and 
cohorting of RSV-infected patients lowers the risk of nosocomial cross-infection of other 
patients.23,24 However, no good evidence is available of how effective this approach is 
in preventing nosocomial cross-infections amongst patients with bronchiolitis. Such a 
policy would be justified if it could prevent cross-infection and if co-infection leads to 
more severe disease than single infection.1 Since it is unclear which isolation measures 
are most effective, it is advised that the choice of infection control measures is decided 
by individual institutions depending on the patients, the type of ward, and the benefit 
relative to cost.24
We hypothesized that contact isolation measures and maintaining enough distance 
between the beds in a shared room should be sufficient to prevent cross-infection, since 
the major route of transmission of respiratory viruses is by close contact with infected 
secretions and not by small-particle aerosol.24,25 Earlier we showed that room sharing 
between RSV-positive and RSV-negative patients on the first day of admission did not 
influence the risk of co-infection.26 The purpose of the present study was to determine 
the incidence of cross-infection and the severity of single versus co-infection in children 
hospitalized for bronchiolitis, when patients with bronchiolitis share the same room 
irrespective of the causative virus, during the entire course of admission.
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materials and methods
Patients
The study was conducted at the pediatric ward (30 beds) of Isala, a general teaching 
hospital in Zwolle, The Netherlands. We plan to continue the study during 3 to 4 winter 
seasons to allow inclusion of a sufficiently large number of patients. The results presented 
here are the preliminary results of the first season. From December 2012 through March 
2013, all eligible infants younger than 2 years of age hospitalised for acute bronchiolitis 
were prospectively enrolled. Bronchiolitis was defined as acute respiratory disease, ac-
companied by coryza, cough, and inspiratory crackles and/or expiratory wheezing on 
auscultation. Infants with chronic lung disease, congenital heart disease and Down’s 
syndrome were excluded.
The study was approved by the medical ethical committee. Written informed consent 
from the parents was obtained before inclusion.
Clinical data collection
We prospectively collected the following demographic and clinical information: age, 
medical history, presence and number of room mates, virological diagnosis of the pa-
tient and their room mates, oxygen supplementation, apnoea, tube feeding, intensive 
care admission, and daily dyspnoea score assessed by an independent researcher.27 This 
person was not aware of the virological diagnosis.
Virological diagnosis
A nasopharyngeal aspirate was collected for virological diagnosis immediately at admis-
sion, every fourth day during admission, at discharge, and 4-7 days after discharge, ac-
counting for an incubation period of 4-7 days in most respiratory viral pathogens.28 The 
nasopharyngeal aspirate was collected by placing a catheter through one of the nostrils 
in the nasopharynx. Then 1-2 ml of saline was instilled and aspirated. The specimen was 
stored with saline, transported to the laboratory and frozen at -85oC for later analysis. 
All specimens were analyzed batchwise by the RespiFinder TwoStep kit (Pathofinder, 
Maastricht, The Netherlands) for the purpose of this study.29 Results of this multiplex-
PCR were not made available to the attending physicians, but were only collected for 
research purposes. Neither the parents of the patients nor the nurses and doctors were 
aware of virological diagnosis.
Treatment protocol and hygienic measures
All patients were managed according to our local bronchiolitis practice guideline. In-
fants younger than 3 months of age were monitored for at least 3 days for apnoea and 
oxygen saturation; oxygen was being supplemented when saturation fell below 92%. 
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Patients were discharged when respiratory support was no longer needed and their oral 
intake was at least two-thirds of their normal intake.
All patients with bronchiolitis were treated with standard contact hygienic measures. 
Medical and nursing personnel wore gowns and gloves during patient contact and 
washed their hands before and after each patient contact. Parents and visitors were 
asked to wash hands before leaving the room. Patients were nursed together in a 2 or a 
4-bed room, with beds separated at least 1.5 meters.
Statistical analysis
Chi-square test was used to compare categorical data, Mann-Whitney U-tests for con-
tinuous data because of skewed distributions. Statistical analyses were performed using 
Statistical Package for the Social Sciences (SPSS) version 20.
This study is registered at clinicaltrials.gov (NCT01441466)
results
Of the 94 patients with bronchiolitis hospitalized during the study period, two were 
excluded because of relevant background disease (cardiac disease), 17 because parents 
declined consent, and four because they were older than two years of age. Four patients 
were missed, in one no nasal wash specimen was obtained immediately at admission 
table 1 Patient characteristics
n=65
age, months 3.5 (1.0-6.3)
male 43 (66%)
Birth characteristics
…….gestational age, weeks 38 (37-40)
…….preterm birth (<37 weeks) 7 (11%)
…….birth weight, gram 3250 (2770-3770)
environmental factors
day care attendance (missing data in 6) 48 (81%)
…….siblings (missing data in 5) 51 (85%)
disease severity
…….length of hospitalization (days) 4 (3-6)
…….oxygen supplementation 53 (82%)
…….tubefeeding 43 (66%)
…….highest dyspnoea score (0-10) 4 (3-5.5)
…….mechanical ventilation 2 (3%)
Data are presented as median and interquartile range in parentheses, or number and percentage in 
parentheses. Highest possible dyspnoea score 10.
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and in one patient data were not collected. A total of 65 patients completed the study. 
Demographic and clinical data are given in Table 1.
RSV was the major pathogen detected in 61 (94%) of patients on admission. No virus 
was detected at admission in two patients; influenzavirus was found in one, and human 
metapneumovirus in combination with parainfluenza in another. Co-infection on admis-
sion was found in 10 patients (15%): one patient was infected with metapneumovirus 
in combination with parainfluenza , nine were infected with RSV in combination with 
adenovirus (n=1), Rhinovirus (3), or Coronavirus (4). One patient had 3 viruses on admis-
sion (RSV, adeno and parainfluenza).
Cross-infection, defined as acquired co-infection during admission, was found in 8 pa-
tients (12%), all of whom were initially infected with RSV and co-infected with rhinovirus 
(n=5), enterovirus (n=5), and influenza (n=1), respectively.
Of all included patients, 56 (86%) had shared a room with other bronchiolitis patients, 
18 of whom had shared a room with a patient infected with a different virus. Of the eight 
patients who acquired co-infection during admission two had never shared a room with 
another patient, four had shared a room with patients with the same virus and two had 
shared a room with patients with another virus. Only one of the latter cross-infected 
patients was cross-infected with a virus identified in one of the roommates. The other 
seven cross-infected patients had never shared a room with a patient that was identified 
with the virus they were cross-infected with.
Co-infected patients did not suffer from more severe disease than patients infected 
with a single virus, and disease severity was equal in RSV-infected patients compared to 
RSV-negative patients. (Table 2)
table 2 Comparison of disease severity between mono- versus co-infected patients and RSV-infected 
versus RSV-uninfected patients










age, months 3 (1-6) 5 (2-7) 0.168 3 (1-6) 6 (4-13) 0.083
length of hospitalization, days 4 (1-12) 4 (3-6) 0.750 4 (3-6) 3 (1.5-7.5) 0.450
oxygen supplementation 13 (72%) 40 (85%) 0.231 50 (83%) 3 (60%) 0.196
days of oxygen supplemantation 2.5 (0-4) 3 (1-4) 0.667 3 (1-4) 2 (0-6) 0.283
tubefeeding 13 (72%) 30 (64%) 0.522 40 (67%) 3 (60%) 0.762
days of tubefeeding 3.5 (0-5) 2 (0-13) 0.317 2 (0-4) 2 (0-6) 0.990
highest dyspnoea score (0-10) 4 (4-6) 4 (4-5) 0.633 4.5 (3-6) 4 (2-4.5) 0.194
Data are presented as median and interquartile range in parentheses, or number and percentage 
in parentheses as appropriate. P value: Mann-Whitney-U test for continuous variables, Х2 test for 
dichotomous variables.
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discussion
This study showed that co-infection, including nosocomially acquired cross-infection, is 
frequently seen in infants admitted for bronchiolitis. However, cross-infection between 
patients sharing a room is rare, occurring in only one patient in this study population. 
Furthermore, co-infection was not associated with more severe disease. Our findings 
therefore suggest that roomsharing of patients with bronchiolitis irrespective of the 
virological diagnosis, is safe.
We want to emphasize that these are preliminary results, and firm conclusions are 
limited by the relatively small number of patients. We will continue this study for an-
other three to four winter seasons, to obtain a sufficiently large number of patients, and 
to account for the variability in viral prevalence and virulence between different years.
We did not address the source of the cross-infections other than the roommates. In 
future studies we will investigate viral carriership in medical personal and visitors of 
admitted patients with bronchiolitis to further elaborate this issue.
We cautiously conclude that roomsharing of patients with bronchiolitis is not an 
important cause of nosocomially acquired cross-infection. These findings suggest that 
roomsharing of infants with bronchiolitis, irrespective of virological diagnosis, is a safe 
procedure, when standard hygiene measures are guaranteed. This conclusion implies 
that routinely performing virological tests for the purpose of cohorting may not be 
necessary for this purpose. Larger study samples are warranted before firm conclusions 
can be made.
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general discussion and future PersPectives
In this thesis we evaluated various diagnostic measurements in paediatrics – across a 
wide age range, from neonates to older children – aimed at clarifying (demystifying) 
these commonly used procedures. We translated our aim into the following research 
questions:
1. What is the validity and interobserver reliability of the semi-quantitative measure-
ment of glucosuria using reagent strips? Is this method reliable and feasible under 
the specific setting of a neonatal intensive care unit (NICU)?
2. What is the diagnostic value of various clinical signs, including glucosuria, in identi-
fying late-onset neonatal sepsis (LONS) in prematurely born neonates?
3. What is the reliability and usefulness of fluid balance charts kept for moderately ill 
neonates admitted to a high-care neonatal unit?
4. What is the validity, reliability and utility of clinical findings including current com-
posite paediatric dyspnoea scores, when assessing severity of dyspnoea in wheezing 
children?
5. What is the benefit of identifying and isolating RSV-infected infants hospitalised 
for bronchiolitis, for the purpose of reducing the risk of nosocomial cross-infection 
among patients with bronchiolitis? In other words: what is the incidence and clinical 
severity of cross-infections in patients admitted with bronchiolitis, when patients 
with different causative viral agents share a room during their stay in hospital?
In general we conclude that the adage “meten is weten” (the knowledge is in the numbers) 
still holds true, provided that one knows what is being measured, how the measurement 
is performed, by whom, and for what reason. The main findings, strengths, limitations, 
and clinical and research implications of each of the five research topics are discussed 
below, followed by some final, summarising reflections on the role played by evidence-
based medicine (EBM) when investigating this theme.
chaPter 1  semi-Quantitative measurement of glucosuria in 
neonates
In this chapter, we present a study we performed to investigate the validity, reliabil-
ity and utility of semi-quantitative measurement of glucosuria, which can be used to 
monitor glucose homeostasis, a parameter frequently disturbed in prematurely born 
neonates. We conducted an observational study, in which we used 300 experimentally 
derived urine samples tested under the specific circumstances of a neonatal intensive 
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care unit – assessed independently by three different nurses – and compared the results 
of the reagent strips with the urinary glucose concentrations measured quantitatively 
in the laboratory.
Main findings
The validity of the semi-quantitative measurement of glucosuria using visually read 
reagent strips was moderate, with more than one-fifth of reagent strips readings incor-
rectly predicting the laboratory measurement. Measurement using the reagent strips 
gave the urine samples a score in one of five categories (0 to 4+). Under or overestima-
tion of the degree of glucosuria occurred predominantly in the categories 1+ and 2+. 
The discriminative power between the lower categories of glucosuria (1+ and 2+) was 
low. When the categories 1+ and 2+ were taken together as a single category, the false 
ratings were halved (from 21.7% to 10.6%). In category 0, only 5.1% of readings were 
incorrect, i.e. the validity of the reagent strips for ruling out glucosuria is fairly good.
The interobserver agreement for glucosuria assessment using reagent strips was high 
(Kappa 0.81). The maximum difference between observers was one category, which 
seems acceptable for clinical use. The degree of glucosuria as measured by reagent 
strips is not influenced by the time spent by the urine in the diaper, and only slightly by 
incubator temperature and urine collection method.
Strengths and weaknesses
The main strength of our study is the use of a large number of samples that cover the 
complete range of glucose concentrations, which is important for obtaining reliable 
Kappa values.1 Interobserver variation was thoroughly investigated by adequate blind-
ing of the observers. This is the first study to examine the reliability of glucosuria reagent 
strips when used in the specific setting of a neonatal intensive care unit.
The main limitation lies in the generalisability of the results. While our study was 
performed under controlled study conditions (standardised light and temperature, 
single investigator), in real-life clinical practice the reagent strip is read under variable 
circumstances (differences in ambient light and temperature) and by both experienced 
and inexperienced staff members. Future studies using urine samples from patients in 
real-life clinical practice with a wide spectrum of glucosuria are needed to elucidate this 
matter.
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Clinical and research implications
• Glucosuria can be assessed reliably and simply in a semi-quantitative way using visually read 
reagent strips in a NICU setting, provided that categories 1+ and 2+ are taken together as a 
single category.
• Changes in glucosuria of more than one category are likely to be real (change exceeds 
measurement error).
Future studies should assess interobserver reliability under real life circumstances.
chaPter 2  early diagnosis of late-onset sePsis in Preterm 
infants
In this second chapter, we explored the predictive value of various clinical symptoms, 
including glucosuria, as markers for late-onset neonatal sepsis (LONS) in preterm 
infants. We did this by performing an observational study in 350 premature infants dur-
ing a two-year period (2005-2007). We prospectively collected daily measurements on 
glucosuria in all infants – blinded to treating physicians – and followed these children 
for the occurrence of sepsis episodes, thus creating a case-control study within this 
prospective cohort.
Main findings
Most of the individual clinical symptoms had only moderate predictive value for identify-
ing LONS in preterm infants suspected of infection. The clinical signs that had the high-
est predictive value for LONS were as follows: increased respiratory support, capillary 
refill time > 2 seconds, pallor or grey skin colour, and a central venous catheter in the 24 
hours preceding the onset of suspected infection. When we represented these clinical 
signs graphically in a nomogram, their predictive value for identifying LONS improved. 
This nomogram allows users to calculate the expected risk of LONS in individual patients 
with suspected infection. Other clinical signs that were too non-specific to be useful 
in excluding or confirming LONS included glucosuria, temperature instability, apnoea, 
tachypnoea, tachycardia, dyspnoea, hyper and hypothermia, feeding difficulties and 
irritability. Although glucosuria was associated with LONS, the association was too weak 
to be of diagnostic value, probably because glucosuria was also strongly associated with 
gestational age, birth weight and postnatal age, which are well-known risk factors for 
LONS.
Strengths and weaknesses
The main strength of this study was the prospective and blind method of data collection 
and the fact that we evaluated both clinical and blood-culture-proven sepsis. Clinically 
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confirmed but culture-negative sepsis is frequently encountered in clinical practice. This 
was the first study to examine the association between glucosuria and LONS.
A major limitation was incorporation bias: some clinical signs were used both in the 
definition of suspected sepsis and in the reference standard for clinically confirmed 
sepsis. Incorporation bias increases the risk of misclassification and overestimates test 
accuracy.2
Clinical and research implications
• Glucosuria, temperature instability, apnoea, tachycardia, dyspnoea, feeding difficulties or 
irritability are too non-specific to be of diagnostic value when identifying LONS.
• Clinical signs that increase the likelihood of LONS in preterm infants include the following, 
particularly when represented together in a nomogram:
o increased respiratory support,
o capillary refill > 2 seconds,
o pallor/grey skin,
o a central venous catheter in the 24 hours preceding the episode of suspected infection.
• This nomogram may help to decide on duration of antibiotic therapy, for example in situations 
where no blood culture is available. Moreover, it may be possible to postpone the start of 
antibiotics in cases of low risk, under close monitoring of clinical symptoms.
For the future: Clearly, this model needs external validation in new patient groups. Further research to 
evaluate the reliability and interobserver and intraobserver variation for the more subjective symptoms 
is also warranted. It might also be useful to further analyse our data to evaluate the usefulness of daily 
monitoring of glucosuria in the early detection of LONS.
chaPter 3 fluid Balance charts in neonates
In this chapter we investigated the reliability and utility of the fluid balance in neonates. 
In 2009-2010 we performed a randomised controlled trial in 172 neonates admitted to 
our high-care neonatal unit. In one group, physicians were blinded to the fluid balance 
data, while in the other group fluid balance data were made available to attending 
physicians. We also investigated reliability in this study population by comparing the 
data on daily fluid balance with that on daily changes in body weight.
Main findings
The agreement between fluid balance data and daily weight changes in neonates was 
poor, with differences of >20% of daily fluid intake (our predefined threshold for clinical 
relevance) occurring in 40% of fluid balances charts. Fluid balance charts are imprecise, 
both over and underestimating body weight changes in an unpredictable pattern, and 
are therefore unreliable measures of fluid status in sick neonates. In the randomised 
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trial, keeping a fluid balance chart did not influence length of hospitalisation, degree of 
weight loss or degree of medical interventions by the attending physician.
Strengths and weaknesses
The main strengths of this study include the randomised controlled trial design, the me-
ticulous attention paid to avoid revealing of the fluid balance data to the physicians in 
the intervention group, and the close reflection of clinical practice, using measurements 
and techniques commonly used in neonatal wards.
The main limitation was the moderate disease severity in our patients. Keeping a fluid 
balance might be more useful in sicker newborns, for example in a neonatal intensive 
care setting.
Clinical and research implications
• Because of their imprecision, keeping fluid balance charts in sick neonates with moderate 
disease severity is not useful.
• This study is an example of how a time-consuming and error-prone tradition appears to be of 
little use in improving patient care.
Further studies are needed to investigate the usefulness of keeping a fluid balance in the setting of a 
neonatal intensive care unit.
chaPter 4 clinical assessment of dysPnoea in children
In this chapter we investigated the clinical assessment of dyspnoeic children. We 
performed a systematic review that assessed the validity of all published composite 
dyspnoea scores. We also explored the intraobserver and interobserver variability of the 
individual clinical items used in existing composite dyspnoea scores by asking several 
professionals to assess video recordings of 27 dyspnoeic children.
Main findings
Of the 36 paediatric dyspnoea scores published in the literature, 14 were unsuitable 
for clinical use because of either insufficient face validity, use of items unsuitable for 
children, or difficult scoring systems. Although the other 22 scores were easy to use, 
information on reliability was sparse, and none of the scores had been sufficiently vali-
dated to allow for clinically meaningful use in children with acute dyspnoea or wheeze, 
in particular not when the purpose of using the score is evaluation of treatment effect.
We found intraobserver variation between the individual items of the composite 
scores to be modest. However, in two-thirds of observations the interobserver varia-
tion was too large to allow detection of any clinically relevant changes in dyspnoea in 
response to treatment.
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Strengths and weaknesses
The limited methodological validation of paediatric dyspnoea scores does not neces-
sarily exclude their suitability for use in clinical practice and research. However, the 
collection of additional data – thereby enabling quality scoring – will improve the 
acceptability and usefulness of existing dyspnoea scores. The main limitation of our 
study was the use of video recordings without auscultation, which may have limited the 
accuracy of the observations.
Clinical and research implications
• None of the numerous paediatric dyspnoea scores currently available have been sufficiently 
validated to allow clinically meaningful use in children with acute dyspnoea, in particular not for 
the purpose of evaluating effects of treatment.
• Intraobserver reliability of the clinical assessment of dyspnoea in children is fair.
• The large interobserver variation in the assessment of dyspnoeic children obscures detection of 
clinically important improvement, limiting its usefulness in clinical practice and research.
Future studies should not be aimed at developing new scores, but at validating existing dyspnoea 
scores more comprehensively, using live assessments and evaluating the added value of auscultation. 
Interventions to reduce observer variation (training and education) should be examined. Future studies 
should also make a direct comparison between the physician’s general impression of dyspnoea and the 
results of the composite scores.
chaPter 5  viral tests for cohort isolation in children 
hosPitalised for Bronchiolitis
During the annual winter epidemic of bronchiolitis – most commonly caused by respira-
tory syncytial virus (RSV) – rapid diagnostic RSV tests are frequently applied in order 
to separate patients infected with RSV from those infected with other viruses (cohort 
isolation). We investigated whether such cohort isolation was really necessary, thus 
questioning the use of expensive viral testing. As a proof of principle, during the winter 
season of 2011-2012 we first performed an observational cohort study in 48 patients 
who only shared rooms during the first day of admission, pending the results of the 
rapid RSV test. In the following season (2012-2013) we continued this study, including 
65 patients who shared rooms during their entire stay in hospital.
Main findings
Although co-infection (including nosocomial cross-infection) was frequently seen in 
infants admitted for bronchiolitis, cross-infection between patients sharing a room was 
uncommon, and co-infection was not associated with more severe disease. Our findings 
therefore suggest that it might be safe for patients with bronchiolitis to share a room, 
irrespective of the causative virus.
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Strengths and weaknesses
The major strength of the study is its originality: the effects of room sharing on cross-
infection have not previously been reported. The main limitations include the fact that 
we did not address potential sources of cross-infection other than roommates, and the 
small sample size.
Clinical and research implications
• Room sharing among patients with bronchiolitis appears to be safe when appropriate hygiene 
measures are taken during contact with patients.
• Routine performance of virological tests for cohorting purposes may not be necessary.
Future studies should include larger study samples and should assess the source of co-infections (family, 
visitors or medical staff).
summarising reflections: is the knowledge in the numBers?  
and how has evidence-Based medicine shaPed this thesis?
“There is no safety in numbers, or in anything else.”
James Thurber (New Yorker, 1939)
In this thesis, we evaluated five frequently used measurements in paediatrics, and found 
that the majority appeared to be imprecise and of limited clinical use. This calls into 
question the overall usefulness of measurements in paediatric clinical practice. Many 
measurements have a strong tradition in medicine in general, including paediatrics. 
From the perspective of medicine as a scientific discipline, measurements such as the 
ones evaluated in this thesis are commonly viewed as being “objective”, as opposed to 
the more “subjective” data obtained by history taking.3 Both healthcare professionals 
and patients (or their parents) tend to prefer such “objective” measurements, under the 
assumption that “the knowledge is in the numbers” (meten is weten).4,5,6,7 But the fact that 
such measures or procedures are commonly used – and have been used for ages – does 
not mean they are valid, precise or useful. In fact, it is quite striking to note that many of 
these measurements have been widely accepted as part of routine clinical practice, de-
spite the fact that their validity, precision, and usefulness have never been examined.8,9
Based on the results of this thesis, we conclude that the adage “meten is weten” (the 
knowledge is in the numbers) only holds true if one knows what is being measured, 
how the measurement is performed, by whom, and for what reason. For example, in our 
study of fluid balance data we found that the measurement error in neonates is large: it 
is simply not accurate when compared with the daily fluid intake and changes in body 
weight. Together with the results of the randomised controlled trial – which showed 
no effect of fluid balance keeping on patient health outcome – these findings led to 
174  General discussion and future perspectives
our conclusion that routine recording of fluid balance is not useful in sick neonates. 
Nevertheless, if in other patient groups (e.g. adults) the measurement error for fluid 
balance charts is relatively small when compared with the total fluid intake, this same 
measurement could still be sufficiently reliable to be of use in other specific situations 
or patient groups.
Why should we investigate time-honoured routine measurements?
With many innovations in the field of medical therapies and diagnostic technologies, 
it seems somewhat anachronistic to investigate time-honoured, routine measurement 
procedures. One therefore might question our reasons for investigating these topics in 
the first place and how we arrived at the research questions explored in this thesis. One 
way of answering this question is to turn it around: why would we thoroughly test new 
therapies and diagnostic technologies if we already accept and use many older thera-
pies and diagnostic procedures that have not been sufficiently investigated for validity, 
reliability and utility? Instead of investing limited research resources on developing new 
technologies and measurements, is it not important to investigate the utility and valid-
ity of procedures already in common use, so that we can avoid using measurements and 
techniques that are insufficiently valid, precise, or useful?
An important stimulus for us to investigate such commonly used measurements in 
paediatrics was the fact that – at the time – we were implementing evidence-based 
practice (EBP) in our paediatric department. This approach to clinical practice stimulated 
a self-critical attitude, leading us to question not only new tests, but also our day-to-
day routines. The implementation of EBP is not without its hurdles, however. Firstly, 
for most doctors and medical departments, a paradigm shift is required before we can 
easily recognise and admit the many gaps in our knowledge, analogous to the way in 
which we deal with medical errors.10 Secondly, doctors must above all be self-critical and 
recognise for themselves any questions that they might have. And finally, if doctors are 
to admit publicly that they do not know something, or they are to question department 
routine, then the environment must also be sufficiently safe. we feel that having a self-
critical and curious attitude is essential for evidence-based practice, and that it is this 
attitude that has stimulated us to question not only new medical developments, but 
also existing ones.
Implementing evidence-based practice
As mentioned above, the basic strategy of critically evaluating one’s own clinical habits, 
traditions and routine clinical procedures is a key component of the application of EBM 
in practice. In 2005, the paediatric department decided to further develop its clinical 
practice into an approach that included EBP. The reason for this decision was that we felt 
that critically evaluating our own practices and habits would help to reduce unnecessary 
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variations in diagnostic and therapeutic strategies between paediatricians in commonly 
encountered clinical problems in our department. We also thought that, as a result, this 
would help to improve health outcomes for patients, improve patient safety, and reduce 
health expenditure in our department.11,12,13
To achieve and implement evidence-based practice, we developed a project plan 
covering 5 years. The project plan consisted of three parts: training, implementation 
of EBM activities, and development and maintenance of clinical practice guidelines. 
For the training programme, one paediatrician from our department (JB) completed 
a core course in clinical epidemiology (EMGO Institute, VU University, Amsterdam); a 
further two paediatricians participated in several international EBM courses, some of 
them teaching courses (Centre for Evidence-based Medicine, University of Oxford; UCL 
Institute of Child Health, London; and McMaster University, Toronto). We subsequently 
developed a two-day, interactive, basic workshop on EBM skills – specifically targeted at 
Dutch hospital-based medical practice – and a trial version of the workshop was held for 
the entire consultant staff of our paediatric department. This enabled all consultants and 
nurse practitioners to become competent in basic EBM skills. At the same time, these 
skills were being introduced into the weekly routine of our department (the second part 
of our project plan), a process involving various activities during which the five steps of 
EBM were practised on a weekly basis. An overview of the weekly schedule is provided 
in Table 1.
The third and final part of our project comprised the development of clinical practice 
guidelines for approximately 100 topics, including the 20 most commonly encountered 
clinical problems, both on our paediatric ward and at our paediatric outpatient clinic. 
For this purpose, all paediatricians systematically searched the literature on these clini-
cal problems in their specific area of expertise – including published evidence-based 
guidelines – and either summarised and adapted the literature or retrieved existing 
guidelines, both for local purposes. This generated a library of dozens of local evidence-
based guidelines which were sufficiently concise and specifically adapted to the local 
situation. This library was used to encourage optimal application in our department. If 
consultants or junior doctors using the developed guidelines encountered problems in 
practice when applying them to patients they had seen, the guidelines were reviewed 
and discussed within the team during the weekly “guideline discussion” meeting.
All of the issues critically reviewed and analysed in this thesis originated from discus-
sions within our paediatric team during one of the EBM activities (Table 1).
Paradigm shift is necessary for successful implementation of EBP
During the first phase of this project, we discovered that several clinicians in our depart-
ment were struggling with the newly introduced custom of critically questioning both 
one’s own and each other’s ways of addressing clinical problems, and of discussing the 
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reasons for these differences between doctors. This taught us that the first prerequisite 
for successfully implemented EBP is to ensure that the working (and learning) climate 
is both self-critical and safe.14 After all, the first step of EBM is to formulate a structured, 
answerable, clinically relevant question, as shown in Figure 1.11 However, the tradition in 
medicine has long been one of avoiding raising critical questions in public because this 
would either acknowledge that one does not know something, or suggest that one is 
critical about a colleague’s knowledge or skills.15 Since childhood we have been taught 
to raise our hands in class when we know the answer to the teacher’s question, but 
not the other way around. Throughout our youth and training this emphasis on show-
ing knowledge and skills is reinforced, perhaps even more so now that “excellence” is 
increasingly being sought in students. Knowing is hot, while ignorance is not. Neverthe-
less, the first step in EBM, is to recognise and admit that one does not know or is not sure 
of something. This requires a paradigm shift which is still difficult for many physicians, 
even though it has become generally accepted that “to err is human”10 and that all doc-






















figure 1. Principles of evidence-based practice, showing the five steps
It should also be noted that although medicine is a scientific study in which it is es-
sential to raise questions and ask why and how, the many uncertainties that doctors 
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deal with in busy daily clinical practice lead them to rely heavily on experience, patterns 
and routine for most of their actions.3,16,17 The high reliance on experience and routine 
and the time constraints of a busy day in the hospital discourage clinicians from asking 
critical questions about their own and their colleagues’ behaviour.
Diagnostic studies and the limitations of EBM
While developing research questions that were based on identifying gaps in our knowl-
edge of the topics that originated from our EBM meetings, we discovered that the EBM 
methodology is better developed in the therapeutic field than in the field of diagnostic 
studies. While most if not all clinicians are familiar and feel comfortable with the meth-
odology of the randomised controlled trial, the great majority of doctors have limited 
knowledge of the methodology of diagnostic studies.18 While diagnostic studies are 
difficult to perform and diagnostic reasoning is complex,19,20 understanding diagnostic 
methodology may help to clarify and demystify our diagnostic reasoning. Doctors are 
well-trained in making diagnoses, and have several ways of arriving at certain diagno-
ses, ranging from spot diagnosis and pattern recognition to probabilistic reasoning 
and the use of clinical prediction rules.21 Although the terms specificity and sensitivity 
cross our path during our medical training, when experienced consultants are asked to 
calculate the post-test likelihood that a patient has a disease – given a certain disease 
prevalence and a specified test sensitivity and specificity – most are unable to do so.22 
Given that diagnostic studies are far less frequently published than therapeutic studies, 
most doctors have little experience in appraising diagnostic studies and they therefore 
find it difficult to appraise the validity and results of these studies. In our department, 
the implementation and weekly practice of EBM activities enabled us to become more 
familiar with diagnostic studies and the methodology behind them, which encouraged 
us not only to question the day-to-day use of tests in our own practice, but also to study 
them critically.
Closing remarks
All of the questions addressed in this thesis emerged from one of our departmental 
EBM meetings. For this reason, we believe that EBP has two main advantages. Firstly, it 
leads to improved healthcare by giving the patient the best available treatment, based 
on solid methodological evidence which takes into account both the doctors’ experi-
ence and the patient’s preferences. Secondly, it has beneficial effects on the self-critical 
attitude of doctors, which helps to raise interesting research questions that are relevant 
for clinical practice. Such changes in attitude help to raise interesting research questions 
that are relevant for clinical practice. We hope that our experience in this area, reflected 
in the studies in this thesis, helps other physicians and medical teams to adopt EBM skills 
and to develop evidence-based practice.
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Measurements are essential In medical practice. Throughout their training, doctors are 
taught the adage “meten is weten” (the knowledge is in the numbers). In this thesis we 
evaluated various diagnostic measurements in paediatrics – across a wide age range, 
from neonates to older children – aimed at clarifying (demystifying) these commonly 
used procedures.
In the introductory chapter we discuss the general aspects of uncertainty in medicine, 
since uncertainty is a major reason for performing diagnostic tests in the first place. We 
emphasize that apart from additional tests, such as laboratory or radiology investiga-
tions, every part of history taking and physical examination can be viewed as a diag-
nostic test. This is followed by a brief explanation of methodological issues concerning 
the architecture of diagnostic research and the clinimetric evaluation of measurements. 
Furthermore we explain the way evidence-based medicine may help doctors to deal 
with this feeling of uncertainty.
In the first chapter we present an experimental study in which we evaluated the validity 
and interobserver reliability of the semi-quantitative measurement of glucosuria using 
reagent strips in neonates. We conclude that glucosuria can be assessed reliably and 
simply by visually read reagent strips in the specific setting of a neonatal intensive care 
unit, provided that category 1+ and 2+ are taken together as one category. Changes 
in glucosuria of more than one category (of five categories) are likely to exceed the 
measurement error.
In the second chapter we investigate the diagnostic value of various clinical signs, in-
cluding glucosuria, in identifying late-onset neonatal sepsis (LONS) in prematurely born 
neonates, through an observational study. We present a nomogram that may help to 
identify LONS in prematures. This nomogram graphically depicts the likelihood of LONS 
depending on the presence of the following signs and symptoms: increased respiratory 
support, capillary refill > 2 seconds, pallor and/or gray skin, or the presence a central ve-
nous catheter in the 24 hours preceding the episode of suspected infection. Glucosuria, 
temperature instability, apnoea, tachycardia, dyspnoea, feeding difficulties or irritability 
all were too non-specific to be of diagnostic value in LONS.
In the third chapter we show - from a randomised controlled trial - that fluid balance 
charts are imprecise and not useful for routine use in moderately ill neonates.
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The fourth chapter is about the clinical assessment of severity of dyspnoea in children. 
We present a systematic review, which shows that none of the numerous dyspnoea 
scores in the current literature has been sufficiently validated to allow for clinically 
meaningful use in children with acute dyspnoea. In an observational study we found 
large interobserver variation in the assessment of dyspnoeic children, obscuring the 
detection of clinically important improvement, limiting its usefulness in clinical practice 
and research.
In the fifth chapter we present two observational studies investigating the benefit of 
identifying and isolating RSV-infected infants hospitalised for bronchiolitis, for the pur-
pose of reducing the risk of nosocomial cross-infection. We looked for the occurrence of 
nosocomial cross-infections when patients with different causative viral agents share a 
room during their stay in hospital. We found that roomsharing of children with bronchi-
olitis appears to be safe, when proper standard hygienic measurements are taken.
In the last chapter we summarize our research questions, main findings and discuss 
the strengths, limitations, clinical and research implications of each of the five research 
topics, followed by some final, summarising reflections on the role played by evidence-
based medicine (EBM) when investigating this theme.
In general we conclude that the adage “meten is weten” (the knowledge is in the numbers) 
still holds true, provided that one knows what is being measured, how the measurement 
is performed, by whom, and for what reason.
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Dit proefschrift gaat over een aantal metingen die vaak gedaan worden binnen mijn 
vakgebied, de kindergeneeskunde. Dokters worden opgevoed met het adagium “meten 
is weten”. In dit proefschrift probeer ik deze stelling aan een kritisch oordeel te onder-
werpen: Is meten wel weten?
Waarom meten dokters zo graag?
Naast het feit dat dokters opgeleid worden met “meten is weten“, is een aantal andere 
redenen te noemen: onzekerheid over bijvoorbeeld de diagnose, geruststelling van de 
patiënt (of de dokter zelf ), maar ook een onvoorwaardelijk vertrouwen in getallen , vooral 
als ze uit geavanceerde machines komen. Daarnaast worden metingen vaak uitgevoerd 
omdat we dat zo gewend zijn. We hebben dit zo geleerd, het zijn routinehandelingen.
Waarom is het verkeerd als je ten onrechte iets meet of als je teveel meet?
De meting op zichzelf kan schadelijk zijn, zeker als het een invasieve meting betreft. 
Daarnaast zijn aan elke meting kosten verbonden. Bovendien hebben we bij elke meting 
te maken met vals-positieve uitslagen. Een vals positieve uitslag betekent dat gezonde 
mensen als ziek of afwijkend worden bestempeld. Een vals positieve uitslag kan erin 
resulteren dat gezonde mensen ten onrechte een behandeling krijgen of worden bloot-
gesteld aan vervolgonderzoeken. Inmiddels is uit onderzoek duidelijk geworden dat - bij 
een lage voorafkans op ziekte “ het doen van aanvullend onderzoek niet leidt tot minder 
ongerustheid of klachten bij de patiënt, dan wanneer geen aanvullende testen worden 
verricht. In ons vak, de kindergeneeskunde, is de voorafkans op ziekte doorgaans laag: 
de meeste kinderen zijn gezond omdat de meeste ziekten in onze westerse wereld 
welvaartsziekten zijn die vooral volwassenen treffen. Daarom is het kritisch kijken naar 
“meten is weten“ vooral in de kindergeneeskunde belangrijk.
Evidence-based medicine
Op de Amalia kinderafdeling van Isala, een groot opleidingsziekenhuis in Zwolle, zijn we 
in 2005 actief begonnen met het implementeren van evidence-based medicine (EBM) 
in onze praktijk. Dit betekent dat we proberen steeds kritisch naar ons eigen handelen 
te kijken. We vragen ons regelmatig af, of we het wel goed doen en houden hier we-
kelijks besprekingen over, waarbij een klinische vraag op een gestructureerde manier 
behandeld wordt (dit noemen we een CAT, critically appraised topic, een kritisch beoor-
deeld onderwerp). Als we op een vraag in de beschikbare literatuur geen bevredigend 
antwoord kunnen vinden, stellen we vaak een onderzoeksvraag, en gaan we kijken of 
we deze onderzoeksvraag met een studie in onze eigen praktijk kunnen oplossen. De 
188  Nederlandse samenvatting voor de leek
onderwerpen die in dit proefschrift aan bod komen, zijn allemaal voortgekomen uit 
deze EBM-besprekingen en de daaruit voortvloeiende studies.
Dit proefschrift
In dit proefschrift onderzoek ik de betrouwbaarheid en het nut van vijf veelgebruikte 
metingen of procedures binnen de kindergeneeskunde:
1. De semikwantitatieve bepaling van glucose in de urine met behulp van test-strips.
2. Klinische symptomen bij het opsporen van ernstige infecties bij te vroeg geboren 
kinderen.
3. Vochtbalans bij zieke pasgeborenen.
4. De beoordeling van de mate van benauwdheid bij kinderen.
5. Het gebruik van virale tests bij bronchiolitis.
Betrouwbaarheid van test-strips voor het bepalen van de hoeveelheid glucose in de urine 
(glucosurie)
In het eerste hoofdstuk onderzoeken we de betrouwbaarheid van test-strips voor het 
bepalen van de hoeveelheid glucose in de urine (glucosurie). Deze test-strip verkleurt 
na contact met urine, waarbij de mate van verkleuring een maat is voor de hoeveelheid 
glucose in de urine. De uitslag wordt weergegeven in vijf categorieën, 0, 1+, 2+, 3+ en 
4+. We hebben drie verpleegkundigen onafhankelijk van elkaar 900 urinemonsters laten 
beoordelen. De urinemonsters werden bewaard onder verschillende omstandigheden 
(kamer vs. couveuse temperatuur, kort of lang verblijf in de luier) en de urine werd op 
verschillende manieren uit de luier verkregen (de strip werd direct op de natte luier 
gedrukt, of de urine werd met een spuitje uit een gaasje dat in de luier lag gedrukt). De 
uitslagen van de test-strips werd vergeleken met de glucosewaarde in de urine zoals die 
kwantitatief werd gemeten in het laboratorium. Uit de resultaten bleek dat de uitslag van 
de teststrip goed overeenkwam met de glucosewaarden bepaald in het laboratorium, 
behalve in categorie 1+ en 2+. Als deze 2 categorieën samen als één categorie worden 
beschouwd, is de betrouwbaarheid van de teststrip voor het bepalen van glucosurie 
goed. Deze betrouwbaarheid wordt niet beïnvloed door de specifieke omstandigheden 
op een neonatologie intensive care (temperatuur, contact met luier) of de methode van 
urine opvangen. De test-strips zijn dus geschikt om te gebruiken voor het meten van 
glucosurie bij neonaten op een neonatale intensive care afdeling.
De waarde van klinische symptomen, waaronder glucosurie, voor het vroegtijdig herkennen 
van een ernstige infectie (sepsis) bij te vroeg geboren kinderen.
In het tweede hoofdstuk hebben we de waarde van verschillende klinische symptomen, 
waaronder glucosurie, onderzocht voor het vroegtijdig herkennen van een ernstige in-
fectie (sepsis) bij te vroeg geboren kinderen (zwangerschapsduur < 32 weken). Ernstige 
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infecties zijn een belangrijke reden voor overlijden bij deze kinderen, reden waarom we 
deze infecties zo snel mogelijk willen opsporen, om tijdig met antibiotische behande-
ling te kunnen starten. Helaas is het zo dat het lastig kan zijn deze infecties vroegtijdig te 
herkennen; de symptomen van een infectie bij vroeg geborenen zijn niet erg specifiek, 
wat betekent dat de symptomen ook kunnen voorkomen zonder dat sprake is van 
een (ernstige) infectie. Dit is vooral zo bij een beginnende sepsis. Om de waarde van 
de verschillende symptomen, die zouden kunnen duiden op een infectie, te bepalen, 
hebben we bij ruim 300 vroeg geborenen dagelijks glucosurie gemeten met bovenge-
noemde test-strips. Vervolgens hebben we gekeken bij welke kinderen een verdenking 
op een ernstige infectie bestond. Bij de 142 kinderen bij wie een dergelijke verdenking 
optrad, werd gekeken welke klinische symptomen werden gezien en of daadwerkelijk 
sprake was een ernstige infectie, bijvoorbeeld wanneer een bacterie werd gevonden in 
het bloed van de baby. Uit de resultaten bleek dat meer behoefte aan ondersteuning 
van de ademhaling, een verlengde capillary refill (slechte doorbloeding van de huid), 
een grauwe huidskleur en de aanwezigheid van een centraal veneuze lijn (een infuus 
in een groot bloedvat) de belangrijkste tekenen van een ernstige infectiewaren. Gluco-
surie, temperatuurinstabiliteit, apneu (onvoldoende doorademen), tachycardie (snelle 
hartslag), dyspneu (benauwdheid), voedingsproblemen en geprikkeldheid bleken te 
aspecifiek te zijn om een infectie te kunnen aantonen, danwel te kunnen uitsluiten. De 
kenmerken die we “objectief” kunnen meten (glucosurie, lichaamstemperatuur, apneus 
op de monitor, hartslag) bleken dus van onvoldoende waarde bij het voorspellen van 
ernstige infecties bij te vroeg geboren kinderen.
Betrouwbaarheid en nut van de vochtbalans bij zieke pasgeborenen.
In hoofdstuk drie onderzochten we de betrouwbaarheid en het nut van het dagelijks 
bijhouden van de vochtbalans bij zieke pasgeborenen. Het bijhouden van de vochtba-
lans wordt bij veel patiënten gedaan om een indruk te krijgen van de vochthuishouding. 
Hiertoe wordt gedurende 24 uur alles wat de patiënt inneemt (voeding, maar ook 
infusen en medicatie) en wat de patiënt uitscheidt (urine, defecatie, braken, zweten, 
etc) bijgehouden. Als een vochtbalans goed wordt bijgehouden zou het resultaat van 
de balans (hoeveel vocht er in de patiënt gaat min de hoeveelheid vocht die de patiënt 
uitscheidt) overeen moeten komen met het verschil in lichaamsgewicht van de baby 
tijdens diezelfde periode. Bijvoorbeeld: als de vochtbalans +40 ml is verwacht je dat 
de baby 40 g is aangekomen (1 ml water weegt immers 1 g). Tot enkele jaren geleden 
was het op onze neonatologie high care afdeling gewoonte om bij elke opgenomen 
pasgeborene tijdens de eerste 5 dagen van de opname een vochtbalans bij te houden. 
Dit kost de verpleegkundigen veel tijd.
In het onderzoek in hoofdstuk drie werd bij 170 pasgeborenen die op de high-care 
afdeling voor pasgeborenen werden opgenomen, de vochtbalans vergeleken met het 
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dagelijks gewichtsverschil. De vochtbalans en het gewichtsverschil lieten een slechte 
overeenkomst zien. Bij 40% van de vochtbalansen was het verschil met de gewichtstoe-
name of afname meer dan 50 ml (overeenkomend met 20% van de dagelijkse vochtin-
name), een verschil dat we voor het onderzoek als klinisch relevant hadden gedefini-
eerd. In een vervolgstudie werden deze 170 patiënten gerandomiseerd toegewezen aan 
twee verschillende groepen: in de ene groep had de arts inzage in de vochtbalans in 
de andere groep had de arts geen inzage in de vochtbalans. Uit dit gerandomiseerde, 
geblindeerde onderzoek, bleek geen verschil tussen de twee groepen: de opnameduur, 
gewichtsverlies verschilden niet, evenmin was er een verschil in behandeling gericht 
op de vochthuishouding (bijvoorbeeld gebruik van diuretica). We concluderen dus, dat 
de vochtbalans niet nauwkeurig gemeten kan worden bij matig zieke pasgeborenen 
en ook geen invloed had op klinisch relevante uitkomsten voor deze groep kinderen. 
Daarom is het bijhouden van een vochtbalans niet nuttig bij deze patiënten. Op onze 
neonatologie high care afdeling zijn we op grond van de resultaten dan ook gestopt 
met het routinematig bijhouden van de vochtbalans bij opgenomen pasgeborenen. Dit 
scheelt de kinderverpleegkundigen erg veel (nutteloos) werk.
Klinische beoordeling van benauwde kinderen
Hoofdstuk 4 gaat over de klinische beoordeling van acuut benauwde kinderen. 
Benauwdheid is een veel voorkomend probleem op de kinderleeftijd. Longfunctie-
onderzoek is bij (jonge) kinderen niet mogelijk, zeker niet in acute situaties. Artsen 
en verpleegkundigen gebruiken om deze reden vaak benauwdheidsscores waarbij 
verschillende klinische symptomen bij elkaar worden opgeteld. Met behulp van een sys-
tematisch literatuuronderzoek zijn we nagegaan of de bestaande benauwdheidsscore 
wel voldoende onderzocht waren op betrouwbaarheid (validiteit) en bruikbaarheid. We 
vonden 36 verschillende benauwdheidsscores, en geen van deze scores was voldoende 
gevalideerd! Vervolgens hebben we -aan de hand van video-opnames van 27 benauwde 
kinderen in ons ziekenhuis- naar de variatie in de beoordeling gekeken tussen negen 
verschillende kinderartsen en kinderverpleegkundigen bij de beoordeling van de mate 
van benauwdheid. Het bleek dat de variatie binnen dezelfde beoordelaar acceptabel 
was, maar dat de variatie tussen de verschillende beoordelaars erg groot was. Deze vari-
atie tussen kinderartsen en –verpleegkundigen was zodanig groot dat bij tweederde 
van de situaties geen onderscheid kon worden gemaakt tussen de meetfout als gevolg 
van deze variatie en een eventueel effect van behandeling. Omdat de mate van be-
nauwdheid van kinderen tijdens een ziekenhuisopname altijd door verschillende artsen 
en verpleegkundigen wordt beoordeeld is deze grote variatie tussen beoordelaars een 
groot probleem. Eigenlijk kunnen we de mate van benauwdheid van deze kinderen, en 
de veranderingen die daarin van dag tot dag optreden, onder andere door onze be-
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handeling, dus niet goed beoordelen. Vervolgonderzoek zal moeten uitwijzen of betere 
training van artsen en verpleegkundigen dit probleem kan oplossen.
Virale tests bij kinderen met een bronchiolitis
In het laatste hoofdstuk onderzochten we het nut van virale tests bij kinderen die in het 
ziekenhuis worden opgenomen met een bronchiolitis (een virale infectie van de lagere 
luchtwegen die vooral bij jonge kinderen voor benauwdheid en slecht drinken zorgt en 
waar sommige kinderen extra zuurstof voor moeten krijgen of zelfs op een intensive care 
moeten worden opgenomen). In het winterseiszoen worden grote aantallen kinderen 
met een bronchiolitis opgenomen, meestal veroorzaakt door het RS-virus. Vanwege de 
besmettelijkheid is het gebruikelijk om kinderen met een RS-infectie apart te verplegen 
van kinderen zonder RS-virus, om te voorkomen dat kinderen met een bronchiolitis 
een dubbel-infectie oplopen (co-infectie). Om deze reden wordt bij opname vaak een 
RS-(snel) test afgenomen. Deze gewoonte berust op de aanname dat kinderen met een 
co-infectie een ernstiger ziektebeloop hebben dan kinderen met maar één virus. In een 
observationele studie hebben we onderzocht of het veilig kan zijn om kinderen met een 
bronchiolitis samen op één kamer te verplegen. In het winterseizoen 2011-2012 deelden 
de kinderen met een bronchiolitis gedurende de eerste dag van opname één kamer. 
Van de 48 kinderen met een bronchiolitis kregen twee kinderen (4%) een co-infectie 
tijdens opname. Beide kinderen hadden tijdens de hele opname alleen op een kamer 
gelegen, en konden de co-infectie dus niet hebben gekregen van een ander kind op 
dezelfde kamer. Bij geen van de 37 kinderen die een kamer deelden trad een co-infectie 
op. In het winterseizoen 2012-2013 deelden de patiënten met bronchiolitis gedurende 
de gehele opname een kamer met andere bronchiolitis patiënten. Van de 65 kinderen 
die in deze studie werden geïncludeerd, trad bij acht (12%) een co-infectie op. Bij slechts 
een van deze acht kinderen was de co-infectie te herleiden tot een kamergenoot. De 
kinderen met een co-infectie waren niet zieker dan de kinderen met een mono-infectie. 
We concluderen dat het zeer waarschijnlijk veilig is om kinderen met bronchiolitis op 
één kamer te verpleging, onafhankelijk van de virale verwekker. Het verrichten van 
virale test met als doel kinderen met RS-infecties te onderscheiden van kinderen zonder 
RS-infecties is derhalve niet nodig. Op onze kinderafdeling doen we deze tests dan ook 
niet meer routinematig (maar alleen nog in het kader van vervolgonderzoek). Het niet 
meer doen van deze tests levert de kinderafdeling een aanzienlijke kostenbesparing op.
Meten is weten, maar met onzekerheid!
Samenvattend klopt het adagium “meten is weten“ in de kindergeneeskunde dus 
meestal niet. Eigenlijk klopt het alleen onder de voorwaarde dat je weet wat, hoe, wie 
en waarom je meet! Daarnaast blijkt uit dit proefschrift dat het nuttig kan zijn om veel 
gebruikte, routinematige metingen onder de loep te nemen. We willen benadrukken 
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dat onze evidence-based practice een belangrijke rol heeft gespeeld bij het creëren van 
een een zelf-kritische en nieuwsgierige houding en een belangrijke rol heeft gespeeld 
bij het tot stand komen van dit proefschrift. Daarmee willen we het belang onderstre-
pen van zo’n evidence based practice. Het werken als kinderarts wordt er interessanter 




List of Co-authors 195
c
list of co-authors
Yvette (Y) van Asperen, MD.
Beatrix Children’s Hospital, University Medical Center Groningen, Groningen
Joline (JF) Bakker, MsC
Isala, Zwolle
Ine Marije (IM) Bartels, MD
Department of General medicine, University Medical Center Groningen, Groningen
Paul (PLP) Brand, Prof, MD
Amalia Children’s Center, Isala, Zwolle
Lesla (ES) Bruijnesteijn
Laboratory for Clinical Microbiology, Isala, Zwolle
Wieke (H) Eggink, MD
Department of Neurology, University Medical Center Groningen, Groningen
Liesbeth (JM) Groot-Jebbink
Amalia Children’s Center, Isala, Zwolle
Boudewijn (BJ) Kollen, PhD
Department of General Practice, University Medical Center Groningen, Groningen
Joke (JH) Kok, Prof, MD
Department of Neonatology, Amsterdam Medical Center, Amsterdam
Veerle (VJ) Langenhorst, MD
Amalia Children’s Center, Isala, Zwolle
Sjef (JJCM) van de Leur,
Department of Clinical Chemistry, Isala, Zwolle
Roelien (R) Reimink, MANP
Amalia Children’s Center, Isala, Zwolle
196  List of Co-authors
Hans (JB) Reitsma, MD, PhD
Julius Center for Health Sciences and Primary Care, University Medical Center, Utrecht
Gijs (GJHM) Ruijs, MD, PhD
Laboratory for Clinical Microbiology, Isala, Zwolle
Irma (HLM) van Straaten, MD, PhD
Amalia Children’s Center, Isala, Zwolle
Mirjam (MM) Wessels, MANP
Amalia Children’s Center, Isala, Zwolle
List of publications





 1. Bekhof J, Kollen BJ, Leur van der SJCM, Kok JH, Straaten HLM. Reliability of reagent strips for 
measurement of glucosuria in a neonatal intensive care setting. Accepted for publication in 
Pediatr Neonatol.
 2. Bekhof J, Reimink R, Brand PLP. Systematic review: insufficient validation of clinical scores for the 
assessment of acute dyspnoea in wheezing children. Paediatr Respir Rev. 2014;15:98-112
 3. Bekhof J, Bakker J, Reimink R, Wessels M, Langenhorst V, Brand PL, Ruijs JHM. Co-infection in 
children hospitalized for bronchiolitis: role of roomsharing. J Clin Res Med. 2013;5:426-31.
 4. van Ijsselmuiden MN, Bekhof J, Peek AM. A neonate with the ‘blueberry muffin syndrome’. Ned 
Tijdschr Geneeskd. 2013;157:A6460.
 5. Bekhof J, van Asperen Y, Brand PL. Usefulness of the fluid balance: a randomised controlled trial 
in neonates. J Paediatr Child Health. 2013;49:486-92.
 6. Bekhof J, Reitsma JB, Kok JH, Van Straaten IH. Clinical signs to identify late-onset sepsis in preterm 
infants. Eur J Pediatr. 2013;172:501-8.
 7. van Asperen Y, Brand PL, Bekhof J. Reliability of the fluid balance in neonates. Acta Paediatr. 2012 
May;101:479-83.
 8. Bekhof J, Kollen BJ, Groot-Jebbink LJ, Deiman C, van de Leur SJ, van Straaten HL. Validity and 
interobserver agreement of reagent strips for measurement of glucosuria. Scand J Clin Lab Invest. 
2011 May;71:248-52.
 9. Leen WG, Klepper J, Verbeek MM, Leferink M, Hofste T, van Engelen BG, Wevers RA, Arthur 
T, Bahi-Buisson N, Ballhausen D, Bekhof J, van Bogaert P, Carrilho I, Chabrol B, Champion MP, 
Coldwell J, Clayton P, Donner E, Evangeliou A, Ebinger F, Farrell K, Forsyth RJ, de Goede CG, Gross 
S, Grunewald S, Holthausen H, Jayawant S, Lachlan K, Laugel V, Leppig K, Lim MJ, Mancini G, 
Marina AD, Martorell L, McMenamin J, Meuwissen ME, Mundy H, Nilsson NO, Panzer A, Poll-The 
BT, Rauscher C, Rouselle CM, Sandvig I, Scheffner T, Sheridan E, Simpson N, Sykora P, Tomlinson 
R, Trounce J, Webb D, Weschke B, Scheffer H, Willemsen MA. Glucose transporter-1 deficiency 
syndrome: the expanding clinical and genetic spectrum of a treatable disorder. Brain. 2010 
Mar;133(Pt 3):655-70.
 10. Emmen E van, Roord STA, Brouwer AFJ, Kuiters GRR, Bekhof J. Puistjes en blaasjes bij pasge-
borenen. Ned Tijdschr Geneeskd 2007;151:277-83.
 11. Baatenburg de Jong R, Bekhof J, Langenhorst V, P Zwart, Roorda RJ. Ontwikkelingsachterstand 
bij borstgevoede kinderen door ontoereikend dieet van de moeder. Ned Tijdschr Geneeskd. 
2006;150:465-9.
 12. Crone MR, van Spronsen FJ, Oudshoorn K, Bekhof J, van Rijn G, Verkerk PH. Behavioural factors 
related to metabolic control in patients with phenylketonuria. J Inherit Metab Dis 2005:28:627-37
 13. Bekhof J, Norbruis OF, Scheenstra R, Weerd de W. Actief beleid bij een kind dat een knoopbatterij 
heeft ingeslikt. Ned Tijdschr Geneeskd. 2005;149:163-7.
 14. Baatenburg de Jong R, Bekhof J, Roorda RJ, Zwart P. Severe nutritional vitamin deficiency in a 
breast infant of a vegan mother. Eur J Pediatr. 2005;164:259-60.
 15. Bekhof J, De Langen R, Verkade HJ. Icterus prolongatus reden voor laboratoriumdiagnostiek, ook 
bij borstgevoede zuigelingen. Ned Tijdschr Geneeskd. 2005;149:613-7
 16. Bekhof J, van Rijn M, Sauer PJJ, Ten Vergert EM, Reijngoud DJ, van Spronsen FJ. Plasma phenylala-
nine in patients with phenylketonuria self managing their diet. Arch Dis Child. 2005;90:163-4
200  List of publications
 17. Bekhof J, Norbruis O, Scheenstra R, Dikkers F, De Langen R, de Weerd W. Babies and batteries. 
Lancet. 2004 Aug 21;364:708.
 18. van Rijn M, Bekhof J, Dijkstra T, Smit PG, Moddermam P, van Spronsen FJ. A different approach to 
breast-feeding of the infant with phenylketonuria. Eur J Pediatr. 2003 May;162:323-6.
 19. Bekhof J, van Spronsen FJ, Crone MR, van Rijn M, Oudshoorn CG, Verkerk PH. Influence of knowl-
edge of the disease on metabolic control in phenylketonuria. Eur J Pediatr. 2003 Jun;162:440-2.
 20. Spaapen LJ, Bakker JA, Velter C, Loots W, Rubio-Gozalbo ME, Forget PP, Dorland L, De Koning TJ, 
Poll-The BT, Ploos van Amstel HK, Bekhof J, Blau N, Duran M, Rubio-Gonzalbo ME. Tetrahydrobi-
opterin-responsive phenylalanine hydroxylase deficiency in Dutch neonates. J Inherit Metab Dis. 
2001 Jun;24:352-8.
 21. van Spronsen FJ, van Rijn M, Bekhof J, Koch R, Smit PG. Phenylketonuria: tyrosine supplementa-
tion in phenylalanine-restricted diets. Am J Clin Nutr. 2001 Feb;73:153-7.
 22. de Koning TJ, Nikkels PG, Dorland L, Bekhof J, De Schrijver JE, van Hattum J, van Diggelen OP, 
Duran M, Berger R, Poll-The BT. Congenital hepatic fibrosis in 3 siblings with phosphomannose 
isomerase deficiency. Virchows Arch. 2000 Jul;437:101-5.
other
 1. Reimink R, Nijboer CM, Langenhorst VL, Norbruis OF, Bekhof J. Acute gastro-enteritis bij kinderen: 
Implementatie van een richtlijn gebaseerd op snelle enterale rehydratie met ORS. Tijdschr Kin-
dergeneeskd. 2013;5(81):119-125.
 2. Draaisma E, Bekhof J. Partiële wisseltransfusie bij de polycythemische pasgeborene: effectiviteit 
en veiligheid. Praktische pediatrie, Nascholingstijdschrift over kindergeneeskunde. 2013;3:168-
172.
 3. Tiemersma S, Bekhof J. Bij welk gewicht kunnen prematuren in de wieg. Praktische Pediatrie, 
Nascholingstijdschrift over kindergeneeskunde. 2011;3:194-197.
 4. Bekhof J, Brand PLP, Boluyt N. Bij welke saturatiegrens is opname geïndiceerd bij kinderen met 
een (RSV-)bronchiolitis? Praktische Pediatrie, Nascholingstijdschrift over kindergeneeskunde. 
2010;3:200-3.
 5. Schakel W, Bekhof J. Prematuren geboren na 36 weken zwangerschapsduur: 48 uur observatie op 
de kraamafdeling is voldoende. Tijdschr Kindergeneesk. 2010;78:3-6
 6. Bekhof J. Evidence-based medicine in de kliniek: van theorie naar praktijk. Nederlands Tijdschrift 
voor Obstetrie & Gynaecologie. Maart 2010;123:50-52.
 7. Bekhof J, Boluyt N, Boere-Bonekamp M. Het effect van helmredressietherapie bij positionele 
plagiocephalie. Tijdschrift voor Jeugdgezondheidszorg. Dec 2009 41(6):115-118
 8. Bekhof J, Boluyt N, Boere-Bonekamp M. Het effect van helmredressietherapie bij positionele 
plagiocephalie. Praktische Pediatrie, Nascholingstijdschrift over kindergeneeskunde. 2009;2:140-
143.
 9. Bekhof J. Pasgeborenen met meconiumhoudend vruchtwater: Hoe lang is observatie nodig? 
Praktische pediatrie, Nascholingstijdschrift voor kindergeneeskunde. 2008;1:79.
 10. van Rijn M, Bekhof J, Dijkstra T, Smit GPA, Modderman P, van Spronsen FJ. Borstvoeding: ook voor 






Onderzoek doen, doe je niet alleen. Daarnaast kun je als medisch specialist met een full-
time baan alleen een promotie onderzoek afronden, wanneer de mensen in je omgev-
ing je daarvoor de ruimte geven. Aangezien dit promotie-onderzoek een behoorlijke 
tijdspanne in beslag heeft genomen, ben ik aan veel verschillende mensen mijn dank 
verschuldigd. Ik hoop van harte dat ik niet iemand vergeten ben in dit dankwoord.
Het allerbelangrijkste voor mij is het “thuisfront”: Marco, Noor en Sara, maar zoals dat 
een beetje gebruikelijk is in dankwoorden van proefschriften, noem ik jullie pas als 
laatste (maar op deze manier komen jullie – terecht - 2 keer aan bod!).
Mijn onderzoek heb ik volledig gedaan op de kinderafdeling van Isala; de vragen zijn 
voortgekomen vanuit de Zwolse werkvloer en het onderzoek hebben we uitgevoerd 
met Zwolse patiënten. Mijn collega’s, de vakgroep kindergeneeskunde ben ik dan ook 
veel dank verschuldigd. Toen ik, als arts-assistent in opleiding, in Zwolle kwam werken, 
dacht ik al vrij snel: ‘ik hoop dat ik hier later als kinderarts kan werken“. Naast het feit 
dat het inhoudelijke werk in Isala voor een kinderarts zeer de moeite waard is , door 
het ruime aanbod aan patiënten in combinatie met de ruime expertise, is de sfeer bin-
nen de vakgroep een enorme motivator. Door de kritische houding die als het ware 
“inborn“in“de“Zwolse-kinderarts“ is, of anders op zijn minst ernstig besmettelijk is, 
werd ik van meet af aan erg aangetrokken. Door deze houding werd ik al tijdens mijn 
opleidingsperiode in Isala gestimuleerd om onderzoek te doen. Loes, Danielle, Dorien, 
Gert, Pieter, Obbe, Angelien, Eelco, Eric, Paul, Veerle, Hans en sinds kort Francis en Sarah, 
mijn collega-kinderartsen, en ook de collega-neonatologen, bedankt voor jullie niet 
aflatende steun.
Paul, je bent een groot voorbeeld voor mij en ik waardeer het enorm dat je mijn eerste 
promotor wilt zijn. Je bent een vriendelijke, hardwerkende en prettige collega en barst 
van de energie en ambitie, die op onze gehele vakgroep afstraalt. Jouw manier van on-
derzoek doen, naar “gewone” praktische zaken binnen de geneeskunde heb ik altijd erg 
inspirerend gevonden. Je bent iemand met een tomeloze soms jaloersmakende energie. 
Je reageert zo snel op mails dat ik me al zorgen begon te maken als ik na een uur of 12 
niets van je hoorde…. Ik ben erg blij dat je jouw ambities niet naar een academisch 
ziekenhuis hebt verplaatst en ben er trots op met jou te mogen werken en hoop dat we 
samen nog vele “heilige huisje” omver kunnen werpen.
Irma, heel fijn dat je mijn co-promotor wilt zijn. We zijn per slot van rekening samen aan 
de glucosurie studie begonnen. Ik heb jou altijd als een van de kritische neonatologen 
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gezien, en heb veel van je geleerd tijdens mijn periode op de NICU, niet alleen medisch-
inhoudelijk maar ook van de manier waarop je ouders te woord staat tijdens de vaak 
zeer aangrijpende momenten met hun zieke kind. Dank daarvoor.
Joke Kok, dank dat je me hebt willen helpen met dit promotie-onderzoek. Ondanks dat 
we weinig met elkaar hebben kunnen werken, ben ik je erkentelijk voor je positieve 
inzet en warme begeleiding.
Hans Reitsma, arts-epidemioloog, bedankt voor je hulp bij het onderzoek naar klinische 
voorspellers van sepsis bij prematuren. Je hebt me goed ingewijd in de methodologie 
van regressie analyses en hebt ons het idee voor het nomogram aangereikt, waarvoor 
dank.
Ook Boudewijn Kollen, epidemioloog, inmiddels werkzaam in het UMCG, wil ik bedan-
ken voor je hulp bij de statistiek.
Uiteraard wil ook de leden leescommissie, Prof. Dr. M. Offringa, Prof. Dr. E.E.S. Nieuwen-
huis en Prof. Dr. E.A. Verhagen, hartelijk bedanken voor de genomen moeite om mijn 
proefschrift te beoordelen.
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